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Abstract
Members of the Gammaherpesvirinae are characterised by their ability to establish
latency within lymphoid cells. Gammaherpesviruses include the human pathogens
Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus. Symptomatic
disease and long-term persistence has been widely studied both in vivo and in vitro.
However, as primary infection is largely asymptomatic, it has not been possible to
determine virus-host interactions prior to the onset of symptoms. This has been
further complicated by the narrow host range of the gammaherpesvirinae. Murine
gammaherpesvirus-68 (MHV-68) is able to replicate in a number of cell lines in vitro
and readily infects laboratory mice. It is therefore an important and flexible small
animal model which provides a unique system for studying host-virus interactions at
early time points post-infection.
The aim of this project was to determine the role of the innate immune system in the
control of gammaherpesvirus infections. It has previously been shown that type 1
interferons (IFN) are critical for host survival. RT-PCR analysis confirmed that
MHV-68 infection leads to induction of type I IFN at early time points post¬
infection. In addition, in vitro studies indicated that type 1 IFNs play a role in the
inhibition of the exit of viral particles from the cell. A strong trend towards higher
titres of cell-free virus from cells lacking type I IFN receptor compared to titres of
cell-free virus from wt cells was observed. IFNp knockout mice were utilised to
show that IFNP is important at early time points but does not play a role in long term
control of infection. MHV-76 is a deletion mutant of MHV-68, lacking four genes
(M1-M4) and eight vtRNAs unique to MHV-68 and present at the left hand end of
the genome. This study found no difference in the type I IFN response following
infection with either MHV-68 or MHV-76. These results suggest that M1-M4 and
the 8 vtRNAs do not play an extensive role in the regulation of the type 1 IFN
response. IFN stimulated genes (ISGs) are important for establishing an anti-viral
response. Mice lacking ISG12a were utilised to show that ISG12a plays a role in the
early stages of the establishment of latency following MHV-68 infection. In vivo
studies showed that virus titres and the degree of splenomegaly were increased in the
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spleens of lSG12a knockout mice resulting in an elevated latent infection compared
to wt spleens. However, the mechanism by which ISG12a affects latency is not clear.
No difference in viral titres was observed in the lungs or mediastinal lymph nodes
between ISG12a knockout and wt mice. The role ofNK cells was investigated by in
vivo depletion ofNK cells and by monitoring NK activation following infection. The
NK cell population is expanded and activated at day 2 compared to day 4 post¬
infection and is capable of cytotoxic killing following infection with MHV-68.
However, a lack ofNK cells in vivo did not result in significantly elevated virus titres
suggesting that NK cells are not essential for the control of MHV-68 infection. No
difference was observed between MHV-68 or MHV-76 infection in the presence or
absence ofNK cells, nor in the expansion or activation ofNK cells post-infection. It
was therefore concluded that the genes M1-M4 and the 8 vtRNAs do not play a role
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1.1. The innate antiviral immune response
The innate immune system provides a first line of defence against disease, providing
a primary non-specific response to an invading pathogen. The innate immune
recognition of a virus leads to a variety of antiviral immune responses. Host cell
receptors recognise pathogen-associated molecular patterns (PAMP) present on
virus-associated molecules such as viral DNA or dsRNA. For example, Toll-like
receptor (TLR) 3 recognises dsRNA, a common replication intermediate of RNA
viruses (Alexopoulou et al.t 2001). Following recognition of viral components, the
type I interferon (IFN) response is initiated and results in the induction of hundreds
of genes involved in antiviral responses, immunomodulation, and the cell-cycle.
Natural killer (NK) cells are also important for defence against viral infection. NK
cells can kill virally infected cells through non-specific signals such as poor
expression ofMHC class I molecules. Other innate immune components involved in
antiviral responses include phagocytes, complement, various chemokines and
cytokines. Dendritic cells (DCs) are also involved in the innate immune system as
they express TLRs and have reciprocal activation functions with NK cells (Gerosa et
al„ 2005).
1.2. Type I IFNs
The type I IFNs were discovered by Isaacs and Lindenmann (Isaacs and Lindenmann
1957) as cytokines that interfered with virus replication. They are the first cytokines
produced in infected cells in response to viruses and can act in an autocrine and
paracrine manner; antiviral responses are induced in infected cells and the
neighbouring uninfected cells. Type I IFNs are highly pleiotropic as signalling
through their receptor leads to the expression of hundreds of genes. As well as direct
antiviral actions, they can modulate downstream immune components, for example
activation ofNK cells (Biron etal., 1999), and can control apoptosis of infected cells
-2 -
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(Tanaka et al., 1998). This family of cytokines can be divided into various subtypes
























IFNk Human and mouse Keratinocytes IFNAR
IFN co Human Leukocytes IFNAR




IFN£ Limitin Mouse High IFNAR
Table 1.1. Summary of type 1 IFN subtypes. * Activity levels for murine subtypes
taken from (Van Pesch et al., 2004).
The type I IFNs are an intronless family of genes clustered on chromosome 4 in mice
and chromosome 9 in humans. The roles of IFNa and P have been widely studied
and are the main focus of interest. Multiple IFNa genes have been found in the
human and murine genomes. 14 genes encoding 13 functional IFNa subtypes
(IFNal and IFNal3 encode the same protein) are found in the human genome and
14 genes (plus 3 pseudogenes) encoding functional IFNa subtypes are found in the
murine genome (Van Pesch et al., 2004). IFNa can be secreted by most cell types
although production is mainly associated with plasmacytoid dendritic cells (pDCs)
that can produce up to 1000 times more IFNa following virus infection than other
cell types (Asselin-Paturel et al., 2001; Siegal et al., 1999). Studies of murine IFNas
showed that they differ in their antiviral and antiproliferative activities. For example,
-3 -
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IFNa4 and IFNal2 demonstrated higher activity than IFNal (Van Pesch et al.,
2004). It has been suggested that these differences may be related to differences in
receptor binding affinity (Meister et al., 1986). IFNP is only encoded by a single
gene locus and is traditionally known as fibroblast IFN although it can be expressed
by most cell types. The type 1 IFNs share the same receptor known as the IFNa
receptor (IFNAR). The receptor is ubiquitously expressed and consists of IFNAR1
and IFNAR2 subunits. IFN binding results in signalling cascades leading to the
expression of the downstream interferon stimulated genes (ISGs). IFNy is a type II
IFN. It is produced indirectly during virus infection from NK cells, CD8T T cells and
CD4 Thl T cells in response to antigens presented on MHC class I and II molecules
(Goodbourn et al., 2000). IFNy signals through the IFNy receptor but functional
overlap exists between the type I and II IFNs as many components of the IFNy-
induced antiviral response are also induced by the type I IFNs. A further group of
IFNs related to type I IFN family has been discovered, the IFNA. family (also termed
interleukin (IL)-28A, IL-28B and IL-29) (Sheppard et al., 2003). Members are
homologous to type I IFN, are induced in response to viral infection and induce an
anti-viral state. However, they are a distinct group (termed type III IFNs) as they
utilise a heterodimeric receptor consisting of the IL-10R2 and IFNA.R1, are clustered
on chromosome 19 and contain several introns (Kotenko et al., 2003; Meager et al.,
2005). Why are there multiple type I IFN subtypes? It is possible that the different
subtypes induce different gene sets. For example, hypoxia-inducible factor 1 gene is
induced by IFNp but not IFNa (Der et al., 1998). Alternatively, multiple IFN
subtypes may be important at different times throughout an infection. IFNP and
IFNa4 are produced initially, followed by other IFNa subtypes for further control if
virus is still present within the cell. Different viruses may influence the type I IFN
subtypes induced. Interferon regulatory factor (IRF) 5 induced different IFNa
subtypes to those induced by IRF7 and was specific to Newcastle disease virus
infection (NDV) (Barnes et al., 2001). However, this remains controversial as other




The early expressed type I IFNs, IFNa4 and IFNp, can signal through the IFNAR
receptor on the infected cell as well as uninfected neighbouring cells. The binding of
IFN to the receptor results in the activation of a Jak/STAT signalling pathway. The
cytoplasmic domains of the two receptor subunits, IFNAR l and IFNAR2, are
associated with 'Janus' tyrosine kinases. IFNAR 1 is associated with Tyk2
(Colamonici et al., 1994) and IFNAR2 is associated with Jakl (Novick et al., 1994).
IFN receptor binding leads to conformational changes allowing dimerisation of the
two subunits and thus autophosphorylation and activation of Tyk2 and Jakl (Novick
et al., 1994). Phosphorylation of a tyrosine residue on the IFNAR 1 subunit by Tyk2
creates a binding site for the 'signal transducer and activator of transcription'
(STAT) 2. Tyk2 is then responsible for the phosphorylation of STAT2.
Phosphorylated STAT2 recruits STAT1 to form STAT1/STAT2 heterodimers that
dissociate from the IFNAR and are translocated to the nucleus. The heterodimers
then associate with the DNA binding protein IRF9. A heterotrimeric complex is
formed which is known as the interferon stimulated gene factor 3 (ISGF3, reviewed
in (Goodbourn et al., 2000). ISGF3 can bind to the interferon stimulated response
element (ISRE) contained in the promoters of ISGs via the DNA binding domain of
the IRF9 component (Veals et al., 1992). The pathway is summarised in figure 1.1.
The importance of IFNAR signalling is demonstrated in mice that lack the IFNAR
receptor. A lack of functional type I IFN signalling makes mice more susceptible to
viral infections and often results in subclinical infections becoming lethal (Dutia et
al., 1999; Van Den Broek et al., 1995).
1.2.2. Interferon Regulatory factors
Interferon regulatory factors (IRFs) are characterised by the presence of a DNA-
binding domain in the N-terminus which mediates binding to the ISRE. IRFs (except
IRF6) also contain an IRF-association domain which enables dimerisation between
family members (Lohoff and Mak 2005). IRF3, 5, 7 and 9 are involved in the
induction of type I IFNs. IRF5 is upregulated in macrophages and DCs following
-5-
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Figure 1.1. Type I IFN Jak/STAT signalling. IFN binding to the IFNAR results in the activation
of a Jak/STAT signalling pathway. Binding of the ISGF3 complex to the ISRE of target genes
and brings about activation of ISGs such as PKR, OAS and the Mx proteins. Figure adapted
from Goodbourn et al., 2000.
-6-
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TLR signalling but it is unclear whether it can be induced by viral infection (Barnes
et al., 2001; Cheng et al., 2006; Takaoka et al., 2005). IRF9 is a component of the
ISGF3 complex, stimulating expression of ISGs through the ISRE and resulting in
induction of 1RF7. 1RF3 is constitutively expressed and is located in the cytoplasm. It
is phosphorylated upon viral infection and then translocates to the nucleus where it
can form homodimers or heterodimers with IRF7 that associate with CREB-binding
protein (CBP) or p300 as part of the enhanceosome (see figure 1.3). IRF7 is
constitutively expressed in small amounts but is strongly induced in response to type
I IFN signalling. It also undergoes nuclear translocation following phosphorylation in
response to viral infection. IRF3 efficiently activates the IFNp gene whereas IRF7
strongly activates IFNP and IFNa genes (Honda and Taniguchi 2006).
IFN induction is thought to occur through a positive feedback loop. Following viral
infection, IRF3 becomes phosphorylated and thus activated by the kinases, TANK-
binding kinase 1 (TBK1) and IkB kinase s (IKKs) (Fitzgerald et al., 2003).
Activated IRF3 can then induce expression of the IFNa4 subtype and IFNp.
Expression of other IFNa subtypes rely on the expression of IRF7, upregulated in
response to the early IFN subtypes produced. IRF7, again activated through
phosphorylation by TBK1 and IKKs, binds to the promoters of the 'delayed' IFNas
such as IFNa2, 6 and 8 and induces their expression (Marie et al., 1998). Recently
this model of IFN induction has been shown to be over-simplified. A study by
Prakash et al. (2005) showed that type I IFN induction after infection with influenza
virus was reliant on IRF7 production, and thus positive feedback, in most tissues
including the respiratory tract. However, pDCs were found to constitutively express
high levels of IRF7 and could rapidly produce high levels ofmultiple IFNa subtypes
in response to infection without positive feedback (Prakash et al., 2005). Therefore,
there appears to be cell type-specific differences in the induction of IRF7 and
therefore the expression of the type I IFNs. Differential induction of the type I IFNs




1.2.3. Signalling through Toll-like receptors
Toll-like receptors (TLRs) are transmembrane receptors which are encoded by 10
genes in humans and 12 genes in mice. They function as pattern-recognition
receptors that sense a variety of PAMPs on pathogens. Most cells express at least
some of the TLRs although phagocytic cells such as DCs and macrophages appear to
express the greatest levels of TLRs (Zarember and Godowski 2002). All TLRs
encode a Toll/IL-1 receptor (TIR) domain which recruits TIR-containing adaptor
proteins for downstream signalling (Honda and Taniguchi 2006). TLR3, 7, 8 and 9
are important for sensing viral products. TLR3 recognises dsRNA, TLR7 and 8
recognise ssRNA and TLR9 recognises unmethylated cytidine-phosphate-guanosine
(CpG) DNA motifs which are present in viral DNA. Therefore, TLR9 becomes
activated in response to infection with DNA viruses such as herpesviruses. Mice
lacking functional TLR9 are more susceptible to MCMV infection and have impaired
type I IFN production and NK cell activation (Tabeta et a/., 2004). TLR9 is located
in the endosome and senses viral nucleic acid released following cell entry.
In particular, pDCs express TLR7 and TLR9 which signal through the adaptor
protein, myeloid differentiation primary response protein 88 (MyD88). All TLRs
except TLR3 signal through the MyD88-dependent pathway. Induction of type 1 IFN
occurs through the association of MyD88 to IL-1R associated kinases (IRAK) 1,
IRAK4 and TNF receptor-associated factor 6 (TRAF6). TRAF6 activates TGFP
activating kinase 1 (TAK1) which phosphorylates the kinases IKKa and IKKp
leading to phosphorylation and degradation of IkB and then translocation ofNFkB to
the nucleus. TAK1 additionally activates ATF-2/c-Jun via activation of mitogen-
activated protein (MAP) kinases. MyD88 also associates with IRAKI and IRF7.
These pathways stimulate the expression of type I IFNs as well as the expression of
other cytokines such as IL-12 and IL-6. Along with TRAF6-mediated ubiquitination,
IRAKI phosphorylates IRF7 allowing its activation and translocation to the nucleus
leading to type I IFN production (Kawai and Akira 2006). The signalling pathways
following activation of TLR9 are shown in figure 1.2. It is thought that the high basal
-8-
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Figure 1.2. Recognition of viral DNA by TLR9. Recognition of viral DNA leads to recruitment
of the adaptor protein MyD88. MyD88 interacts with IRAK 4 and TRAF6 which leads to
activation of TAK1 by an ubiquitination (U)-dependent mechanism. TAK1 activates NFkB
and ATF-2/c-jun via IKK-mediated IkB degradation and MAP kinase (MAPK) activation
respectively. MyD88 can also associate with IRAKI and IRF7. IRF7 is phosphorylated (P) by
IRAKI and translocates to the nucleus. Activation of IRF7 also requires TRAF6-mediated
ubiquitination (U). Type I IFN is induced as a consequence of TLR9 signalling. Adapted from
Kawai and Akira (2006).
-9-
Chapter 1 Introduction
levels of IRF-7, IRAK4 and TRAF6 present in pDCs allows for the rapid and
significant expression of IFN upon detection of viral DNA (Izaguirre et al., 2003;
Uematsu et al., 2005).
1.2.4. TLR-independent signalling
Retinoic acid inducible gene I (RIG-I) and melanoma differentiation associated gene
5 (mda5) are dsRNA receptors in the cytoplasm and are therefore important detectors
of certain virus infections e.g. NDV and vesicular stomatitis virus (VSV). They have
a RNA-binding helicase domain and 2 caspase recruitment domains (CARDs)
(Yoneyama et al., 2004). RIG-l recruits IFNP promoter stimulator protein (IPS) -1
leading to downstream signalling. The IRF kinases, TBK1 and IKKs become
activated and in turn activate 1RF3 and IRF7 which can then bind the promoter
region of IFNP (Kawai and Akira 2006). IPS-1 knockout mice can still produce type
I IFN in response to synthetic DNA or vaccinia virus (Kumar et al., 2006).
Furthermore, herpes simplex virus (HSV)-l can stimulate type I IFN production
from non-pDC cells in a TLR9 independent manner (Hochrein et al., 2004). Upon
cell entry HSV-1 can induce an efficient antiviral response in an IRF3-dependent
manner which is independent of either the TLR or RIG-I pathways (Paladino et al.,
2006). However, a cytosolic receptor for dsDNA has not yet been identified.
1.2.5. IFNP enhanceosome
Expression of IFNP does not rely on de novo protein synthesis but requires multiple
interactions between transcription factors that result in highly specific gene
expression following viral infection. The IFNP enhanceosome is located between
110 and 45bp upstream of the transcriptional start site (Merika and Thanos 2001). It
consists of specific positive regulatory domains (PRD) IV, III-I and II that are
recognised by the ATF-2/c-Jun heterodimer, IRF3 and 7, and the NF-kB p50 and p65
heterodimer respectively (figure 1.3) (Falvo et al., 2000; Wathelet et al., 1998). Two
copies of the architectural proteins, the high mobility group I (Y) proteins
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PRD IV PRD lll-l PRD II
Figure 1.3. The IFNp enhanceosome. Transcription factors associate to form the IFNp
enhanceosome. The components of AP-1 (c-jun and ATF-2) bind to positive regulatory
domain (PRD) IV in association with HMGI(Y) molecules. IRF3 or IRF7 interact with PRD III
and I. The NFkB subunits, p50 and p65, bind to PRD I with HMGI(Y) molecules. Adapted
from Falvo et a/., 2000.
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within PRD IV in association with ATF-2/c-Jun and the other situated within PRD II
in association with NF-kB, aiding the stability of the nucleoprotein complex (Yie et
al., 1999). The co-activators CBP or p300 are also associated with the complex and
are thought to interact with multiple components (Wathelet et al., 1998). The
enhanceosome is much more effective at inducing IFNP expression than any of the
individual components binding the promoter.
1.2.6. Cellular negative regulators of IFN signalling
As well as IRF-mediated control of IFN expression, the Jak-STAT signalling
pathway can be suppressed by a number of other cellular proteins. Suppressors of
cytokine signalling (SOCS) inhibit signalling by binding to the kinase domain in the
cytoplasmic domains of Jaks suppressing their activation (Endo et al., 1997; Fenner
et al., 2006). SOCS1 is induced by type I IFN. It is thought that SOCS1 associates
with and regulates the IFNARl subunit leading to attenuated activation of STATl
and thus reducing the extent of IFN signalling (Fenner et al., 2006). The protein
inhibitor of activated STAT (PIAS) l associates directly with STATl to prevent
binding to DNA therefore inhibiting the induction of downstream effector genes (Liu
et al., 2004a).
1.3. Interferon stimulated genes
There are hundreds of interferon stimulated genes (ISGs) induced by type I IFNs that
contribute to the anti-viral response, as well as the induction of the adaptive immune
response. The ISGs encode a wide range of proteins including enzymes, cytokines,
chemokines and transcription factors. Many such proteins are uncharacterised. A few
of the best studied antiviral proteins are discussed below.
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1.3.1. Protein kinase R
Protein kinase R (PKR) is constitutively expressed in the cytoplasm in an inactive
form. It is a serine/threonine kinase that binds dsRNA present in the cytoplasm of
infected cells and is upregulated by 1FN signalling. Upon binding dsRNA, PKR
undergoes a conformational change which allows it to dimerise and become activated
as the catalytic domain is unveiled (Katze et al., 1991). The optimal length of dsRNA
for activation is approximately 80bp (Samuel 2001). Active PKR shuts down host
protein synthesis by phosphorylating the eukaryotic translation initiation factor 2a
(eIF2a) (Meurs et al., 1992). At translation initiation, Met-tRNA is recruited to the
40S ribosomal subunit via eIF2 bound to GTP. This complex associates with mRNA
and other initiation factors and bound GTP is hydrolysed to GDP. In order for
translation initiation to continue GDP must be exchanged for GTP via eIF2B (a
guanine exchange factor). However, once eIF2a is phosphorylated it interacts
strongly with eIF2B. Subsequently, the recycling of GDP to GTP is prevented
stopping translation initiation and thus viral replication (Ramaiah et al., 1994).
PKR has other functions in the infected cell. NF-kB is essential for IFNP induction
and can be activated by PKR in response to dsRNA. This function is through
activation of IKK, leading to the degradation of the inhibitors IxBa and IkBP and
resulting in activation ofNFkB. IKK is not activated in response to dsRNA in PKR-
deficient cell lines but the responses could be restored by co-transfection of PKR
with dsRNA (Kumar et al., 1997; Zamanian-Daryoush et al., 2000). PKR has also
been implicated in the regulation of apoptosis. PKR over-expression leads to cells
undergoing apoptosis in response to dsRNA whereas PKR-null cells are resistant.
PKR has been shown to upregulate Fas which interacts with the Fas associated death
domain (FADD), part of the apoptosis pathway (Balachandran et al., 1998).
- 13 -
Chapter 1 Introduction
1.3.2. 2'-5' Oligoadenylate synthetase system
The 2'-5' oligoadenylate synthetases (OAS) catalyse the synthesis of oligomers of
adenosine linked by phosphodiester bonds in a 2' to 5' conformation. The product of
OAS, 2'-5'A, binds to endoribonuclease L (RNase L) which is then activated via
dimerisation. Activated RNase L catalyses cleavage of cellular and viral ssRNAs
which leads to inhibition of protein synthesis. The 2'-5' molecules are highly labile
so the activation of RNase L occurs in the vicinity of the viral transcripts that
activated the 2'-5' OAS (Goodbourn et al., 2000). This helps to ensure that viral
transcripts are degraded preferentially over cellular transcripts. RNase L can also
cleave 28S ribosomal RNA and thus is another effector of translational inhibition
(Iordanov et al., 2000).
1.3.3. Other ISGs
Mx proteins: The Mx proteins are large GTPases that are particularly effective
against RNA viruses. Human MxA localises to the cytoplasm where it targets
nucleocapsids. Mouse Mxl protein localises to the nucleus and can inhibit
transcription of influenza virus. The concentrations of the primary transcripts
encoding the three polymerase proteins of influenza virus PBl, PB2, and PA were
significantly reduced in the presence ofMxl (Pavlovic et al., 1992).
ISG15: ISG15 is an ubiquitin-like protein which covalently conjugates to target
proteins in a process called ISGylation. Evidence suggests that ISG15 functions as an
important antiviral molecule for a broad variety of viruses. ISG15-deficient mice
were shown to be more susceptible to influenza virus, HSV-1, murine
gammaherpesvirus-68 (MHV-68) and Sindbis virus infections (Lenschow et ah,
2007). It has antiviral activity against human immunodeficiency virus (HIV)-l by
inhibiting virus release in vitro but is not thought be important for the control of
lymphocytic choriomeningitis virus (LCMV) (Okumura et al., 2006; Osiak et al.,
2005). 1SG15 can also be detected in the sera of mice after viral infection indicating
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possible cytokine function as it has also been reported to induce NK cell
proliferation, IFNy production and maturation of DCs (Lenschow et al., 2007).
ISG12: ISG12 was originally discovered by Rasmussen and colleagues in MCF7
human breast carcinoma cells in 1993. Found to be preferentially induced by type 1
IFN, it was designated a novel ISG (Rasmussen et al., 1993). ISG12 was first termed
p27 but due to potential confusion with p27kip it was later re-named ISG 12 because
of its molecular weight of 11.5 kDa. ISG 12 is also known as IFNa-induced gene 27
(IFI27) and IFN-induced 11.5kDa protein. The ISG 12 gene encodes a hydrophobic
protein of 122 amino acids which shares 36% amino acid identity with the human 6-
16 gene (Parker and Porter 2004) which is also highly induced in response to type I
IFN. Sequence analysis shows that the promoter region of ISG 12 containp putative
ISRE, IRF1/IRF2 and STAT elements correlating with the ability of IFNa to
upregulate ISG 12 expression (Martensen et al., 2001). ISG 12 status as an IFNa-
inducible protein was confirmed by analysis of ISG12 mRNA expression in various
human cell lines. ISG 12 gene expression was highly induced by IFNa, but not IL-2,
IL-6 or TNF-a (Gjermandsen et al., 2000). ISG 12 expression has also been observed
to be specifically highly up-regulated in mature and activated DCs but not in
immature DCs or lipopolysaccharide-stimulated monocytes (Hashimoto et al., 2000).
For the first time, an ISG has been found to be localised to the nuclear envelope. Cell
fractionation was carried out on cells infected with a baculovirus expressing ISG 12.
ISG 12 was detectable in the nuclear fraction of ISG12-expressing cells but not in
cells infected with a control baculovirus. However, no nuclear localisation signal has
been detected in the ISG12 sequence (Martensen et al., 2001). Due to the localisation
pattern, it has been speculated that ISG 12 could be an inducible part of the nuclear




In silico analysis showed that the original ISG12 is part of a family of ISG12 genes
that consists of 46 members so far in 25 different species. BLAST searches have
found ISG12 genes in organisms including amoeba, fish, mammals and humans. All
members of the family contain an 80 amino acid ISG12 motif. Four 1SG12 family
members have been found in humans, designated hISG12(a), (b) and (c) on
chromosome 14q32, plus the 6-16 gene on chromosome lp35, as grouped through
phylogenetic analysis. Homologues to the ISG12 genes, but not 6-16, have been
found in mice and these are termed mISG 12(a), (bl) and (b2) and are found on
chromosome 12F1 (Parker and Porter 2004). As the BLAST analysis of multiple
ISG12 genes was only carried out in 2004, discussion of studies previous to that
point only refer to a general ISG12 protein.
Sindbis infection of 4-week old mice led to increased expression of ISG12(b 1)
compared to 1-day old infected mice. This correlated with asymptomatic disease in
the 4-week old mice compared to 1 day old mice where death occurred rapidly. In
addition, enforced neuronal expression of murine ISG 12(b 1) in the 1 day old mouse
brain led to significantly delayed mortality in the neonatal mice. These data suggest
that upregulation of ISG 12(b 1) has a protective effect against Sindbis infection
(Labrada et al., 2002).
There are a great many other ISG products that have not been mentioned here and/or
have yet to be fully characterised. There is likely a degree of redundancy between
different ISGs. For example, although individually important components, mice
triply deficient in PKR, RNase L and MxA can still mount an antiviral response to
encephalomyocarditis virus (EMCV) (Zhou et al., 1999).
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1.4. Natural Killer cells
Natural killer (NK) cells are a fundamental component of the innate immune system.
They were originally discovered because of their ability to 'naturally kill' tumour
cells without prior sensitisation. Depletion ofNK cells in an in vivo mouse model led
to enhanced tumour formation showing that NK cells are important for suppression
of tumour growth (Kim et al., 2000). NK cells originate in the bone marrow and
comprise approximately 5-10% of the lymphocyte population in the peripheral blood,
spleen and liver (Lodoen and Lanier 2005). Although NK cells have been shown to
be important for innate immune responses against transformed cells, this review
concentrates on the antiviral activities ofNK cells. They are important for the control
of virus infections; targeting virus-infected cells via a number of mechanisms
including cellular cytotoxicity, production of cytokines and shaping of the
downstream adaptive immune response.
1.4.1. NK cell Receptors
Unlike B or T cells which express a rearranged receptor specific for a single ligand,
NK cells express multiple cell surface receptors that do not undergo rearrangement
and can recognise multiple ligands on a target cell. Such NK cell receptors can be
inhibitory or activatory and can be triggered independently or in combination. Rather
than considering NK cells to be non-specific, increased understanding of the NK cell
receptor repertoire has led to NK cells being thought of as having a degree of
specificity. Examples of inhibitory and activatory NK cell receptors are summarised
in table 1.2 and some are discussed below in more detail. NK cell recognition of
target cells is divided into three areas including recognition of pathogen-encoded
molecules, 'missing-self recognition of host proteins downregulated in infected cells
(providing inhibitory signals from normal cells) and 'altered self recognition of host




The mechanism ofNK cell activation has not been fully determined. It likely results
through the combined actions of cytokine receptors, adhesion molecules and
activatory receptors recognising ligands on the infected target cell surface. NK cells
express many activatory receptors including CD16, activatory killer
immunoglobulin-like receptors (KIRs), NKG2D, natural cytotoxicity receptors
(NCRs) and TLRs. In general, NK cell activatory receptors are transmembrane
proteins that lack signalling activity. Such receptors associate with signal transducing
adaptor proteins via residues in the transmembrane region and induce signalling
through immunoreceptor tyrosine-based activation motifs (ITAM) in the cytoplasmic
tails of the adaptors (Lanier 2001). The signalling adaptor proteins include DAP 12,
DAP 10, FcsRIy and CD3(^. Signalling through the adaptor proteins lead to NK cell
effector functions such as cytotoxicity and the release of cytokines.
Activation through the NK cell receptor CD 16 leads to antibody-dependent cellular
cytotoxicity (ADCC) in human and murine NK cells. However, the adaptor proteins
differ between the two species. Human CD 16 associates with homodimers and
heterodimers of FcsRIy and CD3^ whereas murine CD 16 only associates with
homodimers of FcsRIy. Signalling is thought to occur via a protein tyrosine kinase
cascade leading to the recruitment and activation of Syk and ZAP70 if ITAM-
containing adaptor proteins such as DAP 12, FcsRIy and CD3(^ are used by the NK
cell receptor (DAP 10 does not contain an ITAM, joining the cascade downstream of
ZAPIO/Syk) (Djeu et al., 2002). Downstream effector molecules include
phosphatidylinositol 3-kinase (PI3K), extracellular signal regulated kinase (ERK),
Vav family guanine nucleotide exchange factor and Rho-Rac GTP binding proteins
(Colucci et al., 2002).
The NCRs are a family of immunoglobulin-like proteins and include NKp30, NKp46
and NKp44. Their expression is limited to NK cells only. These receptors appear to
be the main receptors for activation ofNK cells and along with NKG2D induce
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Receptor Ligand Function Species
CD16 IgG activatory Human, mouse









CD244 (2B4) CD48 activatory Human
Mouse
DNAM-1 CD112, CD 155 activatory Human
K1R2DL1 HLA-C inhibitory Human
Ly49 (except D and H) H-2K, H-2D inhibitory Mouse


















Table 1.2. NK cell Receptors. Adapted from (Cerwenka and Lanier 2001; Colucci et at, 2002). CD,
cluster of differentiation; HA, haemagglutinin; HLA, human leucocyte antigen; hu, human; IgG,
immunoglobulin G; KIR, killer immunoglobulin-like receptor; Ly49, lymphocyte antigen 49 complex;
MIC, MHC class I related molecules; MCMV, murine cytomegalovirus; MULT-1, murine UL16-
binding protein like transcript-1; mu, murine; RAE-1, retinoic acid early inducible 1; ULBP, UL16-
binding protein.
virtually all cytotoxic activity (O'connor et al., 2006). The extent of cytotoxic
activity against susceptible target cells correlated with an increased surface intensity
of the NCRs (Sivori et al., 2000). NKp30 and NKp46 associate with the FcsRIy and
CD3<^ adaptor proteins and are expressed by all NK cells (Pende et al., 1999; Sivori
et al., 1999) while NKp44 associates with DAP 12 and is only expressed on activated
NK cells (Cantoni et al., 1999). At present little is known of the ligands for the NCR
family. It has been shown that NKp44 and NKp46, but not NKp30, can bind the HA
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of influenza virus and the HA-neuraminidase of Sendai virus and a subset of those
NK cells require recognition by NKp46 in order to lyse cells expressing the viral
glycoproteins (Arnon et al., 2001; Mandelboim et al., 2001). Furthermore, infection
of cells with vaccinia virus resulted in a significant increase in their susceptibility to
NK cell-mediated lysis. This effect is dependent on the NCRs which are thought to
be activated by viral gene products expressed early in the virus life cycle (Chisholm
and Reyburn 2006).
The NKG2D receptor is a member of the C-type lectin-like family and is encoded in
the NK gene complex in murine chromosome 6 and human chromosome 12 along
with the other NKG2 genes (Raulet 2003). It is expressed by all NK cells as well as
CD8^ T cells, NKT cells and activated macrophages. NKG2D associates with the
DAP10 adaptor molecule which instead of an ITAM motif, contains a different
tyrosine based motif (YINM) which recruits PI3K for downstream signalling (Wu et
al., 1999). The human NKG2D receptor was found to recognise MICA by means of a
monoclonal antibody which blocked the interaction (Bauer et al., 1999). MICB was
also found to be recognised by NKG2D. MIC proteins are encoded by genes within
the human MHC but they do not bind peptide or (32-microglobulin. The MIC proteins
are upregulated on stressed or tumourigenic cells but have a minimal expression on
normal cells (Lanier 2001). Interestingly, the binding of the NKG2D/DAP10
complex provided an activatory signal that could override inhibitory signalling
through the KIR/MHC class I complex (Cosman et al., 2001). UL16 binding proteins
(ULBPs) were also discovered to be ligands for human NKG2D, stimulating
cytokine production from NK cells following binding. UL16 is an early CMV gene
that can bind ULBP1, ULBP2 and MICB. The addition of soluble UL16 blocked
these three ligands from binding the NKG2D receptor. Furthermore, addition of
ULBPs to NK cell resistant target cells resulted in susceptibility to NK cell
cytotoxicity (Cosman et al., 2001). The ligands, retinoic acid early inducible 1 (RAE-
1), H60 and mouse UL16 binding protein-like transcript 1 (MULT-1), for murine
NKG2D have homology to the ULBPs. The importance of such ligands for NK cell
responses to viral infection are highlighted by the evasion strategies employed by
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murine cytomegalovirus (MCMV). The MCMV genes ml 52 and ml 55
downregulate expression of RAE-1 and H60 respectively to avoid NK cell activation
(Hasan et al., 2005).
The C57BL/6 mouse strain is relatively resistant to MCMV infection whereas
BALB/c mice succumb to the infection. Studies using selective depletion of the
Ly49~ NK cell subset showed that the murine NK cell receptor Ly49H is involved
and required for protection against MCMV in C57BL/6 mice (Brown et al., 2001;
Daniels et al., 2001). Ly49H is encoded in the NK gene complex, Cmv-1 in C57BL/6
mice but is lacking in BALB/c mice (Arase et al., 2002). The Ly49 group are found
in mice and are C-type lectin-like receptors and can be either activatory or inhibitory
in function. The expression of Ly49 molecules is stably maintained in the clonal
progeny of a NK cell. Ly49H is an activatory receptor which associates with DAP 12
to signal the initiation of cytokine production and cytotoxicity. The ligand for Ly49H
is a MHC class I-like MCMV glycoprotein, ml57 which is expressed on the surface
of infected cells. Site-directed mutagenesis studies have suggested that
homodimerisation of Ly49H is central to recognising ml57, but not MHC class I.
This result links Ly49 dimer structure-variation to the potential recognition of
various viral products (Kielczewska et al., 2007).
1.4.1.2. Inhibitory receptors
It is important that NK cell activation is closely monitored in order to avoid
autoimmune responses on normal host cells. The missing self hypothesis (NK cells
recognise cells with downregulated MHC class I molecules) has been updated to
state that 'NK cells recognise abnormal cells which lack sufficient MHC class I
molecules or overexpress ligands for activatory receptors'. For example, erythrocytes
do not express any MHC class I molecules yet are not targeted by NK cells and this
may be attributed to the lack of activatory ligands on the erythrocyte surface (Lanier
2005). Therefore, the inhibitory receptors on NK cells can be considered as
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regulatory receptors which reduce, rather than terminate, signalling from the
activatory receptors.
The best characterised inhibitory receptors are members of the KIR family and
CD94/NKG2A. KIRs are present on overlapping NK cell subsets as well as memory
CD8 T cells and recognise different allelic groups of HLA-A, HLA-B and HLA-C
molecules. For example, KIR2DL2 recognises HLA-C S77/N80 and KIR3DL1
recognises HLA-Bw4 (Lanier 2005). The inhibitory KIRs have an immunoreceptor
tyrosine-based inhibitory motif (ITIM) in their cytoplasmic region. Binding of an
inhibitory KIR to a MHC class I molecules suppresses NK cell cytotoxicity and
cytokine release by means of SHP-1 and SHP-2 phosphatases which antagonise the
activatory signalling cascade. Most members of the Ly49 family in mice contain an
ITIM in their cytoplasmic domain (Ravetch and Lanier 2000). Ly49D and H are
activatory receptors and thus lack an ITIM. The ligand for Ly49H, ml57, is also
recognised by the inhibitory receptor Ly49I in some strains of MCMV susceptible
mice, dampening the NK cell response and thus contributing to susceptibility to the
virus (Arase et al., 2002). Ly49A and Ly49G have also been shown to be inhibitory
receptors on NK cells and a subset of T cells. Addition of antibodies to both
receptors led to enhanced lysis of target cells by T cells as well as increased
production of TNFa and granulocyte-macrophage colony stimulating factor (GM-
CSF) (Ortaldo et al., 1998). Such studies demonstrate the similar functions of the
Ly49 family to regulate both NK and T cell functions. CD94/NKG2A heterodimers
are present as inhibitory receptors on human and murine NK cells. They recognise
non-classical MHC class I molecules; HLA-E in humans (Brooks et al., 1999) and
Qal in mice (Vance et al., 1998). The expression of CD94/NKG2A is not stable like
the Ly49 receptors but is influenced by the cytokine environment. For example,
TGF-P and IL-2 can induce upregulation of CD94/NKG2A on T cells in vitro
(Bertone et al., 1999; Derre et al., 2002).
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The role of certain NK cell receptors in the control of herpesviruses has been
investigated. For herpesviruses to establish a persistent infection, MHC class I
molecules are downregulated from the cell surface to avoid recognition by CD8" T
cells. However, this results in infected cells being more susceptible to NK cell
killing. Human cytomegalovirus (HCMV) has evolved many mechanisms to avoid
NK cell recognition. For example, the UL18 glycoprotein is a MHC class I heavy
chain homologue which can bind inhibitory NK cell receptors and therefore inhibit
NK cell activation (discussed in more detail in section 1.5). In contrast to HCMV,
Epstein-Barr virus (EBV) does not appear to encode a MHC molecule homologue.
EBV infects and becomes latent in B cells. During latent infection there is limited
gene expression which aids evasion from NK cell recognition. EBV downregulates
MHC class I molecules from the cell surface during the early stages of lytic infection
in order to evade T cell responses directed to lytic antigens. Consequently, EBV-
infected cells are then more susceptible to NK cell recognition and induction of lytic
replication results in increased NK cell lysis of EBV-infected B cells (Pappworth et
al., 2007). Susceptibility to NK cell cytotoxicity was a result of downregulation of
ligands for the inhibitory NK cell receptors, HLA-A, -B and -C (binding to inhibitory
KIR receptors) and HLA-E (binding to CD94/NKG2A). Additionally, ULBP-1 and
CD112, ligands for the activatory receptors NKG2D and DNAM-1 respectively,
were upregulated (Pappworth et al., 2007). This study has highlighted the important
balance of inhibitory/activatory NK cell receptors for the continued surveillance for
virally infected cells.
1.4.2. Cytokines and NK cells
1.4.2.1. Cytokine regulation of NK cell function
As well as target recognition via cell surface receptors, NK cells can be activated via
cytokine stimulation. A number of cytokines have been shown to influence NK cell
activation and function. IFNa/p, produced from cells such as activated macrophages
and DCs, can induce cytotoxicity and proliferation ofNK cells during viral infection
by signalling through the activatory IFNAR receptor (Biron et al., 1999). IFNAR
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knockout mice displayed inhibited cytotoxicity following infection with MCMV.
STAT1 was shown to be required for IFNa/p-mediated NK cell cytotoxicity as there
was a 70-fold reduction in cytotoxicity in STAT 1-deficient mice despite sufficient
IFNa/p serum levels (Nguyen et al., 2002). IL-15 is important for the survival,
homeostasis and accumulation ofNK cells (Lodolce et al., 1998) and IL-15 knockout
mice lack NK cells (Kennedy et al., 2000). It has been demonstrated that IFNa/p is
important for the induction of IL-15 expression and thus the proliferation of the NK
cell pool during MCMV infection (Nguyen et al., 2002). 1L-12 p70 is produced from
DCs, macrophages and neutrophils and is critical for the efficient induction of IFNy
expression from NK cells during some, but not all viral infections. LCMV infection
does not result in IL-12 induced IFNy production from NK cells (Orange and Biron
1996). lL-12-dependent induction of IFNy occurs during MCMV infection (Nguyen
et al., 2002). The regulation of IL-12 responses is important. IFNa/p inhibits IL-12,
consequently inhibiting IFNy expression (Cousens et al., 1997). STAT 1-deficient
mice express higher levels of IFNy, suggesting an important role for STAT1 in
limiting IFNy levels and thus inhibiting cytokine-mediated immunopathology. IL-18
is produced by activated macrophages as an inactive precursor which is then cleaved
to the active form by caspase 1. IL-18 has been shown to enhance NK cell cytotoxic
activity at early time points following infection with influenza virus (Liu et al.,
2004b). IL-18, TNFa and IL-la/p can all synergise with IL-12 for the production of
IFNy from NK cells (Biron et al., 1999). IL-10 and TGFP negatively regulate NK
cell function by inhibiting IL-12 induction (IL-10 and TGFP) or by inhibiting IFNy
production and cytotoxicity (TGFP) (Biron et al., 1999). Macrophage inflammatory
protein-1 a (MlP-la) is induced during viral infection to induce NK cell
chemoattraction and migration. During MCMV infection MlP-la is required for the




Binding ofNK cell activatory receptors can lead to the production of cytokines, such
as IFNy, GM-CSF and TNFa, which augment the antiviral response. The role ofNK
cell production of IFNy has been well documented. Levels ofNK cell-derived IFNy
typically peak within hours to the first few days of infection, after which the primary
source of IFNy is T cells. NK cell IFNy production is important during some but not
all viral infections. For example, control of MCMV infection requires IFNy
production from NK cells whereas no IFNy production is detectable during LCMV
infection (Orange and Biron 1996). Studies in T cell-deficient mice (so removing T
cells as an alternative source of IFNy) showed that IFNy was detectable at early time
points post-MCMV infection and this was due to NK cells as depletion ofNK cells
resulted in significantly reduced IFNy levels (Orange et al., 1995). IL-12 is a potent
inducer of IFNy and the NK cell IFNy response is reliant on the production of the
biologically active IL-12 p70 heterodimer during MCMV infection. Antibody
neutralisation of IL-12 inhibited NK cell IFNy production and consequently, control
of MCMV infection. Administration of even low doses of IL-12 led to a two-fold
increase in NK cell cytotoxicity and IFNy production in MCMV-infected mice. In
contrast, LCMV replication is not affected by the absence of IL-12 and this
correlates with the lack of IFNy production during infection (Orange and Biron 1996;
Orange et al., 1995). It has been shown that NK cell recruitment into draining lymph
nodes provides a primary source of IFNy to stimulate Thl polarisation of T cells
(Martin-Fontecha et al., 2004). TNFa can lead to DC maturation and therefore helps
to initiate an efficient adaptive immune response. TNFa is also produced by NK
cells upon MCMV infection although NK cells are not the only source of this
cytokine and are not necessary for its production (Orange et al., 1995). IL-2 activated
NK cells can control HCMV infection in vitro by means of TNFa and TNF(3
secretion leading to IFNp production in infected cells (Iversen et al., 2005). NK cells
also produce certain chemokines such as MlP-la and lymphotactin which have




The primary pathway ofNK cell-mediated cytotoxicity is through granule exocytosis
(see figure 1.4). The directional release of perforin and granzymes towards an
infected cell results in lysis. Perforin causes disruption of the target cell membrane,
allowing entry of granzymes and induction of apoptosis. The granules are stored in
the cytoplasm allowing rapid release when the NK cell is stimulated via activatory
receptors on its surface. A common pathway of activation is induced following
binding and cross-linking of activatory receptors to ligands on the target cell surface.
For example, the CD 16 receptor undergoes clustering upon binding of the Fc
fragment of Ig (immunoglobulin) G-opsonised targets. This leads to coupling of the
receptor with its adaptor proteins, induction of the signalling cascade and
consequently ADCC. It has been shown that activation of ERK, a common
downstream effector of the activatory receptor-induced signalling pathways results in
mobilisation of lytic granules towards the target cell (Djeu et al., 2002; Wei et al.,
1998). Rapid reorganisation of microtubules occurs followed by polarisation and
secretion of the cytolytic granule content. Intracellular staining shows that upon
binding of a tumour target, both perforin and granzyme B are redirected towards the
tumour contact zone within five minutes (Wei et al., 1998).
Perforin is a membrane disrupting protein which was traditionally thought of as a
pore forming protein for the passive delivery of granzymes to the target cell.
However, this idea has been discounted recently as there is no firm evidence for the
formation of transmembrane pore complexes in vivo. Perforin is expressed in both
CD8" T cells and NK cells. Infection of perforin-deficient mice with MCMV results
in higher viral titres and increased mortality compared to infection of wild-type mice
(Van Dommelen et al., 2006). Furthermore, NK cells were shown to be an important
source of perforin during MCMV infection as NK cell depletion of IFNy knockout
mice resulted in higher viral titres in the spleen and liver (Loh et al., 2005). This
demonstrates an important IFNy-independent mechanism of MCMV control by NK
cells. In contrast, perforin was shown to be dispensable for the control ofMHV-68 as
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Figure 1.4. Pathways of NK cell cytotoxicity. The granule exocytosis pathway involves the
release of cytotoxic granule contents (perforin, granzymes, serglycin) into the intercellular
space. The uptake of granzyme B into target cells can occur rapidly by receptor-mediated
endocytosis via the mannose 6-phosphate receptor (MPR). Granzyme B and perforin may
bind to the target-cell surface as part of a single macromolecular complex associated with
serglycin. Granzymes can then trigger apoptotic cell death via caspase-dependent or -
independent pathways. Members of the TNF family, FasL and TRAIL, are regulated by
cytokines such as IFN-y. These ligands induce caspase -dependent target cell apoptosis via
Fas-associated death domains (FADD) in the cytoplasmic domains of their corresponding
receptors Fas and DR4/DR5, respectively.
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viral titres did not differ between wild type and perforin deficient mice (Usherwood
et al., 1997). Also, there was no difference in MHV-68 titres following infection of
NK cell-depleted and wild-type mice (Usherwood et al., 2005). Although perforin is
important for granzyme-mediated apoptosis, studies have shown that purified
granzyme B can enter cells without perforin although this is unlikely to be sufficient
for function at physiological levels (Trapani and Smyth 2002). Granzyme B can enter
cells via the mannose-6-phosphate receptor (Trapani and Smyth 2002). The presence
of a target cell receptor suggests that granzyme B entry may, in part, be mediated by
receptor-mediated endocytosis. It has also been suggested that delivery of granzymes
to a target cell may occur via a complex with perforin and serglycin (a chondroitin
sulphate proteoglycan) which act as translocator and scaffold respectively (Metkar et
al., 2002). However, the mechanism of delivery remains to be fully determined.
NK and T cells avoid lysis through the perforin they secrete by the action of
cathepsin B. Cathepsin B is a protease present in the cytolytic granules. It is rapidly
sequestered on the surface of the T or NK cell following granule exocytosis and can
cleave perforin molecules that diffuse back to the effector cell. In the presence of
cathepsin B-specific protease inhibitors cytotoxic cells that release granules die
rapidly via perforin-dependent suicide (Balaji et al., 2002).
The granzymes are a family of serine proteases (enzymes which cleave peptide
bonds and have a serine residue in the active site). Ten granzymes are expressed in
mice (A-K, M and N) and five in humans (A, B, H, K and M). Members cleave at
different residues. For example, A and K are tryptases whereas H is a chymase,
cleaving after hydrophobic residues such as phenylalanine. B is the best studied
member of the granzyme family. Granzyme B induces apoptosis by both caspase-
dependent and -independent pathways, cleaving target cell proteins at specific
aspartate residues. Granzyme B has been shown to interact directly with certain
procaspases. For example, procaspase 3 is cleaved to caspase 3 by granzyme B thus
activating it and leading to apoptosis of the cell. Indirect caspase activation is also
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mediated by granzyme B. It can activate members of the Bcl-2 family directly such
as BH3-interacting domain death agonist (BID). BID interacts with receptors on
mitochondria to cause cytochrome c release which then activates procaspase 9 in the
cytoplasm to result in apoptosis (Russell and Ley 2002). Granzyme A is thought to
act through a distinct pathway from granzyme B as it does not activate caspases but
induces apoptosis through the induction of single-stranded DNA breaks (Beresford et
al., 1999).
The second pathway of NK cell-mediated cell cytotoxicity is termed as death-
receptor mediated and can either be through stimulation of FasL or TNF-related
apoptosis-inducing ligand (TRAIL). The pathways are summarised in figure 1.4.
Such molecules are expressed by NK cells as important mediators of apoptosis.
TRAIL, also known as Apo2 ligand, binds to the human receptors DR4 (TRAILR1)
and DR5 (TRAILR2) to induce apoptosis through death domains in their cytoplasmic
domains (Degli-Esposti 1999). Activation by IL-2, type I IFN, IFNy or 1L-15 results
in high TRAIL expression in human and murine NK cells. NK cell cytotoxicity is
enhanced by type I IFN through upregulation of TRAIL due to the presence of an
ISRE in the murine TRAIL promoter (Sato et al., 2001). The importance of TRAIL-
mediated cytotoxicity for control of viral infection is demonstrated by the
requirement for control of EMCV infection and the fact that TRAIL receptor
expression was increased on CMV infected cells (Smyth et al., 2005). Fas expression
on the surface of target cells is upregulated by IFNy secreted by NK cells. NK cells
can then induce apoptosis of tumour cells in a Fas-dependent manner (Screpanti et
al., 2005).
1.4.4. NK cell proliferation in response to viral infection
NK cells proliferate rapidly during viral infection, significantly expanding the NK
cell pool. NK cell numbers were found to be significantly elevated in patients with
infectious mononucleosis (IM), the acute phase of infection with EBV (Williams et
al., 2005). Similarly, NK cell numbers increase during early MCMV infection. This
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initial phase of proliferation is non-specific, regardless of cell surface receptor
expression, and is thought to be due to the action of proproliferative cytokines such
as IL-15 (Dokun et al., 2001). It is thought that IFNcc/p can induce IL-15 expression,
in a STAT-1-dependent manner, to induce NK cell proliferation. In STAT-1- or
IFNa/p-deficient mice, the degree of NK cell proliferation was drastically reduced
and the reduction was associated with a lack of IL-15 induction (Nguyen et al.,
2002). Furthermore, blocking of IL-15 function by antibodies to the IL-15 receptor
resulted in vastly reduced numbers ofNK cells accumulating in response to MCMV
infection compared to control mice (Nguyen et al., 2002). Although IL-18 alone is
not sufficient to promote NK cell proliferation and survival, it can augment the
action of IL-15 in vitro (French et al., 2006). This effect remains to be determined in
vivo but the production of IL-18 from activated macrophages and DCs may act
synergistically with IL-15 during viral infection to induce an efficient NK cell
response early in infection.
Following non-specific proliferation, a specific phase of proliferation occurs during
MCMV infection. Specific proliferation of NK cells during MCMV infection has
been shown to be due to Ly49H activation through recognition of infected cells and
results in a pool of Ly49FT NK cells, peaking between 4 to 6 days post-infection
(Dokun et al., 2001). This viral-induced specific expansion resembles the clonal
expansion of antigen-specific T cells. Ly49H" NK cells expressing other activatory
receptors proliferated during the initial non-specific phase but did not undergo
expansion during the later specific phase. As the adaptive immune response develops
the NK cell pool contracts and returns to steady-state levels. The contraction phase is
not well understood but may be a result of declining proproliferative cytokine levels
or increasing levels of antiproliferative cytokines.
1.4.5. NK cells and human herpesvirus infection
The importance of the NK cell response against virus infection was demonstrated in
a patient with defective NK cell responses with other immune responses at normal or
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near normal. Studies showed that the patient lacked NK cells as no lymphocytes
expressing CD56 or CD 16 could be found. The patient first presented with a
disseminated, life threatening varicella zoster virus (VZV) infection and varicella
pneumonia and went on to develop severe HCMV and HSV infections (Biron et al.,
1989). Studies in the mouse model have shown a role for NK cells in clearance of
HSV-1. NK cell numbers increased in the lung following intranasal infection. These
cells were activated, had enhanced cytotoxic activity and NK cell-depletion led to
higher virus titres during the early stages of infection (Reading et al., 2006). Studies
of the NK cell response to MCMV have shown that depletion or deficiency leads to
severe disseminating infections and the Ly49H" activatory receptor is associated
with the ability to control infection in mouse strains that are relatively resistant to
MCMV infection (Daniels et al., 2001; Orange et al., 1995). Severe CMV infections
are also observed in humans with defective/no NK cells. In addition, low NK cell
cytotoxicity was associated with increased mortality to HCMV infection in patients
following bone marrow transplants (Quinnan et al., 1982).
The importance of NK cells for EBV control has been demonstrated in a number of
rare genetic disorders. For example, patients with Chediak-Higashi syndrome are
susceptible to disseminating EBV infection (Merino et al., 1983). They have
defective NK cell cytotoxicity due to mutations in the lysosomal trafficking regulator
(LYST) gene. It is thought that this mutation results in defective vesicle attachment
to microtubules therefore inhibiting granule exocytosis (Orange 2002). Patients with
X-linked lymphoproliferative disease (XLP) have a severe immunodeficiency
characterized by mutations in the signalling lymphocytic activation molecule
(SLAM)-associated protein (SAP) and by the inability to control EBV infections
(Benoit et al., 2000). A fatal infectious mononucleosis occurs following acute
infection with EBV. SAP is an important intracellular adaptor protein for the
activatory NK cell receptor 2B4 (CD244). NK cells from XLP patients fail to kill
EBV" B lymphoblastoid cell lines even though the 2B4 ligand, CD48 is highly
expressed on such cells (Parolini et al., 2000). The CD48:2B4 interaction is a
possible mechanism for the recognition of EBV-infected cells and thus a lack of
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downstream signalling contributes to the failure of NK cells to control EBV
infection.
1.5. Virus Evasion of the Innate Immune system
At early times post-infection viruses encounter various components of the innate
immune system which are important for mounting an antiviral response. The potency
of the antiviral response has led to virus families evolving mechanisms to counteract
these responses. Examples of mechanisms to evade type I IFN and NK cells are
discussed in the following section. Given the volume of evasion mechanisms
described this section will concentrate mainly on those employed by the
Herpesviridae.
1.5.1. Evasion of the type I IFN System
Viruses have evolved means to block almost all components of the type 1 IFN
system. Mechanisms include inhibition of IFN synthesis, inhibition of IFN signalling
and inhibition of ISG expression and effector functions (reviewed in (Goodbourn et
al, 2000; Weber et al., 2004).
The Herpesviridae encode a number of genes to limit type I IFN induction and
escape the downstream responses. For example, the immediate-early gene, ICP0, of
HSV-1 can block the activation of IRF3 and IRF7. The ICPO-mediated inhibition of
IRF3 was shown to be through blocking nuclear accumulation of activated IRF3 (Lin
et al., 2004; Melroe et al., 2004). The HCMV structural protein p65 acts in a similar
manner, by inhibiting nuclear translocation and phosphorylation of IRF3 (Abate et
al., 2004). Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a number of
IRF homologues which compete with their cellular counterparts and consequently
inhibit IRF functions. vIRFl, encoded by the K9 gene, is expressed during lytic
replication. It inhibits transcriptional responses to IFN by suppressing the activity of
IRF1 and IRF3. Inhibition occurs directly or through competition for the
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transcriptional enhancers CBP/p300, therefore inhibiting the formation of
transcriptionally competent IRF3-CBP/p300 complexes (Burysek et al., 1999; Lin et
al., 2001). vlRF2 can be detected from 2 to 24 hours post-infection in vitro (Krishnan
et al., 2004). It was shown to inhibit IFNa-driven activation of an ISRE-containing
promoter as well as inhibiting activation of the IFNP promoter by IRF3 (Fuld et al.,
2006). vIRF3 is suggested to downregulate NFkB activity by inhibiting nuclear
translocation thus lowering the level of type I IFN induction (Seo et al., 2004). A
fourth vIRF has been identified but this protein is still to be characterised. The
ORF45 tegument-associated protein of KSHV interacts with IRF7, inhibiting its
phosphorylation and blocking its accumulation in the nucleus (Zhu et al., 2002).
ORF45 may act to complement the vIRFs as its presence within the virion ensures its
presence at the earliest stages of infection.
Herpesviruses can interfere with IFNAR signalling and thus the induction of antiviral
responses. HSV-1 expresses a virion host shutoff protein (vhs) which functions as an
RNase to degrade cellular transcripts. Proteins such as IRF7, that require
transcriptional activation, would be sensitive to vhs-mediated transcript degradation
(Weber et al., 2004). Vhs also led to the rapid downregulation of Jakl and STAT2
from infected cells (Chee and Roizman 2004). HSV-1 also induces expression of
SOCS3 leading to the prevention of Jak and STAT phosphorylation (Yokota et al.,
2004). The MCMV pM27 protein binds and downregulates STAT2. Mutant MCMV
lacking pM27 was susceptible to type 1 IFNs and this effect was reversed in IFNAR-
deficient mice (Zimmermann et al., 2005).
Herpesviruses employ mechanisms for escaping the IFN-induced antiviral proteins.
The HCMV protein TRS1 encodes a dsRNA binding domain at the amino terminus
to sequester dsRNA, whereas the carboxy-terminal domain is necessary for
preventing the phosphorylation of eIF2a (Hakki and Geballe 2005). The vIRF2
protein of KSHV can also block phosphorylation of eIF2a through the binding of
PKR (Burysek and Pitha 2001). The HSV-1 protein Usll can directly bind PKR
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preventing its activation. Usl 1 RNA binding domain is necessary to inhibit the PKR-
mediated protein synthesis inhibition in infected cells suggesting that the RNA
binding function may be required to prevent PKR activation (Poppers et al., 2000).
Usl 1 also is thought to inhibit the activation of 2'-5' OAS through binding available
dsRNA (Sanchez and Mohr 2007). Another HSV-1 protein, ICP34.5 recruits cellular
phosphatase ! to dephosphorylate eIF2a and therefore reverses the translational
block induced by PKR (He et al., 1997). The importance of ICP34.5 is demonstrated
by HSV-1 lacking ICP34.5 which are attenuated in wt mice but exhibit wt virulence
in PKR-deficient mice (Leib et al., 2000). EBV encodes small RNA molecules
known as EBERs which can bind PKR so compete with dsRNA to prevent activation
of PKR (Elia et al., 1996).
1.5.2. Evasion of NK cells
Viral mechanisms for the avoidance/inhibition of NK cell responses can be divided
into five categories: expression of virally encoded MHC class I homologues,
modulation of MHC class 1 protein expression by viral proteins, inhibition of
activatory receptor function, virus encoded cytokine-binding proteins or cytokine
receptor antagonists and direct inhibition ofNK cell function.
Many viruses avoid T cell responses by downregulating MHC class I molecules from
the host cell surface. However, this renders infected cells more susceptible to NK cell
killing due to less opportunity for NK cell inhibitory receptors to bind class I
molecules such as HLA-C. CMV encodes MHC class I homologues, UL18 (HCMV)
and ml44 (MCMV). A ml44-deletion mutant virus was attenuated in vivo and
depletion ofNK cells restored virulence to wild-type levels (Farrell et al., 1997). The
exact mechanisms of these proteins remain to be elucidated but rather than being a
decoy ligand, UL18 can bind the inhibitory receptor, leukocyte Ig-like receptor
l(LIR-l), expressed on B, monocytes and a subset ofNK cells (Cosman et al., 1997).
ml57 from MCMV is a class 1 homologue which can bind the inhibitory receptor
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Ly49I and thus inhibit NK cell function in susceptible strains of mice (Arase et al,
2002).
HCMV UL40 functions to inhibit NK cell cytotoxicity by maintaining HLA-E
expression on the cell surface, even in the absence of other class I molecules. HLA-E
binds a peptide derived from the leader segment ofMHC class I molecules and binds
the CD94/NKG2A inhibitory receptors. UL40 contains the same peptide and can
therefore upregulate HLA-E expression and prevent lysis (Tomasec et al., 2000).
Viral proteins can also target the MHC class I synthesis pathway. The HCMV US2
and US 11 gene products can induce the relocation of class I molecules from the
endoplasmic reticulum (ER) to the cytoplasm where they are degraded by the
proteasome. It has been shown that US2 targets HLA-A, -B and -G but not HLA-C
or -E. US3 binds and retains MHC class I molecules in the ER whereas US6 inhibits
MHC class I expression by blocking translocation of peptides through the
transporters associated with antigen processing molecules into the ER (Lodoen and
Lanier 2005). The KSHV proteins K3 and K5 increase endocytosis of surface class I
molecules for degradation. K3 downregulates HLA-A, -B, -C, and -E, whereas K5
only downregulates HLA-A and HLA-B2 (Coscoy and Ganem 2000).
Interference with activation receptors and their ligands is another mechanism ofNK
cell evasion. K5 ensures inhibition of NK cell-mediated cytotoxicity by
downregulating and ubiquitinating the target cell ligands ICAM-1 and CD86 (B7-2)
(Ishido et al., 2000). MCMV encoded proteins downregulate surface expression of
ligands for the activatory receptor NKG2D. ml55 downregulates H60, ml52
downregulates RAE-1 and ml45 downregulates MULT-1 (Hasan et al., 2005;
Lodoen et al., 2004). Deletion of the ml 38 gene, which encodes an FcyR, resulted in
viral attenuation even in the absence of antibodies and therefore demonstrated an
additional function to IgG Fc binding, ml38 was shown to promote rapid
downregulation of MULT-1 and H60 and thus provides an alternate mechanism for
blocking NK cell activation (Lenac et al., 2006).
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Viruses may indirectly dampen NK cell responses through modulation of cytokines
or chemokines. For example, viral encoded IL-10 homologues such as the BCRF-1
gene of EBV can result in general NK cell inhibition. The M3 gene of MHV-68
encodes a broad spectrum chemokine binding protein which blocks the activity of
several NK cell chemoattractants such as MlP-la and RANTES (Parry et al., 2000).
Viruses may exert direct effects on NK cells, possibly through infection of the NK
cells themselves or by direct contact. The hepatitis C virus envelope protein E2 binds
to CD81 on the NK cell surface resulting in inhibition ofNK cell cytotoxicity. It also
resulted in inhibition of IFNy production even after exposure to IL-12, -15 or CD16
cross-linking (Tseng and Klimpel 2002). Thus E2 can inhibit NK cells by directly
binding an inhibitory receptor.
1.6. Herpesviruses
Herpesviruses comprise a large group of at least 130 viruses that can infect a wide
variety of hosts including oysters, fish, birds and humans. Through a long co-
evolution, herpesviruses are well adapted to their hosts. In immunocompetent
individuals they can persist for a lifetime without overt signs of disease. However,
serious disease can result when an alternative host species or immunocompromised
host becomes infected.
The herpesviruses are double stranded DNA viruses, varying in length from 120 to
250kb. The genetic material is contained in an icosadeltahedral capsid made up from
162 capsomeres. The tegument layer is a complex, proteinaceous layer containing a
number of virus proteins. It appears to have an ordered structure, linking the capsid
to the outer envelope and maintaining virion integrity. Surrounding the tegument is
the viral envelope. Derived from cellular membranes, it encompasses viral proteins
and glycoproteins. The overall size of virions can vary between 120 to 300nm
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(Roizman and Pellet 2001). Members of the family Herpesviridae share four biologic
properties:
1. The genome encodes a large range of enzymes involved in nucleic acid
metabolism (e.g. thymidine kinase), DNA synthesis (e.g. DNA polymerase)
and protein processing (e.g. protein kinase).
2. Viral DNA synthesis and capsid assembly occurs in the nucleus.
3. Production of infectious progeny results in destruction of the host cell.
4. They can maintain a latent infection in their natural host, where a limited
subset of viral genes is expressed from a circular genome.
The capacity to become latent, with minimal gene expression, allows some
avoidance from the host immune system, and allows persistence for the lifetime of
the host. Periodic reactivation from latency leads to production of infectious progeny
for transmission to new hosts (Roizman and Pellet 2001).
1.6.1. Herpesvirus Life Cycle
The process of herpesvirus assembly and maturation is complex and the following is
only a brief overview of key stages. The majority of research has focused on the
replication cycle of HSV-1 so the majority of examples are concerning this virus.
Initial attachment to a host cell usually occurs via binding of viral glycoproteins to
cell surface glycosaminoglycans. The gB and/or gC ligands of HSV-1 bind to
heparin sulphate on the cell surface. Heparan sulphate is also used as a tether in other
members of the herpesvirus family, such as KSHV (Akula et al., 2001). However,
this is not always the case as EBV attaches to target B cells by binding of CD21
(complement receptor 2) via gp350. The various cell receptors used help to explain
the differences in cell and tissue tropisms of herpesviruses. Co-receptor binding
allows for entry into the cell by fusion of the virion envelope with the plasma
membrane. For example, gp42 of EBV binds HLA class II and is critical for entry
into B cells (Spear and Longnecker 2003).
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Following fusion with the plasma membrane, the de-enveloped virus is released into
the cytoplasm where certain tegument proteins such as the virus host shutoff protein
of HSV-1 remain in the cytoplasm to make the cellular environment more favourable
to virus replication. Capsids are transported along microtubules to the nucleus where
viral DNA is released and assumes a circular conformation. Transcription of the viral
genome results in a regulatory cascade comprised of immediate-early (IE), early (E)
and late (L) mRNAs. The IE genes require no de novo protein synthesis for their
expression. The predominant role of this group appears to be transactivation of later
viral gene expression and modulation of the host cell. E-gene expression requires
viral protein synthesis for their expression. These genes are mainly required for viral
nucleic acid metabolism such as the thymidine kinase (TK) gene (Roizman and
Knipe Dm 2001). L-genes are dependent on protein and viral gene synthesis and can
be further subdivided into two groups: the leaky-late, where expression is enhanced
by viral DNA synthesis; and the true late genes, which are not expressed in the
absence of DNA synthesis. The L-genes primarily encode the structural components
of the virion, including gC and gB. DNA replication occurs in a rolling-circle
fashion. The concatameric DNA is cleaved during encapsidation into empty capsids.
Capsids exit the nucleus by budding into the perinuclear space, obtaining a primary
envelope (Mettenleiter 2004). Free capsids are transported to the cytoplasm
following fusion of the primary envelope to the outer nuclear membrane.
Tegumentation occurs within the cytoplasm, through a complex series of protein-
protein interactions that have yet to be fully defined. Final envelopment occurs
through budding into trans-golgi vesicles after which mature virions are secreted
from the cell via the vesicular route (Mettenleiter 2004).
1.6.2. Herpesvirus Classification
The Herpesviridae family can be classified into three subfamilies: the
Alphaherpesvirinae, the Betaherpesvirinae and the Gammaherpesvirinae.
Historically, this classification was based on their biologic properties such as host
range, sites of latent infection and length of the replication cycle. Recently, DNA
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sequencing has become the main approach to classification (McGeoch et al., 2006).
Examples of murine and human herpesviruses from each subfamily are shown in
table 1.3.
A Iphaherpesvirinae
The alphaherpesvirinae, including the genera Simplexvirus and Varicellovirus, have
the capacity to establish latent infections mainly within sensory ganglia. They are
also characterised by a variable host range, rapid spread in vitro and a relatively short
replication cycle. The diseases associated with herpesvirus infections can be wide
Subfamily Genus Virus Abbreviation Major Host
A Iphaherpesvirinae Simplexvirus Herpes simplex virus-1 HSV-1 Human
Herpes simplex virus-1 HSV-2 Human
Varicellovirus Varicella zoster virus VZV Human
Bovine herpesvirus-1 BHV-1 Cattle
Mardivirus Marek's disease virus 1 MDV-1 Chicken
Herpesvirus of turkey HVT Turkey





Muromegalovirus Murine cytomegalovirus MCMV Mouse
Rat cytomegalovirus RCMV Rat
Roseolovirus Human herpesvirus-6 HHV-6 Human
Human herpesvirus-7 HHV-7 Human















Table 1.3. Examples of known herpesviruses from each subfamily and their natural
hosts. Adapted from McGeoch et al., 2006.
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ranging, even within the same genus. HSV-1 is associated with cold sores whereas
HSV-2 is associated with genital lesions. VZV can cause chicken pox, shingles and
post-herpetic neuralgia.
Betaherpesvirinae
Betaherpesviruses can be characterised by their establishment of latency primarily
within cells of the myeloid lineage but virus can also be detected in cells of the
salivary glands and kidneys (Reddehase et al., 2002). They share a set of 80 ORFs
that are common to all betaherpesviruses (Mocarski and Courcelle 2001). Infected
cells often become enlarged in a process known as cytomegalia. In culture the
replication cycle is relatively long with a slow progressing infection. Members of the
cytomegalovirus genus are associated with mononucleosis and HCMV can cause
congenital deformities. HHV-6 and -7 are associated with roseola (exanthema
subitum), characterised by fever and rash which is common in children.
Gammaherpesvirinae
The gammaherpesviruses have a very narrow host range with infection often
restricted to the family or order to which the host belongs. In vivo latent virus is often
found in lymphoid tissue. Latency is maintained primarily within B- and T-
lymphocytes but can also be established in other cell types. In vitro all
gammaherpesviruses can replicate in lymphoblastoid cells with some also being able
to cause lytic infections in epithelial and fibroblast cell lines. EBV is the causal agent
of IM and is also associated with a range of tumours including Burkitt's lymphoma,
nasopharyngeal carcinoma and post-transplant lymphoproliferative disease (PTLD).
KSHV is the most recently discovered tumourigenic herpesvirus. It is associated with
Kaposi's sarcoma (KS), primary effusion lymphoma and some plasma cell forms of
multicentric Castleman's disease (MCD).
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1.6.3. Animal models of gammaherpesvirus infection
Primary infection with gammaherpesviruses is largely asymptomatic. Therefore, the
majority of information regarding infection has been determined by studies of long-
term persistence and symptomatic disease such as PTLD. KS and 1M. In these
studies it has not been possible to determine virus-host interactions prior to the onset
of symptoms. The narrow host range of the gammaherpesvirinae has also impeded
studies. A suitable animal model of gammaherpesvirus infection is required to
thoroughly investigate virus-host interactions and illuminate possible therapeutic
approaches.
Initially, non-human primates were chosen as an animal model system for the study
of EBV and KSHV pathogenesis. EBV infection of cotton-top tamarins (Sagunius
oedipus) leads to B cell proliferation and thus provides a useful model for the study
of PTLD. However, animals surviving lymphoproliferative disease do not become
latently or persistently infected (Epstein et al., 1985). Therefore the cotton-top
tamarin is not a useful model for all areas of EBV pathogenesis.
Lymphocryptoviruses (LCV), closely related to EBV, can infect Old World primates.
Similar to EBV, LCV-infected cell lines produce virus able to immortalise B cells
(Wang et al, 2001). Oral inoculation of rhesus macaques with a rhesus LCV mimics
EBV infection leading to lymphoadenopathy, persistent virus shedding from the oral
mucosa and an asymptomatic latent infection in the peripheral blood (Moghaddam et
al, 1997).
Simian KSHV homologues can be found within the New World primates, for
example, herpesvirus saimiri (HVS) infection of squirrel monkeys, as well as in the
Old World primates, such as rhesus rhadinovirus (RV2mac) infection of macaques
(Macaca mulatto) (Damania and Desrosiers 2001). RV2mac was found to contain a
viral IL-6 gene homologue analogous to that of KSHV suggesting similar host-virus
interactions (Mansfield et al., 1999). KSHV and RV2mac have extensive homology
and similar transcription profiles but RV2mac does lack genes present in KSHV such
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as the immune evasion genes K3 and K5 (Dittmer et al., 2005). Nonetheless, co-
infection of rhesus macaques with simian immunodeficiency virus and RV2mac can
result in lymphoproliferative disease resembling MCD and arteriopathy resembling
KS vascular lesions (Mansfield et al., 1999) thus providing a model for human co-
infection with HIV and KSHV.
Although non-human primate models are useful for the investigation of
gammaherpesvirus infections, study is often limited by mandatory high security, high
expense and strict government regulations. A murine model of disease is
advantageous for a number of reasons; they are smaller, cheaper, easier to keep and
development of transgenic animals is more straightforward. Furthermore, the murine
immune system has been studied in greater depth than that of non-human primates.
There are numerous in-bred and transgenic mouse strains with which to study virus-
host interactions in vivo. For example, severe combined immunodeficient (SCID)
mice inoculated with peripheral blood mononuclear cells from EBV-seropositive
individuals develop disease resembling PTLD (Johannessen and Crawford 1999).
MHV-68 provides an amenable small animal model for studying gammaherpesvirus
infection as productive and latent infections, analogous to EBV infection, are
observed in inbred strains of mice (Sunil-Chandra et al., 1992). MHV-68's gene
organisation and homology to other gammaherpesviruses are shown in figure 1.5.
Recombinant MHV-68 viruses, with deletion of endogenous genes or addition of
foreign genes, allow the study of virus-host interactions and gene function with
MHV-68 as well as EBV and KSHV genes.
1.6.4. Course of MHV-68 infection
MHV-68 (also known as murid herpesvirus-4) was originally isolated in 1980 from
bank voles (Clethrionomys glareolus) in Slovakia (Blaskovic et al., 1980). The
genome consists of an 118kbp unique region flanked by 1239bp of terminal repeats
which vary in number. The genome encodes 73 ORFs as well as 8 vtRNAs and 9
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Figure 1.5. Diagrammatic representation of the MHV-68 genome aligned with the genomes




Initial studies by Sunil-Chandra et al. showed that MHV-68 could infect the inbred
mouse strain BALB/c, and give rise to disease similar to that of EBV infection
(Sunil-Chandra et al., 1992). The natural route of infection is uncertain. Infection of
laboratory mice is usually carried out via the intranasal or intraperitoneal route.
Given that MHV-68 is more often detected in the respiratory tract than the spleen in
free living wood mice (Blasdell et al., 2003) it appears likely that the intranasal route
of inoculation is the most accurate reflection of natural infection. However, the
digestive route may also be a possibility as productive infection could be detected in
intestinal epithelia following gastric instillation (Peacock and Bost 2000).
Following intranasal inoculation of BALB/c mice, a lytic infection occurs
predominantly in the alveolar epithelial cells although some mononuclear cells in the
lung are also virus-positive (Sunil-Chandra et al., 1992). Viral titres rise to a peak at
day 5-7 post-infection which is accompanied by bronchiolitis. The virus induces an
inflammatory infiltrate in the lungs, which was characterised by bronchoalveolar
lavage. The infiltrate consists mainly of macrophages (peaking at day 3), monocytes
and CD8 T cells (peaking at day 7) (Nash et al., 2001; Sarawar et al., 2002). Acute
infection in the lung resolves after 7-10 days, primarily due to the action of CD8* T
cells (Ehtisham et al., 1993). MHV-68 cannot be detected by plaque assay after 10
days although inflammation resolves later in the second week of infection and foci of
mononuclear cells can still be detected up to 30 days post-infection (Sunil-Chandra
et al., 1992).
MHV-68 is trafficked to the mediastinal lymph node (MLN) from the lung where
lymphoadenopathy occurs due a transient expansion of B cells driven by CD4~ T
cells (Usherwood et al., 1996a). Virus trafficking to the MLN is likely to be
mediated by DCs. Virus can be detected in CD1 lc+ DCs regardless of the presence
or absence of B cells. In the absence of B cells, virus still reaches the MLN and
infects macrophages and DCs but fails to spread to other lymphoid compartments.
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This suggests B cells are primarily infected in the MLN and are the principal cell
type required for trafficking of the virus to other organs (Nash et al., 2001).
From the MLN, virus traffics to the spleen where a latent infection is established
within germinal centre B cells, macrophages and DCs (Flano et al., 2000). Acute-
phase latency is associated with splenomegaly which peaks during the second week
of infection due to rapid proliferation of B cells and T cells (Usherwood et al.,
1996b). The elevated numbers of latently infected cells are located in enlarged and
more numerous germinal centres. Splenomegaly and thus the number of latently
infected cells is controlled by CD4T T cells as mice in which CD4~ T cells are
depleted do not develop splenomegaly and have reduced levels of latent virus
(Usherwood et al., 1996a). Surprisingly, the virus can still establish a latent infection
even in the absence of CD4" T cell-driven B cell expansion. The number of long-
term latently infected cells remains constant whether CD4^ T cells are present in the
host or not (Nash et al., 2001).
A peripheral mononucleosis, resembling IM caused by EBV, occurs during MHV-68
infection, peaking at around 35 days post-infection. It is characterised by a skewed
expansion of circulating CD8 T cells expressing the Vp4 T cell receptor (Tripp et
al., 1997). It is thought that this phenomenon is MHC-independent and the Vp4^
CD8 T cells are recognising an as yet uncharacterised viral ligand. These cells
persist long-term, probably due to continued ligand expression (Flano et al., 2004).
Following the transient peak of latent infection, the numbers of latently infected cells
fall to levels around the limit of infection (Sunil-Chandra et al., 1992). Long term
latency is maintained mainly in germinal centre and memory B cells. Wilier and
Speck showed that latency was largely found within the surface IgD" subset of
splenic B cells, which resemble memory B cells, at 6 months post-infection (Wilier
and Speck 2003). Furthermore, maintenance of latency is dependent on the
development of memory B cells as latency was lost in CD40" B cells. CD40 is
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required for the survival of memory B cells (Kim et al., 2003). Latent virus can also
be detected in macrophages and DCs (Flano et al., 2000). The maintenance of
latency in non-B cells is confirmed in the spleens of p.MT (B cell deficient) mice
where persistent virus could be detected 6 weeks post-infection (Week et al., 1996).
Viral persistence also occurs in sites other than the spleen. Virus genomes were
detectable in bone marrow, nasopharyngeal-associated lymphoreticular tissue, lung
and spleen at 3 months post-infection although the higher viral frequencies in the
lung and spleen indicated these as major reservoirs for long-term latency ofMHV-68
(Flano et al., 2003). MF1V-68 was shown to persist in the lungs of wt and ju.MT mice.
Latent virus was determined by in situ hybridisation for the vtRNAs (as markers of
latent infection) within lung sections of both p.MT and wt mice suggesting that
persistence was occurring independently of B cells. Further investigation determined
that latency was occurring in epithelial cells (Stewart et al., 1998). In contrast Flano
et al. (2003), showed that B cells, macrophages, DCs and "null" (predominantly
stromal and epithelial) cells in the lung were MHV-68 genome-positive at 14 days
post-infection (after clearance of lytic virus). However, by 3 months post-infection B
cells were the only substantial population of latently infected cells. This discrepancy
may due to the techniques employed and remains to be resolved.
1.6.5. Immune response to MHV-68
1.6.5.1. Natural Killer cells
Little is known about the impact ofNK cells during gammaherpesvirus infections. A
paper published during this study suggested that control of MHV-68 infection is
independent ofNK cells. A lack ofNK cells did not have any effect on the control of
acute or latent infection, nor did it appear to affect CD8' T cell responses
(Usherwood et al., 2005). In support of these findings, perforin-deficient mice were
able to control MHV-68 infection with similar kinetics to wt mice even though NK
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cell cytotoxic activity was shown to be impaired (Kagi et al., 1994; Usherwood et
al., 1997).
1.6.5.2. Type I IFN
The type 1 IFN system is crucial in controlling the initial stages of MHV-68
infection. Whilst wt mice are resistant to MHV-68 infection, infection of IFNa/p R"
mice (mice with a targeted disruption of the type I IFN receptor) led to higher viral
titres, systemic dissemination and 80-90% mortality. Mice deficient in STAT1 have a
100% mortality rate by day 21 post-infection whereas 50% of IFNa/(3 R_/" mice
survive beyond this point. This suggests that STAT 1-dependent pathways can protect
IFNoc/p R" mice during the second week of infection (Barton et al., 2005). The
number of latently infected cells was increased 10-fold in IFNoc/p R"" compared to wt
spleens during acute-phase latency and this difference was resolved by 3 weeks post¬
infection (Dutia et al., 1999). Type I IFN is also suggested to play a role in inhibiting
viral reactivation during latency as latent virus from IFNa/p R " splenocytes
reactivated with 5-fold increased efficiency compared to wt splenocytes (Barton et
al., 2005).
1.6.5.3. Cytokines and Chemokines
The cytokines and chemokines induced following viral infection are important for
limiting spread and influencing other arms of the immune response. Cells from the
spleen, MLN and cervical lymph node produce high levels of IL-6 and IFNy and
lower levels of IL-2 and IL-10 following MHV-68 infection. Cytokines were induced
from day 3 but peaked around day 10 post-infection, correlating with the clearance of
virus from the lung (Sarawar et al., 1996). Little or no IL-4 or IL-5 (Th2 cytokines)
was detected, possibly due to high IFNy levels skewing cellular responses towards a
Thl environment or lack of IL-4 inducing a Th2 response. It is thought that IL-6 and
IL-10 may have a role in maintenance of persistent gammaherpesvirus infections
(Sarawar et al., 1996). IL-6-does not appear to play a significant role in vivo as there
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was no effect on lytic MHV-68 infection, nor the establishment or maintenance of
latent infection in 1L-6 deficient mice (Sarawar et al., 1998). A recent study has
shown that viral persistence results in significant upregulation of IL-10 production
from antigen presenting cells (primarily DCs but also B cells) resulting in diminished
T cell effector responses (Brooks et al., 2006). 1L-12 production from macrophages
and DCs is important for the development and activation of CD8 T cells and NK
cells. MHV-68 infection of IL-12p40 mice led to lower IFNy levels suggesting that
IFNy production is partly dependent on the presence of 1L-12 (Elsawa and Bost
2004). Chemokine levels peak around day 7 post-infection and are important for the
infiltration of T cells and monocytes. For example, the chemokine IP-10 and its
receptor CXCR3 are upregulated during MHV-68 infection. Mice deficient in
CXCR3 have delayed virus clearance from the lung accompanied by delayed T cell
recruitment (Lee et al., 2005). The importance of the chemokine family is
highlighted by the immune evasion mechanisms employed by MHV-68 to evade
them. MHV-68 encodes a chemokine-binding protein (M3; discussed further in
section 1.6.7.) as well as a CXCR2 chemokine receptor homologue (Virgin et al.,
1997).
1.6.5.4. B cells
B cells are important for the establishment of MHV-68 latency. General IgG2a and
IgG2b levels rise quickly following infection, to far higher levels than virus-specific
antibody production, and remaining high for at least 70 days post-infection (Sangster
et al., 2000). Virus-specific IgG remains low for the first 2 weeks of infection then
increases progressively over at least 70 days (Stevenson and Doherty 1998).
However, no significant difference in virus titres in the lung was observed in p.MT
compared to wt mice, suggesting little role for virus-specific antibody during acute




The importance of CD8~ T cells during MHV-68 infection has been demonstrated in
mice depleted of CD8T T cells. A lack of CD8+ T cell responses led to greatly
elevated infectious virus titres in the lung and spleen and eventual death (Ehtisham et
al., 1993). CD8" T cells are critical for clearance of virus from the lung. They have
also been shown to regulate the number of latently infected cells in the spleen. This
may be due to the actions of granzymes A and B which have been shown to be
important for control of acute phase latency although there is functional redundancy
between the two (Loh et al., 2004). Perforin/granzyme exocytosis is a major
mechanism of cytotoxic T cell killing. The function and activation of CD8+ T cells
during MHV-68 infection is not dependent on the co-stimulatory molecule CD28
(binds B7.1 [CD80] and B7.2 [CD86] on the surface of antigen presenting cells
leading to further activation events), as CD28-deficient mice could clear virus from
the lung with similar kinetics to wt mice and there was no significant difference in
cytotoxic T cell activity between CD28-deficient and wt mice (Lee et al., 2002).
MHV-68 encodes a CD8+ T cell evasion protein, K3. K3 ubiquitinates MHC class I
heavy chains in the ER, therefore targeting them for proteasome-dependent
degradation. A K3 mutant virus was attenuated in the establishment of latency in the
spleen and was accompanied by an increased frequency of virus-specific CD8^ T
cells. Depletion of CD8^ T cells reversed the attenuation observed in the spleen thus
illustrating the importance of CD8" T cell control of MHV-68 infection (Stevenson
et al., 2002).
1.6.5.6. CD4+T cells and IFNy
CD4' T cells do not play a major role in controlling MHV-68 infection in the lung
but are required for the development of splenomegaly and are responsible for aiding
the maturation and proliferation of B cells that lead to development of the antibody
response (Sangster et al., 2000). IFNy is required for CD4 " T cell-mediated control of
MHV-68 as demonstrated via depleting antibodies or in IFNy-deficient mice (Sparks-
Thissen et al., 2005). Short-term depletion of the CD4+ T cell subset made little
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difference to virus titres in the lung (Ehtisham et al., 1993). However, mice lacking
functional CD4+ T cells fail to control MHV-68 infection in the long term. Infection
of MHC class II-deficient mice led to increasing levels of latently infected
splenocytes and resulted in death by approximately day 120 post-infection (Cardin et
al, 1996).
IFNy alone is not sufficient to fully control MHV-68 infection even though it is
produced to high levels in infected tissues. There was little difference in lung virus
titres, cytotoxic T cell activity or cytokine environments between mice lacking
functional IFNy and wt mice, thus indicating a non-essential role for IFNy in the
control of acute infection (Dutia et al., 1997; Sarawar et al., 1997). However, IFNy
does aid control of chronic MHV-68 infection as a lack of IFNy leads to increased
reactivation from latency, increased persistent replication and severe vascular
arteritis (Steed et al., 2006). There is an increase of latently infected cells in IFNy R"
mice at 14-17 days post-infection as well as an infiltration of granulocytes during the
second week of infection. Fibrosis of the spleen develops accompanied by a loss of
B- and T-cells. It is thought that the splenic changes are mediated by CD8^ T cells
and, to a certain extent, CD4T T cells as depletion of each subset reversed the
changes (Dutia et al., 1997).
1.6.6. The immune response to EBV and KSHV
EBV-positive immunocompromised individuals can develop uncontrolled virus-
driven proliferation of B cells leading to a range of malignancies such as B-cell
lymphoproliferative disease. The EBV-disease associations for immunocompromised
individuals highlight the importance of the immune system in controlling EBV
infection. NK cell upregulation and activation has been shown to occur during EBV
infection and EBV-infected cells that enter the lytic cycle become susceptible to NK
cell killing (Pappworth et al., 2007; Williams et al., 2005). During IM, the NK cell
population is elevated at the time of diagnosis. This expansion lasted at least one
month post-diagnosis and the NK cells exhibited enhanced levels of cytotoxicity.
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The elevated NK cell numbers correlated with significantly lower EBV titres in the
peripheral blood (Williams et al., 2005).
An antibody response results in high IgM and developing IgG responses to lytic and
late antigens. Antibody responses to the gp350 antigen (on the viral envelope)
prevent binding to CD21 and therefore limit EBV spread (Crawford 2001). CD8" T
cells are critical for the control of acute infection with the majority of cells during
lymphocytosis being activated CD8+ T cells. During IM, CD8+ T cell responses are
predominantly towards lytic viral antigens and certain individuals may have up to
44% of their CD8^ T cells specific for one epitope from a lytic cycle protein (Callan
et al., 1998). CD8 T cells specific for lytic (predominantly) and latent epitopes
remain detectable during persistent infection, comprising 0.1-1% of peripheral CD8
T cells (Tan et al., 1999). CD4+ T cells do not become expanded to the same extent
as the CD8+ T cells. A study showed only 1.4% of CD4T T cells were EBV-specific
during IM and this fell to 0.22% during persistent infection (Amyes et al., 2003).
Less is known of the immune responses to KSHV. However, there has been a great
deal of investigation of the immune evasion genes encoded by the virus. 22/86
KSHV genes have putative immunoregulatory function. For example, K3 and K5
increase endocytosis of MHC class I molecules from the cell surface for degradation
in the lysosome (Coscoy and Ganem 2000) and thus lower viral antigen presentation
to CD8" T cells. K5 also lowers surface expression of CD86 and thus reduces
binding to the co-stimulatory molecule CD28 on T cells. The result of this is reduced
T cell activation by the infected, antigen presenting B cells (Rezaee et al., 2006).
KSHV has developed a number of other immune evasion genes. Three chemokine
homologues are encoded by K6, K4 and K4.1 and are called vCCL-1, -2 and -3
respectively. They preferentially induce a Th2 skewed response through binding of
the chemokine receptors CCR4 and CCR8 and thus reducing the efficiency of the
antiviral response (Rezaee et al., 2006). KSHV modulates apoptosis to facilitate
persistent infection and survival of lytically infected cells to aid viral replication. For
example, vFLIP inhibits Fas-mediated apoptosis by preventing activation of caspases
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3, 8 and 9 (Djerbi et al., 1999). Genes involved in innate immune evasion are
discussed in more detail in section 1.5.
1.6.7. MHV-76 and the role of the left-end of MHV-68
MHV-76 and MHV-68 were isolated at the same time; MHV-68 from the bank vole
(Clethrionomys glareolus) and MHV-76 from the yellow-necked mouse (Apodemus
flavicollis) (Blaskovic et al., 1980). The MHV-76 genome is identical to that of
MHV-68 except for a deletion of 9538 bp at the left end of the unique region
resulting in a lack of the genes Ml, M2, M3 and M4 and all the vtRNAs. It is thought
that MHV-76 is a deletion mutant of MHV-68, derived either through in vitro
passage or in nature (Macrae et al., 2001). MHV-76 replication in vitro occurs with
identical kinetics to MHV-68. However, MHV-76 is attenuated in vivo as it is cleared
more rapidly from the lungs of BALB/c mice during acute infection. This is
accompanied by a greater inflammatory response. A lower number of latently
infected cells in the spleen and a significantly reduced degree of splenomegaly were
also observed in comparison to MHV-68 infection. Nonetheless, MHV-76 can still
establish a long-term latent infection (Macrae et al., 2001). This study suggests that
the left end of the MHV-68 genome contains components important for viral
pathogenesis, possibly via the evasion of the host immune system.
The genes M1-M4 and the vtRNAs are present at the left end of MHV-68 and are
unique to the virus. The Ml gene exhibits sequence homology to poxvirus serine
protease inhibitors (serpins) and the M3 gene of MHV-68. However, deletion ofMl
does not appear to affect acute infection of the lung or establishment of latency in the
spleen although it is suggested to suppress viral reactivation (Clambey et al., 2000;
Simas et al., 1998).
M3 is an abundant protein, detectable during productive and latent infection (Simas
et al., 1999). It is a secreted, broad spectrum chemokine binding protein, binding all
chemokine classes, CC, CXC, C and CX3C but with no homology to known
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chemokine receptors, binding proteins or chemokines (Parry et al., 2000; Van Berkel
et al., 2000). This suggests a role as a novel immune evasion gene. Infection with an
M3-deletion virus did not affect the course of infection in either the lung or spleen.
However, the study did suggest that M3 is important during acute infection of the
CNS. The titre of an M3-deficient virus was 10-fold lower than wt MHV-68 after
intracerebral inoculation (Van Berkel et al., 2002). Chemokines are induced in the
CNS following MHV-68 infection suggesting that M3 may block chemokine-
mediated functions in a tissue-specific manner. It has been suggested that M3 may be
involved in reducing the inflammatory infiltrate and thus decreasing morbidity and
mortality in response to MHV-68 infection (Townsley 2004). It is possible that M3
plays a more important role in the natural host for MHV-68, the wood mouse
(Blasdell et al., 2003).
M4 is expressed as an i-E transcript and is detectable during lytic replication in the
lung and acute-phase latency in the spleen. When M4 was inserted into MHV-76
(MHV76inM4), it led to higher viral titres compared to MHV-76 at early time points
post-infection (Townsley et al., 2004). These findings suggest a possible
immunoregulatory role for M4 during the innate immune response. M4 has also been
shown to be important for the establishment of latency. Studies using a M4-disrupted
virus showed that there was a rapid decline in the numbers of latently infected
splenocytes from day 10 onwards, resulting in 100-fold less latent virus compared to
wt spleens by day 14 post-infection (Geere et al., 2006).
M2 is a latency-associated transcript, expressed only in B cells in the spleen, with no
discernible homology to other viral or cellular proteins (Husain et al., 1999; Macrae
et al., 2003). It contains an epitope recognised by CD8^ T cells so provides a target
for the cytotoxic T cell response to control latent infection (Husain et al., 1999).
Studies with a M2-deletion virus have suggested a role for M2 in the reactivation
from latency in splenic B cells and/or establishment acute-phase latency (Herskowitz
et al., 2005; Macrae et al., 2003). In vitro studies have suggested that the M2 protein
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may have a type I IFN evasion function. ISG15 expression was upregulated in the
presence of IFNa but not in the presence of IFNa and M2 (Liang et al., 2004). M2
expression was upregulated in IFNci/p R splenocytes, suggesting its regulation by
type I IFN during latent infection in vivo (Barton et al., 2005). It has recently been
discovered that M2 can interact with Vavl and Vav2 (Madureira et al., 2005). Vav
proteins promote GDP/GTP exchange on Rho/Rac proteins, facilitating rapid
transition of those GTPases from their inactive (GDP-bound) to active (GTP-bound)
states during signal transduction. Activation of Rho/Rac proteins leads to
cytoskeletal change, mitogenesis, and cell survival. These findings suggest a role for
M2 in B cell proliferation and survival during latent infection via signal transduction
through Vavl and Vav2 (Rodrigues et al., 2006). The 8 vtRNAs have been found to
be expressed during lytic and latent infection and can be detected in long-term
latency in the spleen but their function remains to be determined (Bowden et al.,
1997). Similarly, the nine predicted microRNAs of the left-end region of MHV-68
remain to be characterised.
1.7. Project outline
The role of the innate immune response in the control of gammaherpesvirus
infections has not been extensively characterised. The aim of this study was to
investigate the role of three innate immune components during MHV-68 infection.
Firstly, virus growth in various IFN knockout cell lines and type I IFN induction was
investigated during in vitro infection. The role of IFNP was further studied in vivo by
means of an IFNp" mouse model. The second aim was to investigate the role of
ISG12a following MHV-68 infection. Finally, the role of NK cells was investigated
by in vivo depletion of NK cells and by monitoring NK activation and cytotoxic
activity following infection.
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2. Materials & Methods
2.1. Cell Culture
2.1.1. Harvesting and Counting of Cells
Cells were maintained at 37°C (5% CO2) and were allowed to reach approximately
70% confluence before sub-culture. Firstly, growth medium was removed and the
cell monolayer washed with 0.02% (w/v) versene. Adherent cells were removed from
the culture flasks by the addition of 0.25% (w/v) trypsin (Invitrogen, UK) followed
by mild shaking. Trypsinisation was stopped by the addition of an equal volume of
fresh growth medium. Cells were centrifuged at 450 x g for 5 minutes and the pellet
resuspended in 10 mis of fresh growth medium. A 40 p.1 aliquot of cells were added
to 0.1% (w/v) trypan blue in a 1:1 dilution for counting. The viable cell count was
determined using the following calculation:
cells/ml = unstained cell count x dilution factor x 10"4cm3
Sterile plastic cell culture T175 flasks (Nunc) were seeded with an appropriate
number of cells in 40 mis of fresh growth medium.
2.1.2. Growth Media
Glasgow's Modified Eagles medium (GMEM) - supplemented with 10% (v/v)
tryptose phosphate broth (Invitrogen, UK), 10% new born calf serum (Invitrogen,
UK), 2 mM L-glutamine (Merck, BDH), 100 U/ml penicillin (Merck, BDH) and 100
U/ml streptomycin (Merck, BDEI).
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Roxwell Park Memorial Institute (RPMI) medium - supplemented with 10% foetal
calf serum, 2 mM L-glutamine, 100 U penicillin, 100 U/ml streptomycin, 50 pM 2-
mercaptoethanol and 25 mM HEPES.
Dulbecco's Modified Eagles Medium (DMEM) - supplemented with 10% foetal
calf serum (Invitrogen, UK), 2 mM L-glutamine, 100 U/ml penicillin and 100 U/ml
streptomycin.
2.1.3. Cell lines Used
Baby Hamster Kidney fibroblast cells (BHK-21) are an immortal fibroblastoid cell
line, originally derived from kidneys of one day old hamsters and were grown in
Glasgow's medium (Macpherson and Stoker 1962).
Yac-1 cells are murine T-lymphocyte leukaemia cell line originally derived from
inoculation of murine Moloney leukaemia virus into newborn A/Sn mice (Kiessling
et a/., 1975). These cells were grown in suspension in RPMI medium.
L929 cells are a fibroblastoid cell line from subcutaneous areolar and adipose tissue
of a 100 day old C3H/ An mouse. These cells were grown in DMEM.
2.2. Virus stocks
MHV-68, clone g.4, was grown in BHK-21 cells. BHK-21 cells were harvested and
counted as previously described. Cells were infected at MOI of 0.001 and incubated
at 37°C with shaking for 1.5 hours to enhance infection. Cells were subsequently
transferred to T175 flasks and incubated for 5-6 days until they reached 100%
cytopathic effect. Once this stage was reached, cells were removed from the flask
with a cell scraper (Nunc) and centrifuged 2000 x g for 20 minutes. The cell pellet
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was resuspended in a minimal volume of chilled, sterile PBS before homogenisation
with approximately 30 strokes of a chilled Dounce homogeniser. The homogenate
was transferred to a glass universal tube and sonicated in a sonicating ice bath for 15
minutes. The homogenate was centrifuged at 2000 x g for 20 minutes at 4°C. The
supernatant obtained following centrifugation was placed in a fresh universal tube
and kept on ice. The pellet was resuspended in 1 ml of sterile PBS, re-homogenised
and centrifuged at 2000 x g for 20 minutes at 4°C. The supernatants were pooled,
aliquoted and stored at -70°C. Virus titre was determined using a similar procedure to
the infectious virus assay (as described below), except a 20 pi aliquot was added to
180 pi ofGlasgow's growth medium to create the initial 1:10 dilution. lOOpl of 1:10
dilution was added to 900 pi growth medium to create a 1:100 dilution. A ten-fold




Wild-type C57BL/6 mice were bought from Harlan UK Ltd. IFNp knockout (ko)
mice on a C57BL/6 background were obtained from A. C. G. Porter, Imperial
College School of Medicine, London (Deonarain et al., 2000). np27 ko mice were
also obtained from A. C. G Porter, wt 129/Sv/Ev and wt 129/ola mice were obtained
from departmental stocks. Mice were housed under specific pathogen-free conditions
in HEPA filtered cages treated under the authority of a UK Home Office Animal
License.
2.3.2. Animal Infections
Mice were infected intranasally (i.n.) with 4xl03 or 4xl05 pfu of virus (in 40 pi of
sterile PBS) at 4-6 weeks of age. Mice were anaesthetised with halothane and
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euthanized via CO2 asphyxiation. At specific times post infection, various organs
were harvested for further analysis.
2.4. Genotyping
2.4.1. IFNp '" mice
Stocks of IFNp"'" mice were backcrossed with wt 129/Sv/Ev mice in order to obtain
appropriately matched control mice. Offspring were genotyped by PCR amplification
of the transgenic region to establish if (1) the green fluorescent protein (GFP) gene
was present and (2) the IFNP gene was absent. DNA was extracted from ear clip
samples by incubation in 50 pi 25 mM NaOH, 0.2 mM EDTA (pH12) at 95°C for 25
minutes with periodic vortexing to break up the tissue. The reaction was neutralised
by the addition of 50 pi of 40 mM Tris-HCl (pH5). 2 p.1 of DNA solution was used in
subsequent PCR reactions. Extracted DNA was stored at -20°C.
2.4.2. np27"/_ mice
DNA was extracted from ear clip samples as described for IFNP_/~ mice. 2 pi of
extracted DNA was used for PCR analysis using a GC-RICH PCR System Kit
(Roche).
2.5. Generation of MEFS
Mouse embryonic fibroblasts (MEFs) were isolated from IFNP~~ and np27v" embryos
at 13.5 days gestation. Neural and haematopoietic areas were removed and
embryonic tissue was minced and digested in two trypsination steps at 37°C for 10
minutes. After washing, MEFs were maintained in supplemented DMEM. IFN type I
receptor"" and wild type MEFs were obtained from B. M. Dutia's stocks.
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2.6. In vitro Assays
2.6.1. Infectious virus assay
In order to determine the virus titre within samples, tissues were homogenised in 1.8
mis ofGlasgow's medium and subjected to one freeze-thaw cycle in order to disrupt
cellular membranes. Upon thawing, homogenates were centrifuged (1300 x g, 5
minutes, 4°C) to get rid of any particulate matter. 440 pi supernatant was added to
3.96 ml of fresh Glasgow's medium to create a 1:10 dilution. A ten-fold dilution
series was created to which 2xl06 BHK-21 cells were added and shaken for 1 hour
(250 rpm, 37°C). 2mls of each dilution was added in duplicate to a 60 mm Petri dish
(Nunc) along with 3 mis ofGlasgow's medium. As a negative control, BHK-21 cells
were plated without the addition of supernatant. The plates were incubated for four
days at 37°C, 5% CCU. Cell monolayers were fixed with 4% neutral buffered
formalin and stained with 0.1% toluidine blue. Plaques were counted and the titre
determined by:
Viral titre (pfu/ml) = (average plaque count x dilution) / 2
2.6.2. Infective centre assay (ex vivo reactivation assay)
Determination of the ex vivo reactivation frequency from latently infected
splenocytes was carried out using the infective centre assay. Briefly, spleen cells
were teased out of the capsule with a scalpel blade into complete RPMI. The
suspension was transferred to a universal pre-rinsed with RPMI and was centrifuged
at 450 x g for 5 minutes. The supernatant was removed and the pellet was
resuspended in the remaining liquid. Erythrocytes were lysed with the addition of
lml sterile distilled water and osmolarity was corrected by the addition of 9mls of
sterile PBS. Excess cell debris was discarded and the remaining liquid was
transferred to a new pre-rinsed universal. The sample was then centrifuged at 450 x g
for 5 minutes. The supernatant was discarded and the pellet resuspended in 5mls
RPMI. Viable splenocytes were counted using trypan blue. Ten-fold dilutions of cells
were added to 1 x 106 BHK cells (in 5mls RPMI medium) in duplicate 60mm petri
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dishes and incubated at 37°C (5% CO2) for 5 days. Cell monolayers were fixed and
stained as described for the infectious virus assay.
The quantity of pre-formed infectious virus present in samples was determined by
subjecting splenocytes to one freeze-thaw cycle before titration according to the
infectious virus assay.
2.6.3. One step growth curve
A one step growth curve was carried out to compare the growth of MHV-68 in vitro
in IFNP"7", IFN type 1 receptor" ", np27"/_ and wild type MEFs. MEFs were infected in
suspension at an MOI of 5 for 1 hour at 37°C. Cells were pelleted by centrifugation
at 450 x g for 5 minutes and resuspended in 40mls of fresh DMEM three times to
remove unbound virus. 5 x 104 MEFs were seeded into each well of a 24 well plate
and at specific times post-infection, cell supernatants were removed and stored
separately, and fresh media added to the monolayer. Cells and supernatants were
harvested and subjected to three freeze-thaw cycles. Infectious virus was titrated on
BHK cells according to the infectious virus assay. All infections were carried out in
duplicate with each well titrated in duplicate.
2.6.4. Expression of GFP in IFNp '" MEFs
2 x 106 IFNp"'" MEFs were added to each well of a 6-well plate in 2 mis of DMEM.
Cells were allowed to settle into a monolayer for 1-2 hours before being infected
with MHV-68 at MOI of 5 pfu/cell. Cells were incubated at 37°C, 5% CO2. Wells
were investigated for the presence of GFP by examination under an inverted
fluorescence microscope at various intervals from 3 to 48 hours post-infection.
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2.6.5. Expression of eGFP in np27"'" MEFs
1 x 106 np27"A MEFs were added to each well in 6-well plates in 2 mis of DMEM.
Cells were allowed to settle into a monolayer for 1-2 hours before being treated as
detailed below:
Untreated
MHV-68 infected - MOI of 5 and 0.5
MHV-76 infected - MOI of 0.5
SFV (A774) infected - MOI of 0.5
Poly inosinic: poly cytidylic acid (poly I:C) treated - 100 pg/ml
IFNa in DMEM - either 200 or 1000 U
Cells were incubated at 37°C, 5% CO2. Wells were investigated for the presence of
eGFP by fluorescence microscopy at various intervals from 3 hours to 3 days post-
treatment.
2.7. Cryostat sectioning
Rapid freezing: Fungs were dissected out and reinflated via the trachea with 50%
water: 50% Tissue-Tek OCT (Sakura Finetek, USA). Tissues were frozen
immediately on dry ice/isopentane. Samples were stored at -70°C until required.
Slow freezing: Fungs were dissected out and the tissues fixed for 3 hours in 4%
paraformaldehyde (PFA) at room temperature (RT). PFA was removed and the lungs
reinflated with 50% water: 50% Tissue-Tek OCT. Embedded tissues were kept in the
dark for 24 hours at 4°C and then slowly frozen at -70°C in a box covered with
cotton wool.
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Tissue sections were cut at various thicknesses (6, 10, 15 and 25 pm) using a cryostat
chilled to -30°C before being transferred onto polylysine coated slides. Slides were
stored at -20°C until examination by fluorescence microscopy.
2.8. DNA Extraction
2.8.1. DNA extraction from lymphocytes
DNA was extracted from lymphocytes using a DNeasy Tissue Kit (QIAGEN, UK).
Approximately 1 x 107 cultured splenocytes or MLN-derived lymphocytes were
centrifuged for 5 minutes at 300 x g and the pellet resuspended in 200 pi PBS. 40 pi
proteinase K and 400 pi buffer AL were added before incubation overnight at 56°C.
Digestion was complete when no cell debris was visible in the sample. Following
digestion, 400 pi of ethanol was added before transfer of the sample to a DNeasy
mini spin column. The mixture was centrifuged at 6000 x g for 1 minute to bind the
DNA to the DNeasy membrane. Bound DNA was washed with 500 pi each of
buffers AW1 (6000 x g, 1 minute) and AW2 (20000 x g, 3 minutes) and
subsequently eluted in 150 pi of buffer AE (6000 x g, 1 minute).
2.8.2. DNA extraction from tissues
DNA was extracted from tissue samples using a DNeasy Tissue Kit (QIAGEN Ltd.,
UK) according to manufacturer's instructions. The amount of starting material varied
according to tissue type.
Whole lungs were homogenised in 2 mis lysis buffer (10 mM Tris-Cl [pH 8], 0.1M
EDTA [pH 8], 0.5% [w/v] SDS). 20 pi of proteinase K was added before samples
were incubated overnight at 56°C with occasional vortexing to help break up tissue.
200 pi aliquots were used in the DNeasy kit. Briefly, 200 pi buffer AL was added to
the samples and incubated for 10 minutes at 70°C. 200 pi ethanol was added and
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mixed thoroughly. The mixture was then applied to a DNeasy mini spin column
where DNA binding, washing and elution was carried out using the same procedure
as described for splenocytes. Extracted DNA was stored at -20°C.
2.8.3. Quantification of DNA
DNA concentration was determined by spectrophotometry (CE 2041, Cecil
Instruments). Samples were diluted 1 in 10 or 1 in 100 in dFEO. The
spectrophotometer was zeroed against water alone before sample readings were
taken at wavelengths of 260nm and 280nm. DNA concentration in unknown samples
was calculated by the following calculation:
concentration (ng/pl) = OD260 x dilution factor x 50
The absorbance ratio at 260 and 280nm was used to estimate the purity of the DNA
in samples.
2.9. Polymerase Chain Reaction (PCR)
2.9.1. Standard PCR
PCR amplifies a region of DNA between two oligonucleotide primers. During each
reaction cycle primers and template were denatured at a temperature of 94°C before
primers were allowed to anneal to the template sequence at a primer-pair specific
temperature. Sequence extension occurred at 72°C for approximately one minute per
kilobase of product length. The product synthesised in the first round can act as a
template in subsequent rounds, doubling the product with each round of
amplification. Standard PCR was carried out in a final volume of 50 pi in 0.5 ml
PCR tubes (Thermohybaid). Each PCR mix contained the following reagents: 100-
500 ng of sample DNA, 3 pi of 3 mM MgCE (Invitrogen, UK), 5 pi of lOx PCR
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buffer (20 mM Tris-HCl (pH8.4), 50 mM KC1, Invitrogen, UK), 50 pmol of each
primer (MWG Biotech, Germany), 100 pM of each of the deoxynucleotide
triphosphate bases (dNTPs [dATP, dCTP, dGTP and dTTP], Roche, UK) and 2 U of
Taq recombinant DNA polymerase (Invitrogen, UK). Typically master mix per
reaction was made up as follows.
lOx buffer 5 pi
MgCU 3 pi
dNTP 1 pi
primer 1 pi each
Taq 1 pi of a 1 in 3 dilution of stock
ddFUO 37 pi
DNA 2 pi
The volume was adjusted to 50 pi with water (RNase, DNase-free, Fluka, UK) in
each case. Reactions were overlaid with mineral oil (Sigma, UK). All reactions were
carried out in an Omnigene thermal cycler (Hybaid) using a hot start protocol. Tubes
were heated to 95°C for 3 minutes and held at 80°C prior to the addition of Taq in
order to ensure high specificity amplification of the product. Negative control
reactions lacking template DNA were included in each run. Cycling conditions and
primers used are listed in table 2.1.
2.9.2. Agarose Gel Electrophoresis
PCR products were electrophoresed on 0.5-2% (w/v) agarose (SeaKem, Flowgen,
UK) in TAE containing ethidium bromide (Sigma, UK). 3 pi of loading buffer
(0.25% [w/v] orange G, 15% [w/v] ficoll, Sigma, UK) was added to 10 pi of each
PCR sample before loading into the gel. 1 kb plus ladder (Invitrogen, UK) was
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included in each run to provide known molecular weight standards, allowing
estimation of DNA fragment size. Electrophoresis was performed at 70-90 V in
horizontal gel tanks containing TAE. Gels were viewed using a UV transilluminator.
2.9.3. Isolation of DNA fragments from Agarose
DNA fragments of interest were isolated from agarose using a QIAquick gel
extraction kit (QIAGEN, UK). Viewed under long-wave UV light, the correct sized
band of DNA was cut out using a sterile scalpel blade in as small a volume of
agarose as possible. The excised band was weighed and, assuming that 1 mg of gel
was equal to 1 pi, added to three volumes of QG buffer. The mixture was incubated
at 50°C for 10 minutes until the gel was completely dissolved. One volume of
isopropanol was added before the mixture was transferred to a QIAquick column and
centrifuged (1 minute, 20000 x g) to bind the DNA to the column membrane. Two
washing steps were performed with 500 pi of buffer QG and 750 pi of buffer PE. To
elute the DNA, 50 pi of buffer EB (10 mM Tris-Cl [pH8.5]) was applied to the
membrane and incubated for 1 minute at RT before centrifugation at 20000 x g for 1
minute. Eluted DNA was stored at -20°C.
2.10. RNA Extraction and Manipulation
2.10.1. RNA Extraction using a RNeasy Mini Kit (QIAGEN, UK)
4 x 106 cultured cells were washed in PBS to remove medium and pelleted at 300 x g
for 5 minutes. 350 jul of buffer RLT+P-mercaptoethanol was added and the sample
loaded onto a QIAshredder spin column (QIAGEN, UK) in order to homogenise the
cells. 350 p.1 of 70% ethanol was added to the lysate. The mixture was then added to
a RNeasy mini column and centrifuged for 15 seconds at >10000 x g to bind total
RNA to the column membrane. The column was then washed with 700 pi Buffer
RW1 once (spun 15 seconds at >10000 x g), then washed twice with 500 pi of Buffer
RPE (spun 15 seconds at >10000 x g then >10000 x g for 3 minutes). RNA was
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eluted from the column by centrifugation (>10000 x g, 1 minute) with 40 pi of
RNase-free water. RNA integrity was checked by gel electrophoresis and quantified
via spectrophotometry (CE 2041, Cecil Instruments). RNA was stored at -80°C.
2.10.2. DNase treatment of RNA
Contaminating DNA was removed from RNA preparations by the addition of
recombinant DNase I using DNA-free™ (Ambion, UK). 4 units of DNase 1 and 1 pi
of 10X DNase I buffer (100 mM Tris-HCl, pH 7.5, 25 mM MgCl2, 5 mM CaCl2)
were added to 10-15 jug RNA in a total volume of 13 pi. The mixture was incubated
at 37°C for 30 minutes. 2 pi of DNase inactivation reagent (Ambion, UK) was added
and the samples incubated for 2 minutes at RT. The inactivation reagent was pelleted
by centrifugation to avoid carryover into downstream reactions. 2-5 pg of DNased-
RNA was transferred into a fresh RNase-free tube for reverse transcription.
2.10.3. Reverse Transcription of RNA
cDNA was generated from RNA using Superscript™ II RNase H- Reverse
Transcriptase (Invitrogen). 2-5 pg of DNased-RNA was incubated for 5 minutes at
65°C in the presence of 200 ng of random primers (Amersham Biosciences, UK) and
100 pM of dATP, dTTP, dGTP and dCTP (Roche, UK) in a total volume of 12 pi.
The mixture was chilled on ice and incubated for 10 minutes at RT. 4 pi of 5X first
strand buffer (250 mM Tris-HCl, pH 8.3, 375 mM KC1, 15 mM MgCl2), 2 pi 0.1M
dithiothreitol and 40 U of RNaseOUT™ (Invitrogen) were added, mixed gently and
incubated for 5 minutes at room temperature followed by incubation at 42°C for 2
minutes. 200 U of Superscript™ II was added and the mixture was incubated at 42°C
for 50 minutes. The reaction was inactivated by incubation at 70°C for 15 minutes.
For reverse transcriptase-PCR, 2 pi of cDNA was used per PCR reaction in a PCR
mix as previously described. cDNA synthesis reactions without addition of reverse
transcriptase and PCR without the addition of template were included as control
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reactions. PCR products were run on 1% (w/v) agarose gels and visualised by
ethidium bromide staining.
2.11. Time course assay of IFN stimulation
Briefly, 4x106 L929 cells were infected in suspension with either MHV-68 (MOI of
10), MHV-76 (MOI of 10), poly I:C (100 pg/ml), 100 gg cycloheximide (Sigma) or
were left untreated. Cells were shaken for 1 hour (37°C) to allow virus to adsorb to
the cells before being transferred to tissue culture flasks and incubated at 37°C (5%
CO2). Cells were harvested at various times post-infection. When the effect of
cycloheximide treatment was investigated, cycloheximide was added to cells 30
minutes prior to the addition of virus. Mock-infected controls were included with the
addition of sterile PBS in place of virus after cycloheximide treatment. Poly I:C was
included as a positive control and was harvested at 5 hours post-infection.
Monolayers were removed and pelleted in DMEM, followed by two washes in ice
cold sterile PBS to remove any unadsorbed poly I:C or virus. RNA was extracted
from cell pellets and cDNA prepared as described above. RT-PCR was carried out
using primers specific for various groups of Type I IFNs. The cycling conditions are
shown in table 2.1.
2.12. Real-time PCR Analysis
2.12.1. Real-time PCR
Real-time PCR analysis was used to quantify viral genome load following DNA
extraction. Reactions contained 100 ng DNA. Levels of dsDNA product were
determined using the intercalating dye, SYBR green (Biogene, UK). Reaction mix
(total of 20 p.1) was made up as follows:
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10.75 pi ddH20
2 pi PCR Reaction Buffer (50 mM Tris-HCl, 10 mM KC1, 5 mM (NH4)2S04, 20 mM
MgCl2, pH8.8)
1 pi Primers (100 nM)
0.4 pi dNTPs (40 pM each of dATP, dTTP, dGTP, dCTP)
0.15 pi FastStart taq DNA polymerase (0.15 U) (Roche)
0.7 pi SYBR green
5 pi DNA
In all reactions, samples were initially denatured at 95°C for 10 minutes before 40
cycles of amplification were carried out. Cycling details are presented in table 2.1. A
10-fold serial dilution of a standard (either cloned template or a PCR amplified
fragment of a gene) was amplified in parallel during each run to generate a standard
curve. At the end of each PCR a melt curve analysis was performed during an
increase of temperature from 65°C to 94°C in order to determine the specificity of the
reaction. All runs were performed on a Rotorgene (Corbett Research, Australia) and
each sample or standard was run in triplicate. Genome copy number was calculated
from the cycle number at which the SYBR green signal crossed the threshold of the
standard curve. In addition to quantifying the viral genome, levels of the
housekeeping gene, P-actin, were quantified in order to normalise the levels of DNA
present within individual samples. The ratio of the p-actin content in relation to the
75th percentile of P-actin levels of all samples was calculated, giving a measure of
each sample's difference in relation to the 75th percentile. This ratio was then used to
normalise the viral gene of interest. This method was used for normalisation as
outliers do little to affect the 75th percentile value and therefore minimise the risk of
results being skewed in a particular direction.
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2.12.2. Generation of DNA standards for real-time PCR
P-actin
A DNA template was generated by taking the PCR product generated from outer
primers (IF & lR) and purifying it from agarose using a QIAquick gel extraction kit
(QIAGEN, UK) as described previously. The purified product's copy number was
quantified and 10-fold serial dilutions generated. Each dilution was used as a
template for real-time PCR using inner primers (2F & 2R) for amplification. The
copy number of the P-actin standard was calculated as shown below:
Concentration ofDNA = absorbance at 260nm x dilution factor x 50
= 0.016x 100x50
- 80 ng/jul
= 80 x 10"9 g/pil
Molecular weight of dsDNA P-actin fragment = no. base pairs x 660 Da
= 400 x 660
= 2.64 x 105 Da
1 mol = 2.64 x 105g
Copy number = Avogadro's constant x DNA concentration
Molecular weight
= 6.02 x 1023 x 80 x 10"9
2.64 x 105
= 1.82 x 10" copies/p.1
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Viral Gene Standards
M4 plasmid DNA (pCR2.1 Topo Cloning Kit, Invitrogen, plus a 1169bp insert from
the M4 gene) was prepared using an Endofree Plasmid Maxi Kit (Q1AGEN, UK).
The resultant plasmid preparation was cut with Eco R1 (New England Biolabs) and
quantified as described above. M3 and RTA standards were obtained from Kerra
Templeton.
2.12.3. Two Step PCR
At early time points in MLN tissue, viral load was low and thus close to or below the
limit of detection. To resolve this problem a two step PCR protocol was performed.
Briefly, 2pl of DNA was amplified in a standard PCR reaction with RTA (ORF50)
primers for 12 cycles of 94°C for 30 seconds, 66°C for 30 seconds and 72°C for 1
minute. The resulting PCR product was diluted 1 in 10 in ddfEO. 5 pi of diluted
product was used for 40 rounds of real-time PCR using the same primers.
2.13. In vivo Cell Depletions
2.13.1. Isolation of immunoglobulin from mouse serum
Blood samples were obtained from non-infected mice and allowed to clot for 1-2
hours at RT. Samples were centrifuged for 5 minutes at 3000 x g before serum was
aspirated off the blood clot. The volume of serum was measured and an equal
volume of saturated ammonium sulphate was added drop-wise whilst undergoing
continuous stirring for 30 minutes. The mixture was centrifuged for 10 minutes at
3000 x g. The pellet was resuspended in one volume of sterile PBS and added to
dialysis tubing before subsequent dialysis against PBS for 4 hours at 4°C.
Immunoglobulin was stored at -70°C.
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2.13.2. Quantification of serum Ig
The concentration of immunoglobulin in the resultant solution was quantified using
the BCA protein assay reagent kit (Pierce). Briefly, the presence of protein in the
alkaline medium results in reduction of Cu2" to Cu'f Cu'^ is detected by
bicinchoninic acid (BCA) and results in a colourimetric change (green to purple)
which exhibits a strong absorbance at 562 nm. Buffer WR was prepared using 50
parts of reagent A (Na2CC>3, NaHCC>3, BCA and sodium tartrate in 0.1M NaOH) to 1
part reagent B (4% cupric sulphate). 25 pi of unknown sample was added to 200 pi
buffer WR. The mixture was incubated at 37°C for 30 minutes before absorbance
was measured. The absorbance value was compared to a standard curve prepared
from a series of dilutions of known concentration (bovine serum albumin) in order to
quantify the immunoglobulin concentration in the samples.
2.13.3. Biotinylation of monoclonal antibody
Immunoglobulin (clone PK.136 (NK1.1)) was prepared by Dr B.M. Dutia and Y.
Ligerwood by growing hybridoma cells in protein-free medium, then concentrating
the medium. SDS PAGE analysis showed the concentrate was over 90%
immunoglobulin. The immunoglobulin concentration was quantified using the BCA
protein assay reagent kit (Pierce) as described above. PK136 was added to 0.1 M
NaHCCE buffer (pH8.5) at a concentration of l mg/ml along with biotin
(biotinamidocaproate N-hydroxysuccinimide ester, Sigma, UK) at 75 pg/ml. The
solution was mixed on a rotating mixer for 5 hours at RT before the reaction was
stopped with 500 pi of 5% (w/v) sodium azide. The mixture was dialysed overnight
at 4°C against 0.9% PBS, 0.01% azide before dialysis against PBS/20% glycerol for
4 hours. During each dialysis the buffer was replaced with fresh solution at regular
intervals. The biotinylated antibody was stored at 4°C until use.
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2.13.4. In vivo depletion of NK cells
To deplete NK cells, C57B1/6 mice were injected intraperitoneally with 200-500 pg
of NKl.l antibody (PK136 - unbiotinylated) in 200 pi of sterile PBS. Antibody
doses were given on days -2, -1 and +2 relative to infection (day 0). When
investigating the role of NK cells at later time points, for example, day 12 post
infection (p.i.), an additional dose of PK136 was administered at day 9. Control mice
were given comparable doses of control immunoglobulin isolated from non-infected
mouse serum as described above. The efficiency ofNK cell depletion was confirmed
by FACS analysis of both depleted and non-depleted splenocytes.
2.14. Fluorescence Activated Cell Sorting Analysis
2.14.1. FACS analysis of NK cell Depletion
During dissection, whole MLNs or a portion of the spleen were reserved for FACS
analysis in order to ensure the NK cell depletions were effective. Cells were teased
out of the MLN or splenic capsule into FACS buffer (0.1% sodium azide, 1% bovine
serum albumin in PBS) to create a single cell suspension. Erythrocytes were lysed by
the addition of 1 ml sterile distilled FEO followed by immediate addition of 9 mis
PBS. Cells were washed twice by being spun at 300 x g for 5 minutes then
resuspended in 2 mis FACS buffer. The pellet was resuspended before being counted
using white blood cell (wbc) counting fluid (5% glacial acetic acid, 2% ethanol (v/v)
in distilled FF>0 plus 1-2 drops of 2% methylene blue). For each mouse analysed,
approximately 5 x 106 lymphocytes were stained with the following antibodies 1.
fluorescein-isothiocyanate (FITC) - labelled anti-CD3 + biotin labelled PK136 +
phycoerythrin (PE) - labelled streptavidin (Pharmingen). 2. FITC - labelled anti-
CD3 + biotin labelled CD49b + PE - labelled streptavidin. Additional controls were
included for gating. These included unstained wbc and wbc stained with 1. PE-
labelled CD 19 alone and 2. FITC-labelled CD3 alone. Antibody suppliers are
detailed in table 2.2. Staining was carried out in a series of 20 minute incubations for
each antibody followed by two washing steps in FACS buffer and each incubation
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was carried out in the dark at RT. Prior to FACS analysis, virally infected cells were
fixed in 400jul FACS buffer + 2% formal saline. Non-virally infected samples were
stored in FACS buffer alone. Flow cytometry was performed on a FACScan using
CellQuest software (BD Biosciences). For each sample a minimum of 10000 events
was counted. Further analysis was carried out on WinMDI software.
2.14.2. Intracellular IFNy staining
MLNs were dissected from C57B1/6 mice at day 2 and 4 p.i. and placed in 2 ml
RPMI (without 2-mercaptoethanol) in the presence of 10 pg/ml Brefeldin A (BFA,
Sigma, UK). Cells were teased out of MLNs and erythrocytes lysed by the addition
of 1ml sterile distilled FLO followed by immediate addition of 9 mis PBS.
Lymphocytes were washed in staining wash buffer (SWB) (lx PBS, 2% FCS, 0.1%
NaNs) + BFA three times to ensure removal of media. lxlO6 cells were stained per
sample. FcR receptors were blocked by incubation with an antiCD16/CD32 antibody
(Pharmingen) for 15 minutes at 4°C before being washed once in SWB + BFA. NK
cell surface marker antibody, FITC-labelled CD49b (Serotec), was added and
incubated for 20 minutes at RT. Cells were washed in PBS + BFA before being fixed
in 2% neutral buffered formalin then placed in permeabilisation buffer (SWB + 0.5%
saponin). Cells were permeabilised for 10 minutes at RT before the addition of PE-
labelled IFN-y antibody (Pharmingen). Samples were incubated for 30 minutes on
ice, washed in PBS and resuspended in SWB for analysis. For a positive control, 1 x
106 cells were incubated in RPM1+BFA with phorbol 12-myristate 13-acetate (PMA)
(50 ng/ml) and ionomycin (500 ng/ml) (both Sigma, UK) for 4 hours at 37°C, 5%
CO2 before being stained as described above. An isotype control antibody was also
included. Flow cytometry was performed on a FACScan using CellQuest software
(BD Biosciences). For each sample a minimum of 50000 events was counted.
Further analysis was carried out using WinMDI software.
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2.15. Chromium Release Assay
2.15.1. Complement Depletion and preparation of effector cells
CD4+ and CD8* T lymphocytes or NK cells were removed from a mixed lymphocyte
population using a complement depletion method. Briefly, 4-8 MLNs were pooled
and the lymphocytes pelleted by centrifugation at 450 x g for 5 minutes. During this
spin, 500 pi of Low-Tox®-H rabbit complement (Cedarlane Labs) was added to
1500 pi of ice-cold RPMI and the mixture sterilised through a 0.2 pm sterilising
filter. Appropriate antibodies were added to give a final antibody concentration of
100 pg/ml. These included an anti-CD4 and anti-CD8 or an anti-NKl.l antibody as
detailed in table 2.2. 1 ml of the complement/antibody mixture was used to resuspend
the pelleted lymphocytes and incubated for 1 hour at 37°C on a shaker. After
incubation the cells were washed 3 times in fresh RPMI to remove any unused
complement then counted, pelleted and resuspended in RPMI for use in a
cytotoxicity assay. To confirm that complement depletion was successful, an aliquot
of 1 x 106 cells were removed for FACS analysis. A range of lymphocyte
concentrations were prepared from the complement depleted suspension to
correspond to various lymphocyte: target ratios in a total volume of 200 pi in the
appropriate wells of a 96-well tissue culture plate.
2.15.2. Preparation of target cells:
Yac-1 is a mouse lymphoma cell line that is particularly susceptible to NK cell
killing due to low expression ofMHC class 1 molecules on the cell surface. This cell
line was therefore chosen as target cells for cytotoxicity assays to measure NK cell
killing. On the day of the assay Yac-1 cells were pelleted and counted and 5 x 105
were aliquoted into a 15 ml tube per sample. If T lymphocyte killing was included in
the assay, Yac-1 cells were infected with MHV-68 (MOI of 5) overnight before use.
The aliquoted cells were pelleted and resuspended in the smallest volume ofmedium
possible prior to labelling. 50 pCi (1850 Bq) of the radioisotope 51Cr (Amersham
Biosciences) were added and the mixture incubated in a lead box at 37°C for 1 hour.
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Cells were then washed in RPM1 medium for 5 minutes at 300 x g to remove excess
extracellular 5lCr. This was repeated 3 times. 100 pi aliquots (1 x 104 cells) were
added to the wells of a 96 well round-bottomed tissue culture plate containing the
effector cells. To measure the spontaneous and maximum release of 5lCr from target
cells, 1 x 104 labelled cells were added to wells containing 100 pi of RPM1 only or
100 pi of 5% Triton X-100 (in PBS) respectively.
Target and effector cells were incubated together for 4-8 hours at 37°C in 5% CCA.
Each sample was run in triplicate. Post-incubation, the plate was centrifuged at 300 x
g for 5 minutes to pellet the cells at the bottom of each well. 100 pi of supernatant
was removed and transferred to a tube to be counted in an automatic gamma-counter.
The percentage of specific lysis was calculated using the following formula:
Specific percentage lysis = (test 51Cr release - spontaneous 5lCr release) X 100
(maximum 51Cr release - spontaneous release)
2.16. Fluorescence-based Cytotoxicity Assay
2.16.1. Magnetic Cell Sorting (MACS)
A NK Cell Isolation Kit (Miltenyi Biotech) was used to separate NK cells from
suspensions of MLN cells via an indirect magnetic labeling system. Non-NK cells
such as T cells, B cells, dendritic cells, granulocytes, macrophages and red blood
cells were removed from the suspension via a mixture of biotin-conjugated
antibodies against CD4 (L3T4), CD8a (Ly-2), CD5 (Ly-l), CD 19, Ly-6G (Gr-1) and
Ter-119. NK cells were left untouched to avoid antibody cross-linking of cell surface
proteins and thus non-specific activation of the cytotoxic response. Microbeads
conjugated to anti-biotin monoclonal antibodies were added to allow non-NK cells to
be retained on the MACS MS column while non-magnetically labeled NK cells were
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washed through using 2 mis MACS buffer (PBS pH7.2, 0.5% bovine serum albumin,
2 mM EDTA).
Aliquots of pre-separation lymphocytes, the post-separation NK-cell enriched
fraction and the post-separation non-NK cell fraction were labeled with an anti-NK
cell antibody (DX5 conjugated to FITC, Serotec) to assess the purity of the NK cell
enriched fraction by FACS analysis.
2.16.2. Cytotoxicity Assay
Preparation of effector lymphocytes: 4-8 female C57B1/6 mice of 4-6 weeks
of age were infected i.n. with 4 x 103 pfu MHV-68. Mice were sacrificed via CCF
asphyxiation at day 2 or 3 p.i. MFNs were harvested and pooled together in order to
get sufficient numbers to carry out the assay. A spleen was also harvested at the same
time point to provide additional lymphocytes for control samples when required.
Splenic lymphocytes were separated from erythrocytes by Ficoll-Hypaque 1077
density gradient centrifugation (Sigma). Due to small cell numbers and the presence
of an anti-erythrocyte antibody in the MACS kit, erythrocytes and lymphocytes from
the MFN were left as a mixed population. NK cells were isolated from a mixed
lymphocyte population by either complement depletion or MACS isolation as
described above. NK cells were counted in trypan blue to ensure viability.
Effector NK cells were pelleted at 300 x g for 5 minutes at room temperature before
being resuspended in 300 p.1 PBS. The green fluorescent dye, DIOCig (3,3'-
dioctadecyloxacarbocyanine perchlorate) (Sigma, UK) was used to stain the
membrane of the effector cells. 20 jul of DIOCig at 200 qg/ml in DMSO was added
to the cell suspension and incubated in the dark at 37°C for 30 minutes. Cells were
washed three times in PBS. Cells were transferred to fresh tubes between washes to
minimise carry-over of unbound DIOCis and thus non-specific staining.
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A range of NK cell concentrations were prepared to correspond to various
lymphocyte to target ratios. 100 pi of each concentration was added to the
appropriate wells of a 96-well tissue culture plate.
Preparation of target cells: Yac-1 cells in the log phase of growth were pelleted
and counted using trypan blue to ensure exclusion of dead cells. Cells were
resuspended at 5 x 105 per ml in complete RPMI. 5 x 104 cells in a volume of 100 pi
were added to 100 pi ofNK cells in each well.
Target and effector cells were incubated together for 4 hours at 37°C in 5% CCE.
Each sample was run in triplicate. Post-incubation, the contents of each well were
transferred to a 5 ml FACS tube. Each sample was washed twice in PBS before being
resuspended in 1 ml of FACS buffer. Samples were kept in the dark on ice until
analysis.
To detect the presence of dead cells, 2 pi of a 50 pg/ml solution of the red
fluorescent dye, propidium iodide (PI) (Sigma, UK) was added to each sample
immediately prior to analysis on a FACScan machine using Cell Quest software (BD
Biosciences). Each sample was run until at least 5000 unlabelled target events had
been acquired. Specific lysis (percentage of the target population killed) was
calculated by subtracting lysis in the absence of NK cells (spontaneous lysis) from
lysis in their presence. The average of three repeats was calculated for each sample.
Controls: To measure the spontaneous and maximum killing of target cells, 5 x 104
Yac-1 cells in 100 pi RPMI were added to wells containing 100 pi of RPMI only or
100 pi of 5% Triton X-100 (in PBS) respectively. As a positive control, 100 pg/ml of
poly I:C was added to an aliquot of NK cells in 1 ml of RPMI. The mixture was
incubated at 37°C, 5% CCE overnight. Post-incubation, cells were stained with
DIOC18, mixed with Yac-1 cells and incubated together in the well of a 96-well plate
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as described above. All control samples were run in triplicate and were stained with
PI to measure the proportion of dead cells. The percentage of specific lysis was
calculated using the following formula:
Specific % lysis = (release in presence ofNK cells - spontaneous lysis) X 100
2.17. Statistical analysis
Data was analysed with the non-parametric Mann-Whitney test unless otherwise
described.
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Table 2.1 (previous page). Primers Utilised in this Study. Cycling conditions: 1st line
indicates denaturing stage, 2nd line indicates annealing stage, 3rd line indicates
elongation stage and 4th line indicates number of cycles.
Table 2.2. Antibodies Utilised in this Study
Cell Surface
Marker
Clone Isotype Label Supplier
CD3 KT3 Rat IgG2a FITC Serotec
CD4 YTS 191.1 Rat IgG2b unlabelled In house
CD8 YTS 169 Rat IgG2b unlabelled In house
CD16/CD32 2.4G2 Rat IgG2b unlabelled Pharmingen
CD19 6D5 Rat IgG2a PE Caltag
CD49b DX5 Rat IgM Biotin Serotec
CD49b DX5 Rat IgM FITC Serotec
NK1.1 PK136 Rabbit IgG2a Biotin In house
IFNy XMG1.2 Rat IgGl PE Pharmingen
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Chapter 3: Role of the type I IFNs in the
control of a MHV-68 infection
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3. Role of the Type I IFNs in the Control of MHV-68 infection
3.1. Introduction
Type I IFNs are expressed almost immediately in response to virus infection. One
IFNP and 14 IFNoc genes have been found in the mouse genome, all of which share a
common dimeric receptor. Mice with a targeted disruption in an essential chain of
the type I IFN receptor gene (IFNa/p R"") have been used to study the role of type I
IFNs during virus infection. Using this system, type I IFN was shown to be important
during both RNA and DNA virus infections including lymphocytic choriomeningitis
virus, Semliki Forest virus and vaccinia virus (Van Den Broek et al., 1995).
The role of type 1 IFNs in gammaherpesvirus infections was highlighted by the
infection of IFNa/p R"" mice with MHV-68. Virus titres in the lungs of IFNa/p R"~
mice were 100- to 1000-fold higher than in wt mice and 90% of IFNa/p R" mice
infected with 4 x 10s pfu ofMHV-68 died by day 10 post-infection. In the spleens of
IFNa/p R" " mice there was an increased incidence of latently infected cells compared
to wt (Dutia et al., 1999). In addition, Barton et al. (2005) showed that infectious
virus was detectable in the spleens of IFNa/p R" mice by day 7 post-infection
whereas infectious virus can only be detected in the lungs of wt mice. These studies
show that type I IFN is critical for the control ofMHV-68 infection. The importance
of the type I IFN response to gammaherpesvirus infection is also highlighted by the
immune evasion strategies that have evolved to counteract its actions (see section
1.5).
In this study, the characteristics of the type I IFN response to MHV-68 have been
examined in vitro in order to further understanding of the control of
gammaherpesvirus infections. The left end of the MHV-68 genome has been
implicated as important for pathogenesis due to the attenuation of MHV-76
replication at early time points post-infection. It has been suggested that the M2
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protein may have a type I IFN evasion function. In vitro, ISG15 was upregulated 10-
fold in response to IFNa in the absence of M2. Conversely, minimal ISG15
induction was observed following IFNa stimulation when M2 was expressed in cells
(Liang et al., 2004). MHV-76 infection was investigated in order to determine if the
genes M1-M4 and the vtRNAs have an immune evasion function during the type I
IFN response.
It was of interest to further characterise the type I IFN response by specifically
investigating the role of IFNP during both in vitro and in vivo infection. Previous
studies have utilised IFNa/p R^'mice. This approach results in the whole type I IFN
system being disrupted but is convenient due to the difficulty of knocking out each of
the multiple IFNa genes present. Only a single IFNP gene is present and has thus
made the generation of an IFNp null strain of mice more straightforward. Mice that
lack the IFNP gene have been shown to be more susceptible to vaccinia virus
infection, succumbing to doses that are sub-lethal to wt mice (Deonarain et al.,
2000).
The aims of this study were to (1) investigate type I IFN responses to a
gammaherpesvirus infection in vitro, (2) elucidate the role for IFNP specifically
during in vitro and in vivo infection and (3) examine and compare type I IFN
responses to MHV-68 and MHV-76 infection to elucidate a role for the left end of
the genome in immune evasion.
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3.2. Role of Type I IFNs in the control of MHV-68 in vitro
3.2.1. In vitro stimulation of type I IFNs by MHV-68 or MHV-76
The kinetics of induction of type I IFNs differ in response to virus infection. In
general, IFNa4 can be produced rapidly post-infection, without the need for de novo
protein synthesis but other IFNa subtypes such as IFNa5 have delayed induction and
rely on the synthesis of IRF-7 produced in response to early IFN production. This
results in the establishment of a positive feedback loop (Harle et al, 2002; Marie et
al., 1998). The ability of MHV-68 to induce type I IFN and thus the kinetics of
induction following MHV-68 infection were examined in vitro. It was also of interest
to investigate IFN induction by MHV-76 infection. Would the lack of the genes Ml-
M4 and the vtRNAs in MHV-76 lead to altered kinetics of IFN production in
comparison to MHV-68? To address this question, the induction of type I IFNs
following infection was examined in a time course assay. L929 cells were infected
with either MHV-68 or MHV-76 (MOl of 10) before being allowed to settle into a
monolayer. Cells were harvested at 0.5, l, 2, 3 and 5 hours post-infection, then RNA
extracted and cDNA prepared. The synthetic double-stranded RNA poly I:C was
added to cells in order to act as a positive control due to its ability to strongly induce
type I IFN responses. It was found that I00p.g/ml of poly I:C was sufficient to
stimulate IFN responses in this assay. Primer pairs designed to detect various IFN
transcripts were designed by Deonarain et al. (Deonarain et al., 2000) and purchased
from MWG: one specific for IFNp, another specific for IFNa4, one to detect all
IFNa transcripts apart from IFNa4 (IFNnona4) and one to detect all IFNa subtypes
(universal IFNa). Optimisation of the cycling conditions for each primer pair was
carried out using cDNA extracted from poly I:C stimulated cells. The optimal
cycling conditions are shown in table 2.1. Unfortunately, optimisation failed to avoid
non-specific binding and band smearing when using the universal IFNa primer pair.
As all IFNa transcripts could be detected by either the IFNa4 or IFNnona4 primers
a decision was made to not use the universal IFNa primers further. Results from the
RT-PCR analysis are shown in figure 3.1. P-actin was readily detectable for each
sample ensuring that cDNA was present and of suitable quality. Band intensity
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indicated that there were similar amounts of cDNA in each sample. For each PCR,
IFN could be readily detected in samples stimulated with poly I:C demonstrating that
each PCR resulted in a band of the expected size. These data show that both MHV-
68 and MHV-76 readily induced type I IFN within hours of infection. After infection
with MHV-68 a band for IFNp could be detected by 1 hour post-infection. Following
infection with MHV-76, IFNP transcripts could be detected by 2 hours post-infection
in two separate experiments. IFNa4 was detectable from 1 hour post-infection
onwards in both the MHV-68 and MHV-76 samples in two separate experiments.
Although the assay is not quantitative, the induction of IFNa4 appeared to be
stronger than the induction of other transcripts examined. The stimulation of the
other IFNa subtypes was investigated using the IFNnona4 primers. In the MHV-68
infected samples IFNnona4 transcripts were detectable by 3 hours post-infection
whereas transcripts were detectable at 2 hours post-infection in the MHV-76 infected
samples in the PCR shown in figure 3.1. However, these differences were not
consistently repeated as detection varied between 2 and 3 hours in a further repeat of
this assay indicating that the results of these experiments were dependent on sample
to sample variability. It was concluded that no consistent difference in the induction
of IFN transcripts between viruses could be observed by this technique. However,
the later detection of IFNnona4 does agree with previous findings that IFNa4 is a
rapidly expressed transcript whereas other IFNa subtypes have a delayed induction.
Cycloheximide (CHX) is a protein synthesis inhibitor that acts specifically on the
60S subunit of eukaryotic ribosomes. Cells were treated with lOOpg of CHX for 30
minutes prior to the addition of either MHV-68 or MHV-76. Cells treated with CHX,
but not virus, were included as controls for any IFN induction due to CHX treatment
alone. Cells were harvested at 5 hours post-infection in order to investigate the
ability of the virus to induce IFN transcripts in the absence of viral protein synthesis.
However, the results obtained with either CHX alone or CHX plus virus were
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Figure 3.1. RT-PCR analysis of IFN induction post-infection. Cells were infected with either
MHV-68 or MHV-76. cDNA was prepared from RNA extracted from L929 cells at specific
times post-infection. RT-PCR was performed using primers specific for various type I IFNs in
addition to murine p-actin. In each PCR, Poly l:C was included as a positive control and was
harvested at 5 hours p.i. A sample containing no cDNA was included as a negative control
and a RNA sample was included without the addition of reverse transcriptase to control for
the carryover of DNA in the reaction (data not shown).
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inconsistent. IFN was detectable in some assay repeats, but not others and was
evident even when no virus was present and thus no conclusions could be drawn.
This technique could have been pursued further but as no particularly fruitful results
were obtained it was decided to explore other aspects of the type I IFN response to
MHV-68 infection.
3.2.2. Genotyping of mice
IFNp" mice were generated by Deonarain et al., (2001), whereby a targeting
construct was used to replace the IFNp gene with a green fluorescent protein (GFP)
reporter gene as shown in figure 3.2. HM-1 embryonic stem cells transfected with the
GFP construct were injected into C57BL/6 blastocysts and the chimeras showing
efficient germ-line transmission were crossed with C57B1/6 mice to generate a
IFNP+/" F1 generation (Deonarain et al., 2000). The heterozygous littermates were
crossed to generate IFNP"/+, IFNP " and IFNP" mice. We obtained IFNp_/" mice to
study the role of IFNp during MHV-68 infection. PCR analysis using DNA extracted
from ear biopsy tissue confirmed the presence of the GFP gene (513bp product) and
absence of the IFNp gene (717bp product) in the IFNP"'" mice (figure 3.2).
3.2.3. MHV-68 replication in IFN knockout cell lines
Single step growth curves were carried out in order to assess the involvement of type
I IFNs during MHV-68 replication in vitro. It was hypothesised that MHV-68
infection of cells lacking IFNP and IFNa would result in lesser control of virus
replication and thus higher viral titres than a wt cell line. Correspondingly, a cell line
lacking only IFNP would result in MHV-68 titres that were intermediate to the
IFNa/p R"" and wt cell lines. The single replication cycle ofMHV-68 was assessed
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Figure 3.2. Genotypic analysis of IFNp"'" mice. (A) Schematic diagram of the generation of
IFNp ko mice. (B) Representative PCR for the genotyping of IFNp"'" x wt 129/Sv/Ev crosses.
DNA was extracted from mouse ear biopsy tissue at 3 weeks of age. PCR was performed
using primers specific for IFNp (717bp product) and GFP (513bp product). Lane 7 shows the
result from an IFNp_/" mouse, lanes 1 and 4 show wt mice and 2, 3, 5, 6 and 8 show
heterozygous mice. A reaction containing no DNA template was included to control for cross-
contamination of samples (data not shown).
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in three mouse embryonic fibroblast (MEF) cell lines. The first lacked all type I IFN
responses (IFNa/p R") due to disruption of the shared type I IFN receptor. The
second lacked IFNp (generated from 13.5 day old IFNP"" embryos) and the third was
a wt cell line. Cells were infected with MFIV-68 at MOI of 5 pfu/cell and duplicate
samples taken at intervals from 0 to 72 hours post-infection. At each time point,
media was removed from the well and titrated separately from the cell monolayer to
examine both cell-associated and cell-free virus. No supernatant sample was taken at
0 hours post-infection as cells had not settled into a monolayer and therefore cell
associated and cell free virus could not be separated. Samples were titrated in
duplicate on BHK-21 cells. When cell-associated virus and cell-free virus were
examined together, it appeared that MFIV-68 replicated with similar kinetics in all
three cell types (figure 3.3). However, when cell-associated virus was examined
independently there were increased levels of cell-associated virus in the wt MEFs in
comparison to the IFNP"" and IFNa/p R" MEFs from 12 hours post-infection
onwards. Conversely, it was evident that from 12 hours post-infection onwards there
were increased levels of cell-free virus in the IFNa/p R"" MEFs than in either the
IFNP"" or wt MEFs. It was decided to repeat the 12 and 24 hour time points on two
further occasions to determine if this effect was reproducible. Cell-free viral titres at
12 and 24 hours post-infection are shown in figure 3.4 and cell-associated viral titres
at 12 and 24 hours post-infection are shown in figure 3.5. In each figure, panels A
and D show results obtained during the full growth curve analysis whereas the other
panels represent data from the two individual repeat experiments focusing on 12 and
24 hours post-infection. These data show that the titres ofMHV-68 tend to be higher
overall in IFNa/p R"~ MEFs in comparison to IFNP" " and wt MEFs. The majority of
virus in the IFNP"'" and wt MEFs is cell-associated rather than cell-free, whereas a
higher proportion of virus was detected in the supernatant of the IFNa/p R " MEFs
compared to the other cell types. The titres of cell-free virus in the IFNP"'" and wt cell
lines were small in comparison to the viral titres from the IFNa/p R" MEFs. The
difference in viral titre between the IFNP"'" and wt MEFs was not as striking as for
the IFNa/p R " MEFs. However, in 2/3 cases at both 12 and 24 hours post-infection,
the titre of cell-associated virus in the wt MEFs was higher than in the IFNP"" MEFs.
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Figure 3.3. Single-step replication of MHV-68 in IFNa/p R~'~, IFNp~'~ and wt MEFs in vitro.
Cells were infected with an MOI of 5 and harvested at various times p.i. Values represent
two separate experiments with each sample titrated in duplicate. Data points represent the
log-io of the virus titre ± standard error of the mean (SEM). The combined viral titres from
both the cells and the cell supernatant are shown in panel A. B represents cell associated
virus only and C represents cell-free virus only.
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Figure 3.4. Titres of cell-free virus in the supernatant of IFNcx/p R"/_, IFNp_/" and wt MEFs at
12 and 24 hours p.i. MEFs were infected with MHV-68 at an MOI of 5 and harvested after 12
(A-C) or 24 (D-F) hours p.i. Each time point was assayed independently on three occasions
and each experiment is shown as a separate graph. Cells were removed and assayed
separately (see figure 3.5). Values represent the virus titre ± standard error of the mean
(SEM) from two independent experiments with each sample titrated in duplicate. Red bars
denote IFNa/p MEFs, blue bars denote IFNp_/" MEFs and black bars denote wt MEFs.
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Figure 3.5. Titres of cell-associated virus in IFNa/p R"7", IFNp_/~ and wt MEFs at 12 and 24
hours p.i. MEFs were infected with MHV-68 at an MOI of 5 and harvested after 12 (A-C) or
24 (D-F) hours p.i. Each time point was assayed independently on three occasions and each
experiment is shown as a separate graph. Cell supernatant was removed and assayed
separately (see figure 3.4). Values represent the virus titre ± standard error of the mean
(SEM) from two independent experiments with each sample titrated in duplicate. Red bars
denote IFNa/p MEFs, blue bars denote IFNp"7" MEFs and black bars denote wt MEFs.
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Conversely, in 3/3 cases at both 12 and 24 hours post-infection, the titre of cell-free
virus in the IFNp7" MEFs was higher than in the wt MEFs. These data suggest that
the viral titres in the IFNp"" MEFs are reflecting the increased proportion of cell-free
virus observed in the IFNa/p R~ " MEFs but to a lesser extent. No statistical analysis
was carried out on these data as there was too much variation in titres between the
first experiment and the further two repeats, hampering reliable interpretation.
3.3. Role of IFNp in the control of MHV-68 in vivo
Studies using mice that lack a functional IFNa/p receptor have highlighted the
importance of the Type I IFNs during MHV-68 infection. IFNp7" mice were used in
this study in order to investigate specifically the role of IFNp during MHV-68
infection. It was hypothesised that a lack of IFNP would result in an intermediate
pathology between that observed in IFNa/p R7" and wt mice. As the IFNp7" mice
were derived from a HM-1/C57B1/6 mixed background, and there was no HM-
1/C57B1/6 wt mice with which to obtain littermate controls, C57B1/6 mice were
chosen to act as controls during initial in vivo studies.
IFNp7" and C57BL/6 mice were infected intranasally with 4 x 105 pfu of MHV-68
and tissues were harvested at day 3, 5, 7 and 10 post-infection. Lytic replication in
the lung was investigated by infectious virus assay and the results are shown in
figure 3.6. At 3 days post-infection, the titre of MHV-68 was similar in the IFNP""
and wt lungs but by day 5 post-infection there was significantly more virus in the
IFNp7" lung compared to the wt lung (p=0.0286). By day 7 post-infection the
difference between the two groups was resolved and virus in the wt and IFNP" " lung
was cleared by day 10 post-infection. Establishment of latency in the spleen was
determined by ex vivo reactivation assay and the results are shown in figure 3.7.
Infective centres could be detected in both the IFNP" " and wt spleen by day 5 post¬
infection with a peak of latency observed between 10 and 14 days post-infection.
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Figure 3.6. Viral titre in the lungs of IFNp ko or wt mice. Mice were infected intranasally with
4 x 10s pfu of MHV-68. Lungs were harvested at days 3, 5, 7 and 10 post-infection and virus
titre was determined by infectious virus assay. Each data point represents the virus titre from
individual mice and the solid line represents the mean virus titre for each group. The dashed
line represents the limit of detection (10 pfu) for this assay. Groups that have mean values
that vary significantly (p< 0.05) by Mann Whitney test are indicated by *.
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Figure 3.7. Latent virus in the spleens of IFNp ko and wt mice. Mice were infected
intranasally with 4 x 105 pfu of MHV-68 and spleens were harvested at days 5, 10, 14 and 21
post-infection. Latent virus titre was determined by infective centre assay. Each data point
represents individual mice and the solid line represents mean latent virus for each group.
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There was no significant difference in viral titres between the wt and IFNP"'" mice at
any time point investigated. Similarly, there was no notable difference in the degree
of splenomegaly between both groups (figure 3.8) as measured by whole spleen
weight.
Given the encouraging results obtained in the initial experiment it was decided that it
might be beneficial to cross the IFNP"'" strain onto a wt 129/Sv/Ev background to
obtain age-matched wt littermates as the most appropriate controls and ensure a more
accurate background match between the wt and IFNP"" mice. Genotypes of the
resultant litters from the IFNp"'" x wt 129/Sv/Ev crosses were determined by PCR
analysis using DNA extracted from ear biopsy tissue. The presence of the GFP gene
was confirmed with a 513bp product and the presence of the IFNP gene was
confirmed by a 717bp product. An example of PCR analysis of littermate genotypes
is shown in figure 3.2.
It was decided to repeat the in vivo analysis using IFNP"'" and wt littermates derived
from crossing the F1 heterozygotes. These mice were thus a better match than the
mice used in the initial experiment. The experiment was carried out using a lower
dose of virus to further elucidate subtle differences in MHV-68 pathogenesis
between the IFNP"'" and wt mice which may have been obscured during infection
with a higher dose of virus. IFNP"" and wt mice were infected intranasally with
4x103 pfu ofMHV-68. Tissues were harvested at days 5, 7, 10 and 14 post-infection.
The level of lytic replication in the lung was determined by infectious virus assay
and the results are shown in figure 3.9. The viral titres in the lungs of the IFNP"'"
mice rose more quickly, peaking at day 7 post-infection, whereas viral titres in the wt
lungs peaked at day 10 post-infection. At day 7 post-infection, the titre of virus in the
IFNP"'" lung was significantly higher than in the wt lung (p=0.0286). By day 10 the
difference had resolved and the infection had cleared from the lungs of both groups
by day 14 post-infection. Real-time PCR was used to confirm the difference in virus
titre between the IFNP" " and wt lungs at day 7 post-infection (figure 3.10). DNA was
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Figure 3.8. Whole spleen weights in IFNp and wt mice. Mice were infected intranasally with 4
x 105 pfu of MHV-68. Spleens were harvested at days 5, 10, 14 and 21 post-infection. Data
points represent the whole spleen weights of individual mice and the solid line represents the
mean spleen weight for each group.
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Figure 3.9. Viral titre in the lungs of IFNp ko or wt mice. Mice were infected intranasally with
4 x 103 pfu of MHV-68. Lungs were harvested at days 5, 7, 10 and 14 post-infection. Virus
titre was determined by infectious virus assay. Each data point represents the virus titre from
individual mice and the solid line represents the mean virus titre for each group. The dashed
line represents the limit of detection (10 pfu) for this assay. Groups that have mean values
that vary significantly (p< 0.05) by Mann Whitney test are indicated by *.
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Figure 3.10. Viral load in the lungs of IFN(3 ko or wt mice at day 7 post-infection. Mice were
infected intranasally with 4 x 103 pfu of MHV-68. Viral load was determined by real time PCR
using primers specific for the viral gene, M3 and normalised as determined by the level of p-
actin within each sample. Each data point represents the viral load from individual mice and
the solid line represents the mean viral load for each group. Groups that have mean values
that vary significantly (p< 0.05) by Mann Whitney test are indicated by *.
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extracted from lung tissue and the viral load was determined using primers specific
for the viral gene, M3. The data were normalised as determined by the level of p-
actin within each sample. The groups were found to be significantly different
(p=0.0286), thus agreeing with both infectious virus assays carried out on the groups
infected with either the low or high doses of virus. Latent virus in the spleen was
assessed by ex vivo reactivation assay and the results shown in figure 3.11. Virus was
detectable in both groups by day 10 post-infection. From day 10 onwards there was a
trend towards higher levels of latent virus in the IFNP"" spleens compared to the wt
spleens. However, this was not significant at any time point investigated. Although at
day 14 post-infection the viral titres in the IFNp~" group appeared higher than the wt
group, there were only two members in the IFNP"" group so no statistics could be
performed. Likewise, there was a trend towards a higher degree of splenomegaly in
the IFNp7" spleen compared to the wt spleen at day 14 and 21 post-infection (figure
3.12). Again, no statistics could be performed at day 14 post-infection as there were
only 2 mice in the IFNp"" spleen group. At day 21 post-infection, the difference in
spleen weight between the IFNp7" and wt groups was almost at significance
(p=0.0571).
3.4. Infection of IFNp '- mice with MHV-68 and MHV-76
MHV-76 replication is attenuated during in vivo infection, being cleared more
rapidly from the lung than MHV-68. Previous studies in BALB/c mice have shown
that MHV-76 viral titres in the lungs are approximately 1 log lower than MHV-68
titres at day 7 post-infection (Macrae et al., 2001). It was hypothesised that if a
component of the left end of MHV-68 was involved in regulation of the IFNp
response, a lack of IFNp would confer an advantage to MHV-76 and it would be
cleared from the lung with similar kinetics to MHV-68. To address this hypothesis,
IFNP" " mice were infected intranasally with 4 x 103 pfu of either MHV-68 or MHV-
76. Lungs were harvested at days 3, 5, 7 and 10 post-infection. Infectious virus
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Figure 3.11. Latent virus in the spleens of IFNp ko and wt mice. Mice were infected
intranasally with 4 x 103 pfu of MHV-68. Spleens were harvested at days 5, 10, 14 and 21
post-infection and latent virus was determined by infective centre (i.e.) assay. Each data
point represents individual mice and the solid line represents mean latent virus for each
group.
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Figure 3.12. Whole spleen weights in IFNp and wt mice. Mice were infected intranasally with
4 x 103 pfu of MHV-68. Spleens were harvested at days 5, 10, 14 and 21 post-infection. Data
points represent the whole spleen weights of individual mice and the solid line represents the
mean spleen weight for each group.
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assays were carried out to assess the productive infection in the lungs (figure 3.13).
There was no difference between the MHV-68 and MHV-76 titres at day 3 and 5
post-infection and the titres of both groups reached a peak around day 5 post¬
infection. At day 7 post-infection, the mean viral titre (6625 pfu/lung) of the MHV-
68 group was significantly higher than the mean (712.5 pfu/lung) of the MHV-76
group (p=0.0286). In agreement with previous findings in wt mice (Macrae et al.,
2001), these data show an approximate log difference between the two groups at day
7 post-infection. Both viruses were cleared from the lung by day 10 post-infection.
These data show that even in the absence of IFNP MHV-76 is cleared from the lung
faster than MHV-68, therefore suggesting that components of the left end of the
MHV-68 genome do not interfere greatly with the IFNP response.
3.5. Further Studies
The wt and IFNP"" mice littermates used for investigating MHV-68 infection
continued the results of the first experiment and suggested that virus might be
trafficking to the spleen faster in the IFNP"'" mice. To confirm these results more
mice were required. One problem that has arisen during the breeding of the matched
littermates was that although the expected ratio of mice was 2:1:1 for heterozygous:
wt: ko, more heterozygotes were usually obtained than expected and thus it was
difficult to obtain sufficient numbers of wt or ko mice. It was therefore decided to
backcross the IFNP"'" mice onto wtl29 to produce IFNP"" mice on the 129/Sv/Ev
background. After two years of crossing, backcrossed homozygous IFNP" " and wt
mice were obtained following approximately seven generations. Unfortunately, there
was an outbreak ofmouse hepatitis virus in the animal unit in which they were being
housed. Neonatal IFNP"'" mice appeared weak and the majority died before they
could be weaned. Prior to the MHV infection there was no problem with the health
of these mice and it is possible that the pups were succumbing to MHV infection. A
decision was made to re-derive the IFNP"" mice from heterozygotes in order to
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Figure 3.13. Viral titre in the lungs of IFNp ko mice. Mice were infected intranasally with 4 x
105 pfu of either MHV-68 or MHV-76. Lungs were harvested at days 3, 5, 7 and 10 post¬
infection. Virus titre was determined by infectious virus assay. Each data point represents
the virus titre from individual mice and the solid line represents the mean virus titre for each
group. The dashed line represents the limit of detection (10 pfu) for this assay. Groups that
have mean values that vary significantly (p< 0.05) by Mann Whitney test are indicated by *.
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produce 'clean' mice. Therefore it was not possible to carry out further experiments
in the available time.
3.6. Analysis of MHV-68 cell tropism
IFN|3 is expressed at early time points following viral infection and is secreted from
infected cells to protect neighbouring cells in a paracrine fashion. In IFNP"" mice, the
IFNp promoter drives expression of GFP and therefore, GFP should be expressed in
and around MHV-68 infected cells. It was decided to utilise this system to
investigate the extent of MHV-68 infection in the lung and proceed to determine the
MHV-68 cell tropism. IFNP"" and wt 129/Sv/Ev mice were infected intranasally with
4 x 105 pfu of MHV-68. Lungs were harvested at day 5 post-infection, re-inflated
and frozen before cryostat sections were prepared. Sections were examined under a
fluorescent microscope for the presence of GFP-expressing cells, signalling the
induction of IFNp following infection. Unfortunately, no GFP-expressing cells could
be detected and it was postulated that this may have been due to high background
fluorescence. It was suggested that paraformaldehyde used for fixation may have
been contributing to background fluorescence via binding to elastin in the lung
tissue. However, when unfixed sections were examined background fluorescence
remained high. It was decided to try a slow freezing protocol designed to better
preserve the structure of the fluorescent protein (Shariatmadari et al, 2001). When
sections were examined, the background fluorescence was reduced but no GFP
expression could be detected. Similarly, infection of IFNP"" MEF monolayers with
MHV-68 (MOI of 5 pfu/cell) failed to generate detectable GFP by examination under
a fluorescence microscope. As GFP could not be detected the cell tropism ofMHV-
68 was not investigated further.
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3.7. Discussion
This study has used in vitro assays and transgenic mice to further understanding of
the type I IFN response to MHV-68 infection. The kinetics of IFN expression
following MHV-68 and MHV-76 infection were investigated by RT-PCR analysis.
To the best ofmy knowledge, this is the first study to show definitively that MHV-68
leads to the induction of type I IFN at early time points post-infection. As expected,
IFNa4 and IFNP transcripts were detected early post-infection, followed by the
expression of the other IFNa subtypes (IFNnona4). This supports previous studies in
which IFNp and !FNa4 were found to be expressed almost immediately, amplifying
their expression through induction of IRF-7 which subsequently leads to the
expression of other IFNa subtypes (Marie et al., 1998; Prakash et ah, 2005). A
recent study has shown that there are cell-type specific differences in the mechanism
of type I IFN production. IFN production was determined to be IRF-7 dependent in
most tissues, including the lungs, of influenza virus-infected mice, consistent with
the requirement of a positive feedback loop. However, plasmacytoid dendritic cells
(pDCs) in the spleen constitutively expressed high levels of IRF-7 and thus produced
high levels of type I IFN rapidly in response to virus infection (Prakash et al., 2005).
It is likely that positive feedback is the mechanism of type I IFN induction in the
tissue culture cell lines employed in this in vitro assay. Some viruses such as
lymphocytic choriomeningitis virus induce IFN only by positive feedback as they do
not stimulate IFN production from pDCs (Dalod et ah, 2002). This study has shown
that MHV-68 can induce type I IFN during in vitro infection. However, given the
difference in host responses between viruses in vivo, it would be of interest to further
investigate mechanisms of type I IFN induction in various cell types and tissues in
response to gammaherpesvirus infection in vivo. Previous studies investigating the
ISGF3 and ISG54 responses to HSV-1 did not observe their induction following
CHX treatment alone (Nicholl et al., 2000; Preston et al., 2001). However, the
experiments in this study to investigate the effect of CHX treatment were
unsuccessful as inconsistent detection of IFN was obtained following treatment with
CHX alone and CHX + MHV-68. Further optimisation of the duration of CHX pre-
treatment and concentrations used may help to resolve these problems.
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There did not appear to be a considerable difference in the kinetics of IFN induction
following infection with MHV-68 compared to MHV-76. The later detection of
IFNnona4 after infection with MHV-76, as shown in figure 3.2, is likely due to the
sample to sample variation of the assay as the detection of transcripts during both
MHV-68 and MHV-76 infection varied between 2 and 3 hours in both repeats of this
assay. IFNP can be detected by 1 hour post-infection with MHV-68 but following
infection with MHV-76, IFNP transcripts could only be detected by 2 hours post¬
infection. It is possible that a gene present in MHV-68, but not MHV-76, might be
responsible for the difference. For example, M4 is an immediate-early gene ofMHV-
68 that could result in induction of an earlier IFNP response. Alternatively, it may be
that the level of IFNP is at or around the limit of detection of this assay at around 1 to
2 hours post-infection and there is no difference between MHV-68 and MHV-76's
ability to induce IFNp. Further analysis and experimental repeats are required before
firm conclusions can be drawn about the induction of IFNp following infection with
MHV-68 compared to MHV-76. Real-time PCR analysis may help to elucidate
whether there is a quantitative difference in the induction of IFNP following
infection with either MHV-68 or MHV-76. These data suggest that there is no down-
regulation of IFN expression by components of the left end of MHV-68. However,
M2, present in MHV-68 but absent from MHV-76, has been implicated in inhibition
of type I IFN responses when expressed by means of a vector system (Liang et al.,
2004). It may be that the system used to express M2 alone does not accurately reflect
conditions during infection where M2 may not be expressed to such high levels and
thus would not have such an antagonistic effect on IFN responses. Furthermore, M2
is a latency-associated transcript which is inconsistent with a role for evasion of type
I IFN.
Analysis of MHV-68 replication in vitro was carried out in cell lines deficient in
IFNa/p, IFNP or wt. MEFs deficient in the type I IFN receptor showed a trend
towards higher viral titres than the IFNP"7" or wt MEFs. In addition, a higher
proportion of virus in the IFNa/p R ~ MEFs appeared to be found in the cell
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supernatant. In comparison, more virus appeared to be cell-associated rather than
cell-free in the IFNp"" and wt MEFs. There did appear to be slightly more virus in
the supernatant of the IFNp"" MEFs compared to wt MEFs, suggesting that a lack of
IFNp did allow increased virus exit into the cell supernatant. This effect was not as
pronounced as for the IFNcc/p R"" MEFs, most likely as relatively efficient control of
virus release was maintained through the presence and action of IFNa. These data
suggest that the exit of virus particles is inhibited by type I IFNs. Following
replication in the nucleus, viral capsids bud through the inner nuclear membrane,
forming primary enveloped virions in the perinuclear space. After fusion of the
primary envelope with the outer nuclear envelope, capsids are released into the
cytoplasm before acquisition of tegument and envelope proteins through secondary
envelopment into trans-golgi vesicles. Mature virions are released from the cell
through binding of the vesicle membrane with the plasma membrane of the cell
(Mettenleiter 2004). Following activation by type I IFNs, various ISGs are likely to
interact with MHV-68 components throughout the process of viral egress, therefore
inhibiting the exit of virions from the cell. Perhaps a lack of type I IFN leads to an
overall lack of ISG induction in various sub-cellular compartments and therefore
more MHV-68 virions exit from the cell. There are hundreds of identified ISGs but
the functions and cellular locations of many are unknown. There is increasing
evidence that many are important for control of virus infections. ISG60 is a type I
IFN inducible protein and is upregulated 42-fold after HCMV infection of human
foreskin fibroblasts. It has been shown to be clustered in the perinuclear space
(Defilippis et al., 2006; Yu et al., 1997). Activation of murine 1SG60 could lead to
inhibition of MHV-68 virions budding through the perinuclear space and
consequently limit viral titres. Similarly, ISG 17 (IFN induced transmembrane protein
1) has a murine homologue and is upregulated >20-fold in response to both IFNa
and IFNP (Der et al., 1998). Located in plasma membrane, it might play a role in
inhibition of virus release from the cell (Tanaka et al., 2005). ISG 15 is an ubiquitin-
like protein, activated by type I IFN, but also upregulated following herpesvirus
infection. In vitro, HCMV infection leads to 13-fold up-regulation at 8 hours post¬
infection (Defilippis et al., 2006). ISG 15 inhibits the assembly and release of HIV-1
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virions by interfering with the ubiquitin-dependent pathway used by the virus to exit
the cell (Okumura et al., 2006). Its importance during infection is further highlighted
by the immune evasion strategy developed by influenza B virus whereby the NS1
protein blocks covalent linkage and thus 1SG15 function (Yuan and Krug 2001). The
importance of individual ISGs during MHV-68 infection could be determined by
transgenic mouse or siRNA knockdown studies. Given the number of ISGs
upregulated in response to type I IFN it is likely that there is a certain degree of
redundancy, with many involved in MHV-68 control.
No statistical analysis was carried out on these data as the variation in titre range
between the first experiment and further two repeats was too large to allow reliable
interpretation. It is possible that the variation observed was due to the different
passage numbers of the MEFs between experiments or the cells being in different
states of health after thawing from liquid nitrogen.
The ability of the IFNP"'" mice to control MHV-68 infection was assessed by
infectious virus and ex vivo reactivation assays. Virus titres in the lungs of IFNP"'"
mice infected with both higher and lower doses ofMHV-68 were significantly higher
at the peak of acute infection (day 5 and 7 post-infection respectively) than in the wt
groups. These data reflect those observed in IFNa/p R" mice where lung titres are
significantly higher than in wt mice during acute infection (Dutia et al., 1999).
However, at time points other than the peak of acute infection, MHV-68 was
controlled and cleared from the lung to a similar degree in both IFNP"'" and wt mice.
It is likely that the presence of other immune components, such as IFNa, results in
compensation for the lack of IFNp, allowing development of an efficient adaptive
immune response and thus the relative control of MHV-68 infection in IFNP"'" mice.
As shown in the in vitro stimulation study, IFNa4 is expressed early after MHV-68
infection so may allow the host to mount an efficient immune response at early time
points post-infection, even in the absence of IFNp. Ideally these experiments would
have been carried out with backcrossed mice. However, as encouraging results were
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obtained with both the C57BL/6 and littermate control mice, and with two different
virus doses, there is strong evidence that the data obtained in the lung reflects a
difference of physiological significance and is not strain-dependent.
There was no significant difference in the ability of either group to control latent
infection in the spleen after infection with 4 x Kf pfu ofMHV-68. In the IFNa/p R"
mice, latent virus is detected earlier in the spleen and reaches a peak approximately
10-fold higher than in wt mice (Dutia et al., 1999). Mice lacking both IFNp and
IFNa lose control of virus replication to a greater extent as the immune response is
not able to compensate as efficiently for the loss of both IFNa and IFNp. It is
possible that by the time latency is established, the lack of IFNp is not important as
the remaining IFNa is present to aid development of the adaptive immune response
to MHV-68 infection. The use of a lower dose of virus (4 x 103 pfu) to expose subtle
differences suggested that there may an increased latent viral load in the spleens of
the IFNP"" mice in comparison to the wt mice. At day 14 post-infection, the mean
latent virus load in the IFNP"7" spleen was considerably higher than the mean load in
the wt spleen but as there were only two mice in the IFNP"'" group, no statistical
analysis could be carried out and no conclusions could be drawn from these data. The
use of a lower virus dose did appear to aid detection of subtle pathogenic differences
between the two groups. These experiments would have been repeated with larger
group sizes in the backcrossed IFNP"7" mice but due to the presence of mouse
hepatitis virus within the small animal facility this was not possible.
It would be of interest to further investigate the development of the immune response
in the absence of IFNp. Quantitative analysis of IFNa levels in the lung would
elucidate whether IFNa was up-regulated to compensate for the absence of IFNP or
was lower due to a less efficient response to MHV-68 infection. Furthermore,
analysis of other cytokines and cell subsets, such as IFNy and NK cells, in the tissues
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of wt, IFNa/p R"" and IFNP"" mice would help to elucidate the contribution of the
type I IFNs to the development of downstream responses to MHV-68.
MHV-68 and MHV-76 infection was compared in the IFNp_/" lung. It was postulated
that if a component of the left end of MHV-68 was involved in regulation of the
IFNP response, a lack of IFNP would confer an advantage to MHV-76 and clearance
from the lung would be similar to that of MHV-68. However, this was not the case as
clearance from the IFNp"" lung occurred with the same kinetics as observed in the wt
lung: MHV-76 was cleared faster than MHV-68. Previous studies have shown that
MHV-76 infection resulted in higher morbidity and mortality in IFNa/p R " mice,
postulated to be due to an excessive inflammatory response to MHV-76 infection in
comparison to MHV-68 infection. However, MHV-76 titres in the lung remained
lower than the titres of MHV-68 at day 9 post-infection (Townsley 2004) showing
that the lack of functional type I IFN did not result in enhanced lytic replication of
MHV-76 over MHV-68. These findings are in support of the results obtained in the
IFNP"'" lung. The MHV-76 lung titres were lower than MHV-68's leading to the
suggestion that the morbidity and mortality was a result of a greater immune
response due to the lack of immunomodulatory molecules in MHV-76 such as M3
(Townsley 2004). Unlike the IFNa/p R"" mice, no increased morbidity or mortality
was observed in the IFNp"7" mice. The most probable explanation for this is that the
remaining IFNa species present during MHV-76 infection aided the control of virus
replication to a higher extent than the IFNa/p R"7" mice and therefore the IFNP"7"
mice do not develop an excessive inflammatory response. MHV-76 does not obtain a
replication advantage in either the IFNP"" or IFNa/p R"" lung and this reflects
observations in wt mice. These data suggest that components of the left end of the
MHV-68 genome do not interfere greatly with the type 1 IFNs. Moreover, these data
are supported by the results from the in vitro IFN induction assays where there was
no evidence of MHV-68-mediated down-regulation of type I IFN induction
compared to MHV-76 infection.
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As the IFNJ3"mice expressed GFP under the control of the IFNP promoter it was of
interest to examine the cell types expressing GFP (in place of IFNP) following
infection with MHV-68. However, no visible GFP could be detected in either
cryostat sections of infected tissues or MEFs infected in vitro although genotype
analysis proved that the GFP gene was present in the mice and cell lines used. In
support of these findings, (Deonarain et al., 2000) showed that GFP transcripts could
be detected in MEFs by RT-PCR but GFP fluorescence in the tissues of IFNp_/" mice
could not be detected by FACS analysis. One reason for this problem might be that
the IFNP promoter is too weak to result in suitable levels of GFP to be detected by
fluorescence microscopy. The use of a stronger form ofGFP, such as enhanced GFP,
would possibly aid detection and thus allow further analysis of the cell tropism of
MHV-68.
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Chapter 4: Investigating the function of
ISG12 during MHV-68 infection
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4. Investigating the function of ISG12 during MHV-68
infection
4.1. Introduction
The downstream effects of the Type 1 IFNs are important for the control of many
herpesvirus infections and an antiviral state is mainly achieved through the activation
of ISGs such as PKR and 2'-5' OAS (reviewed in section 1.5). ISG induction can be
IFN-dependent but can also be stimulated directly in response to viral infection.
Fibroblasts infected with HCMV show rapid expression of ISGs even in the presence
of protein synthesis inhibitors and this IFN-independent regulation of ISG responses
is thought to be due to the activation of IRF3 (Browne et al., 2001; Defilippis et al.,
2006).
There are several ISGs for which there are no known cellular or biochemical
functions. ISG 12 is one such protein. Originally known as p27, it was later termed
ISG 12 to avoid confusion with other non-related genes such as p27kip and as it has a
molecular weight of 12kDa. ISG 12 was found to be preferentially upregulated in
response to IFNa in a wide variety of cell types (Gjermandsen et al., 2000) and
sequence analysis showed that the promoter region contained putative ISRE,
1RF1/IRF2 and STAT binding elements (Martensen et al., 2001). ISG 12 homologues
can be found within a number of species including hamster, rat and mouse. It has
also been shown to localise to the nuclear envelope in HeLa cells although its
function in this location remains unknown (Martensen et al., 2001). In silico analysis
has suggested that there are three members of the murine ISG 12 family: ISG 12(a),
(bl) and (b2) (Parker and Porter 2004). A study showed that during Sindbis
infection, ISG 12(b 1) expression was expressed to a higher extent in 4 week old
mouse brains, resulting in asymptomatic disease compared to 1 day old mouse brains
where death occurred rapidly. Moreover, enforced expression of murine ISG 12(b 1)
in 1 day old mice delayed mortality. These data suggest that up-regulation of
ISG 12(b 1) has a protective effect against Sindbis infection (Labrada et al., 2002).
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Type 1 I FN is important for the control of gammaherpesvirus infections and ISGs are
essential components of that innate immune response. It was hypothesised that mice
lacking ISG12 would be unable to control MHV-68 infection as efficiently as wt
mice. This study has utilised a strain of mice, termed np27"\ that lack ISG 12(a), to
investigate this hypothesis. The aims of this study were to (1) examine the function
of ISG 12(a) during MHV-68 infection in vitro and (2) elucidate the role for ISG12(a)
during in vivo infection.
4.2. Genotyping of mice
Np27_/" mice were generated by Porter et al., through disruption of the ISG 12(a) gene
by insertion of a construct containing eGFP (Porter, A., personal communication).
Chimeras showing efficient germ-line transmission of the targeted gene were bred
onto a wt 129/ola background. The genotypes of the np27"~ mice were checked by
PCR analysis of DNA extracted from ear biopsy samples. A schematic diagram of
the disrupted ISG 12(a) gene is shown in figure 4.1 along with a representative
example of the PCR analysis carried out on wt and np27" " mice. The analysis proved
that the np27"" mice carried the targeting construct containing an eGFP gene and
were negative for the ISG 12(a) gene whereas wt control mice were positive for the
presence of the ISG 12(a) gene and negative for the eGFP targeting construct.
4.3. Characterisation of ISG12 in vitro
4.3.1. GFP expression in vitro
The np27_/" mice have an eGFP gene under the control of the ISG 12 promoter so any
cells responding to IFNa, and thus expressing ISG 12(a), should be green following
infection. It was of interest to investigate the ability of MHV-68 to stimulate
ISG 12(a) in vitro through examination of the eGFP expression. Mouse embryonic
fibroblasts were generated from np27~" embryos at 13.5 days gestation. Cells were
left to settle in 6 well plates for 1 hour before the addition of various stimulants or
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B np27 wt 129/ola
Figure 4.1. Genotypic analysis of np27"" mice. (A) Schematic diagram of primer location
within the ISG12(a) gene. eGFP denotes enhanced GFP and neo denotes neomycin.
Primers 1 and 2 (TARG 1 and 2) are shown in red. TARG 1 is specific for the region out with
the construct and TARG 2 is construct specific. Primers 3 and 4 (KO 3 and 4) are shown in
blue. KO 3 & 4 amplify across exon 2 of the ISG12(a) gene. DNA was extracted from ear
biopsy tissue. Panel B shows a representative PCR for the genotyping of np27_/" mice using
primer set TARG 1 & 2. ko mice give a fragment of 3.5 kb whereas wt mice do not. Panel C
shows a representative PCR using primer set KO 3 and 4. ko mice give a 3kb product from
the targeted gene and wt mice give a 169bp product. For both B and C, numbers 1-5 show
the results from np27~'~ mice and 6-8 show the results from wt mice. A reaction containing no
DNA template (-ve, negative) was included to control for cross-contamination of samples.
-117-
Chapter 4 - Results Function ofISG12
virus to induce activation of the ISG12 promoter and thus the eGFP reporter gene.
MEFs were infected with MHV-68 or MHV-76 with a MOI of 5 or 0.5 pfu per cell
and examined under an inverted fluorescent microscope at various intervals from 3
hours to 3 days post-infection. No fluorescence could be detected throughout the
period of observation. It was postulated that the lack of visible fluorescence could be
a MHV-68 specific effect. It was therefore decided to use other agents that are
known to stimulate IFN responses to act as positive controls. Cells were stimulated
with recombinant murine IFNa, poly I:C (a synthetic dsRNA), and Semliki Forest
virus. Semliki Forest virus is a RNA virus known to stimulate readily detectable type
I IFN responses in vitro (Baigent et al., 2002). Nonetheless, no eGFP expression
could be detected by examination under a fluorescent microscope at any time point
post-infection, with any agent used. It was concluded that the lack of visible eGFP
was not a virus-specific effect and was due to the cell line itself. Therefore, this
investigative approach was not pursued further.
4.3.2. MHV-68 replication in a np27"'~ cell line
Single step growth curves were carried out in order to assess the involvement of
ISG 12(a) during MHV-68 infection in vitro. As ISG12 is thought to be localised to
the nuclear envelope, it was postulated that it might play a role in regulating the
budding of MHV-68 particles from the nuclear envelope to the cytoplasm during
replication. It was hypothesised that if ISG 12 was interfering with the release of
virus particles from the nucleus, virus titres would be increased in the np27~" cell line
where ISG12-mediated regulation was lost. The single replication cycle was assessed
within mouse embryonic fibroblasts either with (wt) or without (np27"/_) the
ISG 12(a) gene. Cells were infected with MHV-68 at an MOI of 5 pfu/cell and
duplicate samples taken at intervals from 0 to 72 hours post-infection. At each time
point, media was removed from the well and titrated separately from the cell
monolayer to examine both cell-associated and cell-free virus. No supernatant
sample was taken at 0 hours post-infection as cells had not settled into a monolayer
so cell associated and cell free virus could not be separated. Samples were titrated in
duplicate on BHK-21 cells. When cell-associated virus and cell-free virus were
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examined in combination, it was evident that MHV-68 replicated with very similar
kinetics in both cell types (figure 4.2). When examined individually, the titre of cell-
associated virus appeared similar for both groups. However, the titre of cell-free
virus in the np27~'~ MEFS appeared to be slightly lower in comparison to the titre in
wt MEFs at 12 and 24 hours post-infection. It was decided to repeat these two time
points on two further occasions, to determine if the effect was reproducible. Cell-
associated viral titres at 12 and 24 hours post-infection are shown in figure 4.3 and
cell-free viral titres at 12 and 24 hours post-infection are shown in figure 4.4. From
the repeat experiments it was evident that there was no difference in the ability of
MHV-68 to replicate in wt or np27_/" MEFs. There was no difference in the titres of
cell-associated, cell-free or combined virus between the np27"" and wt MEFs. As the
variation in titre range between the first experiment and the further two repeats was
too large to allow reliable interpretation, no statistical analysis was carried out on
these data.
4.4. Characterisation of ISG12 in vivo
4.4.1.Preliminary infection of np27"'" mice
The type I IFNs have been shown to be important for the control of
gammaherpesvirus infections. As mentioned previously, knockout of the type I IFNs
(by knockout of the shared receptor) causes mice to be more susceptible to MHV-68
infection (Dutia et ah, 1999). It was postulated that as ISG12 is a downstream
effector of IFNa, mice in which ISG12 is absent may be less able to control infection
due a less efficient innate response. In order to assess the contribution of ISG 12(a)
during in vivo infection, np27~" and wt 129/Sv/Ev mice were infected intranasally
with 4 x l(f pfu of MHV-68. No wt 129/ola mice were available for use at the time
the experiment was set-up so wt 129/Sv/Ev were used as the closest available
matched controls for the preliminary experiment. Tissues were harvested at 5 and 7
days post-infection with four mice per group per time point. This experiment was
termed experiment I. Real-time PCR was carried out on DNA extracted from lung,
MEN and spleen in order to examine the viral load in these tissues. The level of virus
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Figure 4.2. Single-step replication of MHV-68 in np27~'~ and wt MEFs in vitro. Cells were
infected with an MOI of 5 pfu/cell and harvested at various times p.i. Values represent two
separate experiments with each sample titrated in duplicate. Data points represent the log10
of the virus titre ± standard error of the mean (SEM). The combined viral titres from both the
cells and the cell supernatant are shown in panel A. B represents cell associated virus only
and C represents virus within the supernatant only.
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Figure 4.3. Titres of cell-associated virus in np27"'" and wt MEFs at 12 and 24 hours p.i.
MEFs were infected with MHV-68 at an MOI of 5 pfu/cell and harvested after 12 (A-C) or 24
(D-F) hours p.i. Each time point was assayed independently on three occasions and each
experiment is shown as a separate graph. Cell supernatant was removed and assayed
separately (see figure 4.4). Values represent the virus titre ± standard error of the mean
(SEM) from two independent experiments with each sample titrated in duplicate. Green bars
denote np27_/" MEFs and black bars denote wt MEFs.
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Figure 4.4. Titres of ceil-free virus from np27"'~ and wt MEFs at 12 and 24 hours p.i. MEFs
were infected with MHV-68 at an MOI of 5 pfu/cell and harvested after 12 (A-C) or 24 (D-F)
hours p.i. Each time point was assayed independently on three occasions and each
experiment is shown as a separate graph. Cells were removed and assayed separately (see
figure 4.3). Values represent the virus titre ± standard error of the mean (SEM) from two
independent experiments with each sample titrated in duplicate. Green bars denote np27"'"
MEFs and black bars denote wt MEFs.
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DNA was measured by amplification of M3 and normalised to the level of (3-actin
within each sample. At day 5 and 7 post-infection there was no difference in viral
load in the lung or MLN (figure 4.5). However, there did appear to be a trend
towards higher viral loads in the spleens of np27_/" mice compared to wt mice at both
time points investigated (figure 4.6). At day 5 post-infection, 100% (4/4) of np27_/~
spleens contained detectable virus compared to only 25% (1/4) of the wt spleens
although this was not significant by Mann Whitney test (p=0.0571). Similarly, there
appeared to be an increased degree of splenomegaly in the np27"~ spleens at day 7
post-infection compared to the wt spleens but again, this was not significant
(p=0.0571).
4.4.2. Acute infection within the lung and MLN
Previous experiments using the IFNP" mice showed that infecting with a low dose
of virus can help to elucidate subtle pathogenic differences that may be masked when
using a higher dose of virus. As there appeared to be a subtle difference between the
np27_/" and wt groups it was decided to repeat the experiment using 4 x 103 pfu of
MHV-68 instead of 4 x 105 pfu to further investigate the role of ISG 12(a). Wt
129/ola mice were used as strain-matched controls. np27~~ and wt 129/ola mice were
infected intranasally with 4 x 103 pfu of MHV-68 and tissues harvested at 4, 8, 12
and 16 days post-infection. Due to a limited number ofwt 129/ola mice at the time of
infection, no control group was investigated at day 4 post-infection. As in the
previous experiment, real-time PCR was carried out to investigate the viral load
within the lungs, MLNs and spleens of np27~" and wt 129/ola mice. This experiment
was termed experiment II. There was no significant difference in viral load in the
lungs between the np27" " and wt groups at any time point investigated (figure 4.7).
Similarly, the MLNs of the np27"'~ and wt mice contained viral loads that did not
differ significantly at any time point investigated (figure 4.8).
The experiment was repeated with the lower dose of virus. Again, np27~~ and wt
129/ola mice were infected intranasally with 4 x 10J pfu ofMHV-68 and tissues
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Figure 4.5. Experiment I. Viral load in the lungs (A) and MLNs (B) of np27"'" or wt 129/Sv/Ev
mice. Mice were infected intranasally with 4 x 10s pfu of MHV-68. Tissues were harvested at
day 5 and day 7 post-infection with 4 mice per group per time point. Viral load was
determined by real time PCR using primers specific for the viral gene, M3 and normalised as
determined by the level of (3-actin within each sample. Each data point represents the viral
load from individual mice and the solid line represents the mean viral load.
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Figure 4.6. Experiment I. Viral load in the spleen (A) and spleen weight (B) in np27" and wt
129/Sv/Ev mice. Mice were infected intranasally with 4 x 105 pfu of MHV-68. Tissues were
harvested at day 5 and day 7 post-infection with 4 mice per group per time point. Viral load
(A) was determined by real time PCR using primers specific for the viral gene, M3 and
normalised as determined by the level of p-actin within each sample. Each data point
represents the viral load from individual mice and the solid line represents the mean viral
load. In panel B, each data point represents the whole spleen weight from individual mice
and the solid line represents mean spleen weight.
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Figure 4.7. Experiment II. Viral load in the lungs of np27_/" or wt 129/ola mice. Mice were
infected intranasally with 4 x 103 pfu of MHV-68. Tissues were harvested at days 4, 8, 12
and 16 post-infection. Viral load was determined by real time PGR using primers specific for
the viral gene, M3 and normalised as determined by the level of p-actin within each sample.
Each data point represents the viral load from individual mice and the solid line represents
the mean viral load.
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Figure 4.8. Experiment II. Viral load in the MLNs of np27~'~ or wt 129/ola mice. Mice were
infected intranasally with 4 x 103 pfu of MHV-68. MLNs were harvested at days 4, 8, 12 and
16 post-infection. Viral load was determined by real time PCR using primers specific for the
viral gene, M3 and normalised as determined by the level of p-actin within each sample.
Each data point represents the viral load from individual mice and the solid line represents
the mean viral load.
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harvested at 4, 8, 12 and 16 days post-infection. In this case, viral load was
investigated by infectious virus assay as well as real-time PCR to determine if the
titre of replicating infectious virus differed with respect to viral load. This
experiment is referred to as experiment III. There was no significant difference in
viral load in the lungs between the np27"/" and wt groups at any time point
investigated (figure 4.9). Figure 4.9 also shows that there was no significant
difference in the titre of infectious virus in the lungs of either group. Similarly, the
viral load in the MLNs of the np27"/_ and wt mice (figure 4.10) was equivalent at all
time points investigated. Due to the relatively small cell numbers within the MLNs
post-infection it was decided to analyse viral load by quantitative PCR only. These
data are in agreement with the findings in both the lungs and MLNs from experiment
II. These data suggest that ISG 12(a) does not play an important role for the control of
lytic MHV-68 replication in the lung and nor does it influence the trafficking of virus
from the lung to the MLN.
4.4.3. Establishment of latency within the spleen
During MHV-68 infection, virus is detectable in the spleen by approximately day 3
post-infection. From this point there is a rapid increase in the number of latently
infected splenocytes and an accompanying splenomegaly. The viral load in the
spleen following MHV-68 infection of np27~~ and wt 129/ola mice was determined
by real-time PCR (experiment II). As shown in figure 4.11, virus was detectable in
both groups by day 8 post-infection. The viral load in the np27v" spleens was
significantly higher (p=0.0357) than in the wt spleens at day 8 post-infection. By day
12 post-infection, the viral load was no longer significantly different between the
np27"'"and wt groups and this remained the case at day 16 post-infection. The degree
of splenomegaly was assessed by whole spleen weight. The np27"" group exhibited a
significantly higher degree of splenomegaly at day 8 post-infection than the wt group
(p=0.0357) (figure 4.11, experiment II). The later time points investigated were not
significantly different but there was a trend at day 12 and 16 post-infection for the
np27"" spleens to display a higher degree of splenomegaly than the wt spleens.
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Figure 4.9. Experiment III. Virus titre (A) and viral load (B) in the lungs of np27_/" or wt 129/ola
mice. Mice were infected intranasally with 4 x 103 pfu of MHV-68. Tissues were harvested at
days 4, 8, 12 and 16 post-infection. Virus titre was determined by infectious virus assay and
viral load was determined by real time PCR using primers specific for the viral gene, M3 and
normalised as determined by the level of p-actin within each sample. Each data point
represents either the virus titre (A) or viral load (B) from individual mice and the solid line
represents the mean virus titre or viral load. The dashed line represents the limit of detection
(10 pfu) for this assay.
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day4p.i. day8p.i. day12p.i. day16p.i.
Figure 4.10. Experiment III. Viral load in the MLNs of np27"'" or wt 129/ola mice. Mice were
infected intranasally with 4 x 103 pfu of MHV-68. MLNs were harvested at days 4, 8, 12 and
16 post-infection. Viral load was determined by real time PCR using primers specific for the
viral gene, M3 and normalised as determined by the level of p-actin within each sample.
Each data point represents the viral load from individual mice and the solid line represents
the mean viral load.
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np27_/" np27"/_ wt ola np27"'" wt ola np27_/" wt ola
day 4 p.i. day 8 p.i. day 12 p.i. day 16 p.i.
Figure 4.11. Experiment II. Spleen viral load (A) and spleen weight (B) in np277' and wt
129/ola mice. Mice were infected intranasally with 4 x 103 pfu of MHV-68. Tissues were
harvested at days 4, 8, 12 and 16 post-infection. Viral load (A) was determined by real time
PCR using primers specific for the viral gene, M3 and normalised as determined by the level
of p-actin within each sample. Each data point represents the viral load from individual mice
and the solid line represents the mean viral load. In panel B, each data point represents the
whole spleen weight from individual mice and the solid line represents mean spleen weight.
Groups that have mean values that vary significantly (p< 0.05) by Mann Whitney test are
indicated by *.
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The experiment was repeated (experiment III). MHV-68 infection was investigated
by real-time PCR as well as ex vivo reactivation assay to determine if the viral load
differed from the number of latently cells. Figure 4.12 shows that virus was
detectable in 3/4 np27" samples and 2/4 wt samples by ex vivo reactivation assay,
and virus was detectable in 4/4 samples of both groups by real-time PCR by day 8
post-infection. At day 12 post-infection, the viral load in the np27_/" spleen was
significantly higher (p=0.0286) compared to the viral load in the wt mice. The
difference was confirmed in an ex vivo reactivation assay (figure 4.12) as the titre of
latent virus in the np27~" spleen was significantly higher (p=0.0286) than the titre in
the wt spleen. It was speculated that the apparently higher viral load in the np27~"
spleen may have been due to infectious virus in the spleen as opposed to a latent
infection. An infectious virus assay was carried out on the same number of
splenocytes as used for the latent virus assay (figure 4.13). A maximum of 1 plaque
was detected in 3 of 32 samples and thus the vast majority of virus detected in the ex
vivo reactivation assay was a result of a latent infection. Similarly to experiment 11,
experiment III displayed a trend for the np27" spleens to exhibit a higher degree of
splenomegaly than the wt mice although this was not significant at any time point
investigated.
4.5. Discussion
ISGs have been shown to be activated in response to a number of herpesvirus
infections. ISG12 mRNA was found to be increased 7-fold in response to HCMV
infection of human fibroblasts (Zhu et al., 1998). In this study, the role of ISG 12(a)
during MHV-68 infection has been investigated in vitro and in vivo. MEFs that
express eGFP following activation of the ISG 12 promoter were infected with MHV-
68 in order to investigate the kinetics of ISG 12 induction. However, no eGFP
expression was visible under a fluorescent microscope from 3 hours up to 3 days
post-infection. It was hypothesised that the lack of eGFP could be due to MHV-68
mediated down-regulation of ISG 12(a) expression in order to evade its function. The
phenomenon of ISG down-regulation has been observed during other herpesvirus
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np27+ wtola np27+ wtola np27"'' wt ola np27"'" wt ola
day4p.i. day 8 p.i. day12p.i. day 16 p.i.
Figure 4.12. Experiment III. Spleen latent virus (A), viral load (B) and weight (C) in np27"~
and wt 129/ola mice. Mice were infected intranasally with 4 x 103 pfu of MHV-68. Spleens
were harvested at days 4, 8, 12 and 16 post-infection. Latent virus was determined by
infective centre assay, viral load was determined by real time PCR using primers specific for
the viral gene, M3 and normalised as determined by the level of p-actin within each sample.
Each data point represents individual mice and the solid line represents mean values.
Groups that have mean values that vary significantly (p< 0.05) by Mann Whitney test are
indicated by *.
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day4p.i. day8p.i. day 12 p.i. day16p.i.
Figure 4.13. Experiment III. Infectious virus in the spleens of np27~'~ or wt 129/ola mice. Mice
were infected intranasally with 4 x 103 pfu of MHV-68. Tissues were harvested at days 4, 8,
12 and 16 post-infection. Virus titre was determined by infectious virus assay Each data
point represents the virus titre from individual mice.
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infections. ISG induction occurs upon HSV-1 entry to the cell, but only in the
absence of viral protein synthesis, thus suggesting that a viral protein may disarm the
response following the onset of HSV-1 gene expression (Mossman et al., 2001). In
order to determine if the lack of ISG 12(a) activation was a MHV-68 specific effect,
other agents known to be adequate inducers of IFNa and therefore ISGs were
investigated for their ability to stimulate ISG 12(a). However, no eGFP expression
was detected after treatment with IFNa, poly I:C or SFV. These results suggest that
the lack of eGFP expression was not a MHV-68-mediated effect and was due to the
cell line itself. It has previously been shown that ISG 12 expression is variable in
different cell types. For example, in HeLa (epithelial) cells there was a 100-fold
increase in the level of human ISG12 in response to IFNa and 14-fold increase in
response to poly I:C. In contrast, there was only a 3-fold induction of ISG 12 in
response to IFNa and 2-fold induction in response to poly I:C in HT1080 (fibroblast)
cells (Gjermandsen et al., 2000). It is possible that the murine fibroblasts are
inadequate inducers of ISG12(a) in response to MHV-68. The ISG12 promoter may
not be strong enough to result in sufficient, visible levels of eGFP expression. The
presence of eGFP transcripts should be verified by RT-PCR to ensure that the GFP
construct is activated and expressing properly. However, such analysis was not
carried out due to time constraints.
Certain ISGs have been shown to limit virus replication or release in vitro. For
example, ISG 15, a ubiquitin-like protein, has been shown to inhibit the assembly and
release of HIV-1 virions by interfering with the ubiquitin-dependent pathway used by
the virus to exit the cell (Okumura et al., 2006). Interestingly, ISG 12 is the first ISG
found to be localised to the nuclear membrane and is hypothesised to interact with
the nuclear pore complex, although this is yet to be determined (Martensen et al.,
2001). It was hypothesised that ISG12(a) may play a role in regulation of MHV-68
particle release from the nuclear envelope to the cytoplasm during replication.
Subsequently, a lack of ISG12(a) would lead to increased release of virus particles
and therefore elevated viral titres. Analysis of MHV-68 replication was carried out in
np27~" and wt MEFs in vitro. There was no difference in cell-free, cell-associated or
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combined virus titres between np27"/~ and wt MEFs at any time point investigated.
When viral titres at 12 and 24 hours post-infection were investigated in two further
repeat experiments, no consistent trend for either cell-free or cell-associated virus
could be determined between the np27~" and wt cell lines. The differences observed
between experimental repeats are likely due to differences in assay set up rather than
the presence or absence of ISG 12(a). It is possible that the variation was due to
different cell line passage numbers between experiments or the cells being in
different states of health after thawing from liquid nitrogen. The results from this
study indicate that ISG 12(a) is not playing a major role in the regulation ofMHV-68
release from the nuclear envelope into the cytoplasm, and is therefore not having a
major effect on the resultant viral titres. Perhaps a degree of redundancy between
ISGs allows for compensation and therefore there is no evident role for ISG 12(a) in
vitro. The high MOI used in this study may have made it difficult to observe the
effect of the lack of ISG12(a) in vitro. A high MOI infection results in the infection
of the majority of cells and therefore cell shut down rather than induction of ISGs
and a protective state in non-infected cells. In future experiments a low MOI would
help to elucidate a possible protective effect of ISG12(a) in neighbouring uninfected
cells. To investigate ISG12's role in regulation of virus release in more detail it
would be of interest to carry out electron microscopy in order to visualise the
location of MHV-68 virions within compartments of the cell. This technique may
help to elucidate whether the nuclear localisation of ISG 12 is affecting the budding
pathway of MHV-68. It may also be worth further investigating the nuclear
localisation of ISG 12 in MEFs by immunohistochemistry. Localisation to the nuclear
envelope was confirmed in HeLa and 293 cells, both of human epithelial origin.
There may be alternate localisations in other cell types such as fibroblasts, as well as
differences between murine and human systems which should be confirmed to help
elucidate protein function.
The ability of the np27_/" mice to control MHV-68 infection was assessed by
quantitative PCR, infectious virus and ex vivo reactivation assays. The level of lytic
replication in the lungs of np27"/_ and wt mice was found to be similar by both
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quantitative PCR and infectious virus assay at all time points investigated. Challenge
with a lower dose of virus failed to elucidate any subtle differences in the lungs
between the two groups. These data suggest that ISG 12(a) does not play a central
role in the control of lytic MHV-68 replication in the lung. This result was surprising
as it was hypothesised that a lack of ISG 12(a) would result in a less efficient innate
immune response and thus a higher amount of viral replication at early times post¬
infection. In further study it would be of interest to assess if there was any difference
in the extent of acute infection between np27~~ and wt mice at days 1 to 3 post¬
infection. This would elucidate whether the function of ISG 12(a) is evident at earlier
time points than were assayed in this study. Viral load in the MLNs of the np27"" and
wt mice were examined by quantitative PCR. Virus copy number did not differ
significantly at any time point investigated. Virus did not appear to be cleared from
the lung quicker, nor did it become detectable earlier or to a higher extent in the
np27~" MLN. These results suggest that ISG12(a) does not influence the trafficking
of virus from the lung to the MLN.
These data show that a lack of ISG 12(a) leads to higher latency load in the spleen
and a trend for a higher degree of splenomegaly from 8 days post-infection onwards.
This outcome was indicated during infection with 4 x 105 pfu of MHV-68 and was
confirmed in the two experiments investigating infection with 4 x 10J pfu of MHV-
68. These experiments show that the role of ISG12 can be better studied after lower
dose challenges. It was hypothesised that viral load may not accurately reflect the
level of virus that was able to establish a latent infection and perhaps the increased
viral load in np27_/" mice was not entirely due to the presence of latent virus. Both the
quantitative PCR and the ex vivo reactivation assays gave the same result. In each
case the real-time data closely reflected the data from the infectious virus and ex vivo
reactivation assays, although the real-time PCR assay did appear to be more
sensitive. Importantly, the viral load equated to the level of ex vivo reactivation
showing that there are higher numbers of latently infected cells in the np27"" mice.
Infectious virus can only be detected in the lungs of wt mice whereas it can be
detected in other tissues of some immunodeficient strains such as the IFNa/p R~"
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mice (Barton et al., 2005). The increased level of virus in the np27"" spleens was not
due to infectious virus and the lack of ISG 12(a) did not result in lytic infection
outside of the lung. Therefore, the increased level of virus detected in the np27" "
spleen was due to the absence of ISG 12(a), resulting in an elevated latent infection
compared to the wt spleen. Overall, it can be concluded that ISG 12(a) plays an
important role in the early stages of the establishment of latency.
As shown previously, there was no difference in either clearance of virus from the
lung or viral load in the MLN between the np27"" and wt mice. These data suggest
that ISG 12(a) does not greatly influence the trafficking of virus to the MLN from the
lung which is thought to be reliant on dendritic cells and macrophages (Selvarajah
2001). However, trafficking to the spleen is via B cells which are likely to become
infected via dendritic cells in the lymph node. It may be that there is faster infection
of B cells in the MLNs of np27~~ mice, leading to earlier virus dissemination to the
spleen and establishment of a greater latent infection.
Infection in experiment III appeared to be progressing at a slower pace in comparison
to experiment II. The mice in each experiment were of the same age at the time of
infection. However, the difference observed between experiments may be due to
mouse to mouse variation.
The question remains; what is the role of ISG 12 during the establishment of latency
in the spleen? The lack of a phenotype in vitro and its role in vivo strongly suggests
that ISG 12(a) is important for the immune response to viral infection. It is possible
that expression of ISG 12 is important for control of infection in a cell population
specific to the spleen. There are four distinct populations of DCs found within the
murine spleen. They mature in response to type I IFN leading to increased expression
of co-stimulatory molecules such as CD80, CD86 and CD40 (Kawai and Akira 2006)
and are heterogeneous in phenotype and function. One study has shown that ISG 12 is
specifically and highly expressed in mature, activated DCs developed in vitro from
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myeloid precursors. ISG12 mRNA transcripts were found to be upregulated 40-fold
in mature and activated DCs but were not up-regulated at all in immature DCs or
monocytes (Hashimoto et al, 2000). It can be hypothesised that during MHV-68
infection the lack of ISG12(a) leads to a less effective splenic DC response and thus
increased MHV-68 replication and/or increased expansion of MHV-68 infected B
cells in the spleen.
It is possible that ISG12 may be more highly expressed in more than one splenic DC
population. One important DC population found in the spleen is the murine pDCs
(characterised by markers: Ly6G/C+ CD8a" CD11 b" B220+). They are a major source
of type I IFN and IL-12 and can develop from both myeloid and lymphoid
progenitors (Shigematsu et al, 2004). Stimulation with virus or IFNa leads to
enhanced survival and T cell stimulatory activity (Asselin-Paturel et al., 2001). The
importance of splenic pDCs for the control of other herpesvirus infections has been
shown previously. MCMV infection leads to maturation of splenic pDCs leading to
substantial production of type I IFNs, IL-12 and the stimulation of NK cell
responses, all of which are important for MCMV control (Dalod et al., 2003).
Furthermore, pDCs were suggested to be the major IFNa producers in the spleens of
MCMV-infected mice (Asselin-Paturel et al., 2001). A lack of ISG12(a) expression
in a cell type, such as pDCs, that are important for control of herpesvirus infections,
could help to explain the increased viral load in the spleens of np27~" mice.
Although the exact function of ISG12 remains to be determined, a less efficient DC
response in ISG 12(a) ko mice may lead to indirect downstream effects such as
decreased IFNa/p responses, lower IL-12 production and inefficient NK cell
responses leading to a less efficient adaptive immune response. Immunostaining
techniques would help to determine if there is a difference in cellular populations in
the spleen of np27"" compared to wt mice. A lower level of a particular cell type such
as T cells, DCs or NK cells, either resident or migrating to the spleen during
infection could lead to higher viral titres. It would be of interest to investigate the
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phenotypes and effector functions of the DC populations in the np27_/" spleen in
comparison to the wt spleen after infection with MHV-68. Furthermore, analysis of
downstream responses would determine if the level of IL-12 and IFNa/p production
in the spleen is down-regulated and/or ifNK and T cell activation is less efficient.
ISG 12(a) might have a role involving interaction with latency-associated viral
antigens in the spleen during latent infection. One candidate is ORF73, a latency-
associated gene (Martinez-Guzman et al., 2003), expressed in nuclei (Kedes et al,
1997) with homology to the latency-associated nuclear antigens (LANA) of KSHV.
ORF73 ofMHV-68 has been shown to be critical for the establishment of latency in
the spleen but is not important for in vitro replication (Moorman et al., 2003). This
study has shown that ISG 12(a) appears to be important for in vivo, but not in vitro
infection. It is possible that ISG 12(a) has a role to limit ORF73 function in the
nucleus in some way, thus reducing latent virus load in wt mice. Clearly, further
analysis of the interactions with ISG 12 by latent genes, such as ORF73, are required
to determine if this is the reason for increased virus titres within the np27_/" spleen.
Infection of np27"~ mice with an ORF73-deletion mutant of MHV-68 would be
useful for investigating this possibility. Analysis of the MHV-68 latent gene
expression profile in np27~" compared to wt mice would help to elucidate if there
was an up-regulation of latent gene expression in the absence of ISG 12(a).
The presence of more than one ISG 12 gene, as indicated by in silico analysis,
complicates investigation of ISG 12 gene function. In this study, a clear phenotype
has been elucidated for ISG12(a) in vivo. It is likely that all three share function as
each are small hydrophobic proteins suggesting a transmembrane location and
transcripts from each of the three genes were upregulated in response to type I IFN
(Parker and Porter 2004). Although an obvious phenotype has been observed with
ISG 12(a) knockout alone there may be functional redundancy between family
members. Clues to ISG 12 function may become clearer if a multiple gene knockout
model was utilised.
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Chapter 5: The role of natural killer cells
during MHV-68 infection
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5. The role of natural killer cells during MHV-68 infection.
5.1. Introduction
NK cells are an important component of the innate immune response to many virus
infections and have been shown to play a particular role in the control of herpesvirus
infections. Low NK cell cytotoxicity in humans leads to increased susceptibility to
severe disseminating herpesvirus infections such as CMV and VZV. These infections
tend to be recurrent even when other immune components are at normal or near
normal levels (Biron 1997). A critical role forNK cells can also be demonstrated in a
mouse model. NK cell deficient mice, through either antibody depletion or genetic
mutation, have been shown to be more susceptible to various herpesvirus infections.
The role of NK cells have been studied in detail in mice infected with MCMV.
Increased viral titres and mortality is observed in susceptible mouse strains such as
BALB/c when NK cells are depleted. Conversely, adoptive transfer of functional NK
cells back into susceptible mice leads to protection against MCMV infection.
C57B1/6 mice are relatively resistant to MCMV infection in comparison to BALB/c
mice. The loci associated with these strain differences and thus resistance to infection
in C57B1/6 mice have been mapped to the NK gene complex, Cmv-1, on
chromosome 6 (Arase et al., 2002). The Cmv-1 locus was found to encode the
activating NK cell receptor, Ly49H, which binds the MHC-like viral glycoprotein,
ml57. Ly49H is sufficient and required for protection against MCMV in C57BL/6
mice (Daniels et al., 2001). Given the importance of the NK cell response during
infection, MCMV has developed mechanisms to evade the NK cell response. The
MCMV gene ml52, down-regulates the expression of retinoic acid early inducible
gene 1, an activatory ligand for the NKG2D receptor, in order to avoid NK cell
recognition of infected cells. Although ml57 acts as an activatory receptor for NK
cells in MCMV-resistant mice it also binds to an inhibitory NK cell receptor, Ly49I,
in MCMV-susceptible 129/J mice (that lack the Ly49H ligand) and thus reduces the
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NK cell response (Arase et a!., 2002). The viral immune evasion strategies of
MCMV are wide-ranging and are reviewed in more detail in section 1.5.
Far less is known about the role of NK cells in the control of gammaherpesvirus
infection. Studies of primary EBV infection, infectious mononucleosis, have shown
that during symptomatic disease there are elevated NK cell numbers in the peripheral
blood and enhanced NK cell cytotoxicity. In addition, higher NK cell counts
correlated with lower EBV titres in the peripheral blood (Williams et al., 2005). It
may be that the extent of the NK cell response determines the severity of the clinical
disease. Furthermore, low NK cell activity has been linked to uncontrolled EBV
infection in Chediak- Higashi syndrome (Merino et al., 1983).
Are NK cells important in the control of gammaherpesvirus infections? Studies with
EBV suggest that NK cells do play a role but how important are NK cells for the
control of gammaherpesvirus infection? To answer these questions, MHV-68 was
used as a model to investigate the NK cell response to a gammaherpesvirus at early
time points post-infection. It was hypothesised that, given the important role of NK
cells in other herpesvirus infections, NK cells would play a critical role in
determining the outcome of MHV-68 infection. MHV-76 is identical to MHV-68
except it lacks the ORFs M1-M4 and the viral tRNAs. MHV-76 grows in vitro with
same efficiency as MHV-68 but is attenuated during in vivo infection as it is cleared
more rapidly from the lung and achieves a lower maximal titre in comparison to
MHV-68 at early time points post-infection (Macrae et al., 2001). These data
indicate that the left end of the genome has a key role for pathogenesis. Furthermore,
when M4 was replaced back into MHV-76 (MHV76inM4) it led to higher titres
compared to MHV-76 at day 1 post-infection (Townsley et al., 2004). These findings
suggest a possible immunoregulatory role for the left end of the MHV-68 genome
during the innate immune response and therefore a possible role in modulating the
NK cell response.
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The aims of this study were to (1) investigate the level ofNK cell proliferation and
activation post-infection, (2) examine cytotoxic activity and (3) elucidate the role for
NK cells during in vivo infection. In addition, this study postulated that a component
of the left end of the MHV-68 genome may be involved in the regulation ofNK cell
responses.
5.2. The NK cell population in the MLN
During MHV-68 infection lymphocyte expansion and accompanying
lymphoadenopathy is observed in the MLN, the draining lymph node from the lung.
C57B1/6 mice were infected with 4 x 105 pfu ofMHV-68 and the MLNs removed at
early time points until day 12 post-infection. Total lymphocyte counts were
performed for each tissue. The kinetics of lymphocyte expansion within the MLN is
shown in figure 5.1. By day 2 post-infection the number of lymphocytes had
continued to rise to a peak at day 5 post-infection. By day 12 post-infection
lymphocyte numbers in the MLN had begun to return to the resting level, correlating
with the clearance of virus from the lung during acute infection. It was speculated
that a proportion of the expanded lymphocytes within the MLN would be NK cells
activated in response to MHV-68 antigens.
Cell surface markers such as NK1.1, DX5 and the Ly49 group can be used to define
NK cell populations. Expression can differ between mouse strains. For example,
BALB/c mice express DX5 but not NK1.1 whereas C57B1/6 mice express both
markers. The Ly49 family exhibits heterogeneous expression and different
expression patterns occur on overlapping NK cell subsets. NK1.1 and DX5 are the
most commonly used due to their stable expression and the wide availability of
monoclonal antibodies conjugated to various fluorophores. FACS analysis was
carried out to investigate the NK cell population in the MLN post-infection. A major
function ofNK cells is IFNy production post-activation, leading to the activation of
other cell types such as T cells and macrophages. NK cells are induced to express
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Figure 5.1. Total lymphocyte count in the MLNs of C57BI/6 mice following infection with
MHV-68. Mice were infected intranasally with 4 x 105 pfu of MHV-68. MLNs were harvested
at various time points p.i. and total lymphocytes counted. Data points represent one count at
days 1 and 12 p.i. and 7 counts at days 2-5 p.i. For days 2-5 p.i., values represent
lymphocyte counts ± standard error of the mean (SEM).
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IFNy following infection with MCMV. This response has been shown to play a
major role in NK cell-mediated protection against infection (Orange et al, 1995).
Given the importance of NK-cell secreted IFNy during herpesvirus infection it was
decided to use IFNy as a measure ofNK cell activation. MHV-76 was also included
in the study in order to determine if there is a difference in the ability of the NK cell
population to expand and become activated in response to MHV-76 compared to
MHV-68. Mice were infected intranasally with 4 x 105 pfu of either MHV-68 or
MHV-76 and MLNs were harvested at days 2 and 4 post-infection. The percentage
ofNK cells present and the percentage of cells expressing IFNy were determined by
FACS analysis. Cells were stained with an antibody to the NK cell marker, DX5
(CD49b), and intracellular staining carried out with an antibody to IFNy. Figure 5.2
shows representative FACS stains from lymphocyte populations double stained with
antibodies to DX5 and IFNy. Four MLNs from uninfected mice were pooled together
in order to obtain an average value for the percentage ofNK cells and level of IFNy
in uninfected MLNs.
The percentage of NK cells in the MLN post-infection are shown in figure 5.3. The
data suggest that the NK cell population is expanded at early time points post¬
infection. At day 2 post-infection the MHV-68 and MHV-76-infected samples had
mean NK cell populations of 1.06% and 1.36% respectively in comparison to day 4
post-infection where the NK cell population had fallen to 0.67% and 0.74% for
MHV-68 and MHV-76 infection respectively. The uninfected sample had a NK cell
population of 0.34%. This suggests that the population was elevated by day 2 and
was returning to resting levels by day 4. Alternatively, the percentage of NK cells
may be reduced due to increased populations of other lymphocytes by day 4 post¬
infection. This would have to be determined by further FACS analysis of other cell
populations within the MLN during MHV-68 and MHV-76 infection. There was no
significant difference between the NK cell populations of MHV-68 and MHV-76
infected MLNs as determined by Mann-Whitney test at either day 2 or day 4.
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Figure 5.2. FACS analysis of NK populations in the MLN. Mice were infected with 4x10 pfu
of either MHV-68 or MHV-76. MLNs were harvested at day 2 and 4 post-infection.
Lymphocytes were extracted and intracellular staining carried out for IFNy and surface
staining carried out for the NK cell marker, DX5. One mouse was left uninfected to act as a
control and establish resting levels of both NK cells and IFNy.
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Figure 5.3. NK cell populations in the MLN following infection with MHV-68 or MHV-76. Mice
were infected with 4 x 10s pfu of either MHV-68 or MHV-76. MLNs were harvested at day 2
and day 4 p.i. Lymphocytes were extracted and stained with an NK cell specific antibody
(DX5). Each data set represents a combination of three individual experiments, each with
nine to eleven data points per group, except the uninfected MLN data (represented by a
black horizontal line) which was analysed once. The median for each dataset is indicated by
the centre line. The first and third quartiles are shown by the edges of the box area. The
extreme values are indicated by the whiskers extending from the box.
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Intracellular IFNy staining was used to determine if NK cells were activated
following infection. The proportion of NK cells that were expressing IFNy post¬
infection is shown in figure 5.4. At day 2, an average of 34.33% of NK cells were
activated in response to MHV-68. At day 4, an average of 41.13% ofNK cells were
activated in response to MHV-68. Similarly, at day 2 post-infection, an average of
31.36% ofNK cells were activated in response to MHV-76. At day 4, an average of
47.57% ofNK cells were activated in response to MHV-76. These data suggest that
NK cells are activated following infection with MHV-68 or MHV-76. Furthermore
the proportion of activated NK cells appears to be slightly increased by day 4 post¬
infection in response to both MHV-68 and MHV-76. However, this is not significant
as the range of activation had a relatively high level of variation for each group.
There was no significant difference between the levels of activated NK cells of
MHV-68 and MHV-76 infected MLNs as determined by Mann-Whitney test at either
day 2 or day 4. Figure 5.5 shows the number of activated NK cells as a portion of
IFNy positive lymphocytes. At day 2 post-infection, activated NK cells in the MHV-
68-infected MLN comprised a mean value of 0.57% and activated NK cells in the
MHV-76-infected MLN comprised a mean value of 0.60% of the total IFNy+
population. At day 4 post-infection, activated NK cells in the MHV-68-infected
MLN comprised a mean value of 0.49% and activated NK cells in the MHV-76-
infected MLN comprised a mean value of 0.63% of the total IFNy+ population. There
was no significant difference (by Mann-Whitney test) between MHV-68 and MHV-
76 in the ability to stimulate NK cells to express IFNy at either day 2 or day 4 post¬
infection. These data show that activated NK cells express IFNy in response to
MHV-68 and MHV-76 infection.
5.3. NK cell responses following MHV-68 infection
During infection NK cells can lyse target cells by release of cytotoxic granules
containing perforin and granzymes and by binding to receptors to induce apoptosis.
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Day 2 p.i. Day 4 p.i.
Figure 5.4. Percentage of activated NK cells in the MLN following infection with MHV-68 or
MHV-76. Mice were infected with 4 x 10s pfu of either MHV-68 or MHV-76. MLNs were
harvested at day 2 and day 4 p.i. Lymphocytes were extracted and intracellular staining
carried out with an antibody to IFNy and surface staining with a NK cell specific antibody
(DX5). Each data set represents a combination of three individual experiments, each with
nine to ten data points per group. The median for each dataset is indicated by the centre
line. The first and third quartiles are shown by the edges of the box area. The extreme
values are indicated by the whiskers extending from the box.
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Uninfected MHV-68 MHV-76 MHV-68 MHV-76
Day 2 p.i. Day 4 p.i.
Figure 5.5. Activated NK cells in the MLN following infection with MHV-68 or MHV-76. Mice
were infected with 4 x 105 pfu of either MHV-68 or MHV-76. MLNs were harvested at day 2
and day 4 p.i. Lymphocytes were extracted and intracellular staining carried out with an
antibody to IFNy and surface staining with a NK cell specific antibody (DX5). Each data set
represents a combination of three individual repeat experiments, each with nine to eleven
data points per group, except the uninfected MLN data (represented by a black horizontal
line) which was analysed once. The median for each dataset is indicated by the centre line.
The first and third quartiles are shown by the edges of the box area. The extreme values are
indicated by the whiskers extending from the box.
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Cytotoxicity assays were carried out in order to address the question; are NK cells,
activated in response to MHV-68, capable of killing target cells? In the first instance,
chromium release was chosen as an indicator of target cell killing. The murine T cell
lymphoma cell line, Yac-1, was chosen as the target cells for these assays due to the
low level of MHC class I on the cell surface and therefore their susceptibility to NK
cell killing. C57BL/6 mice were infected intranasally with 4 x 105 pfu of MHV-68
and the MLNs harvested at day three post-infection. At least four MLNs were
required, and pooled, per experiment in order to get sufficient numbers of
lymphocytes for analysis. T-lymphocytes were removed from the lymphocyte
suspension by complement depletion to increase the chance of cell-cell contact
between NK cells and the Yac-1 target cells. FACS analysis was carried out on
aliquots of cells from the T lymphocyte-depleted and non-depleted fractions to
ensure elimination of CD3" cell populations. An example is shown in figure 5.6. For
each cytotoxicity assay, each sample was analysed in triplicate including a
spontaneous lysis control containing media only and a maximum lysis control
containing 5% Triton X detergent solution. However, although killing was detected
in the maximum lysis control samples, the data was not reproducible and there was
little or no specific lysis obtained in the MHV-68 infected samples. Numerous
attempts were made to increase the sensitivity and reproducibility of the assay. For
example, cells were pelleted gently prior to incubation to maximise cell contact, the
incubation period was increased from four to eight hours, cell numbers were
increased to optimise the effector/target ratios and the amount of chromium added to
cells was increased to aid uptake and thus sensitivity. Despite these measures,
chromium release from targets incubated with T-cell depleted lymphocytes never
rose above background levels. Similarly, a cytotoxicity assay was carried out to
investigate if CTL-killing of MHV-68 infected targets could be detected with this
assay. Lymphocytes from a MHV-68 infected (day 5 post-infection) mouse were
depleted ofNK cells by complement depletion. The Yac-1 target cells were infected
overnight with a MOI of 5 pfu/cell. This assay also failed to show detectable
cytotoxicity by CTLs. This correlates with observations from K. Robertson
(Robertson 1999) where T lymphocytes failed to kill MHV-68 infected targets. It
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Figure 5.6. Complement depletion of T lymphocytes. CD4+ and CD8+ T lymphocytes were
removed from a mixed lymphocyte population by incubation with complement and anti-CD4
(YTS 191) and anti-CD8 (YTS 169) antibodies for 1 hour. The efficiency of the depletions
were analysed by FACS analysis of untreated (A) or complement-depleted (B) lymphocytes.
The red histograms show B lymphocyte populations. The blue histograms show T
lymphocyte populations.
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may be that the Yac-1 cells were not infected properly, making them poor targets for
CTL killing. Infection of Yac-1 cells with MHV-68 expressing GFP (LHAGFP)
failed to result in detectable GFP when examined under a fluorescent microscope
thus suggesting that these cells are not readily infectable with MHV-68.
It was decided to change the detection method from chromium release to flow
cytometric analysis of NK cell specific lysis in order to increase assay sensitivity.
The principle of the flow-based assay is to label the effector cells with a non-toxic
fluorescent dye before co-incubation with the target cells for four hours. The mixed
cell population is then stained with a DNA dye such as propidium iodide to identify
dead cells and the populations analysed by flow cytometry.
Eight C57BL/6 mice were infected intranasally with 4 x 10s pfu of MHV-68. MLNs
were harvested at either day 2 or 3 post-infection and all eight pooled together per
experiment to get sufficient numbers of lymphocytes for analysis. The NK cell
population was enriched by MACS separation to raise the sensitivity of the assay and
increase the proportion of NK cells contacting the Yac-1 target cells. The NK cell
population was enriched from 3.18% in the unseparated lymphocytes to 87.35% in
the MACS-separated population (figure 5.7). Controls for spontaneous and
maximum lysis were included as per the chromium release assay and all samples
were analysed in triplicate. Poly EC has been shown to significantly upregulate NK
cell killing of K562 target cells (Pisegna et a/., 2004). It was therefore decided to
include poly EC stimulated NK cells as a positive control for the assay. NK cells
were isolated from a spleen taken from day 2 infected mice. Unfortunately, the
stimulated NK cell control did not give suitably high levels of killing. Although
unlikely, it is possible that NK cells could not be activated to a suitable level because
of immune evasion strategies employed by MHV-68 during infection, resulting in
NK cells remaining inactivated or activation being switched off. Perhaps a more
likely explanation is that the stimulation of NK cells requires more optimisation of
poly I:C concentration and incubation conditions. However, due to time restraints
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Figure 5.7. MACs enrichment of NK cells. Mice were infected with 4 x 10s pfu of MHV-68.
MLNs were harvested at day 3 p.i., pooled and lymphocytes extracted. A MACS NK cell
isolation kit was used to enrich the NK cell population for use in a cytotoxicity assay. An
aliquot of lymphocytes were taken pre-isolation (A) and an aliquot taken post-isolation (B) for
analysis by FACS. Cells were stained with a CD49b (DX5) antibody and analysed on a
FACScan.
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they were discarded as a positive control. The green fluorescent membrane dye,
DiOCi8, was chosen to label the effector cells (the NK cells) as it has been shown to
be stable and gives homogeneous staining (Piriou et al., 2000). The red fluorescent
DNA dye, propidium iodide, was used to detect dead cells. Each dye was titrated to
ensure optimal staining for the separate populations. Following co-incubation of the
effectors and targets, cells were analysed by flow cytometry. Single-stained aliquots
of effector and target cells were included for FACS analysis of each experiment to
ensure correct compensations and settings were being used. The gating strategy used
is shown in figure 5.8. Figure 5.9 shows results obtained from the fluorescence-based
cytotoxicity assay of Yac-1 cells by NK cells purified from MF1V-68 infected MLNs.
At an effector/target ratio of 2.5:1, there was mean specific lysis of 2.41%. This
increased to 5.93% at a ratio of 5:1 and 12.8% at a ratio of 10:1. This assay
demonstrates that NK cells activated during MHV-68 infection are capable of
cytotoxic killing of susceptible targets.
5.4. In vivo depletion of NK cells
Following analysis of the NK cell population and cytotoxicity post-infection it was
hypothesised that a lack of NK cells in vivo would render mice more susceptible to
gammaherpesvirus infection. NK cells were depleted by administration of an anti-
NK1.1 antibody in order to investigate their role during infection. This approach was
taken over the use of knockout mice due to the lack of a suitable model in which NK
cells were selectively and efficiently depleted. For example, beige mice carrying the
bg mutation (beige lysosomal trafficking regulator, chromosome 13) have
malfunctioning NK cell cytotoxicity but retain the ability to produce cytokines from
their NK cells. The mutation also affects the granules of other cell types so is not




Figure 5.8. Gating strategy for assessing NK cell cytotoxicity. The combined Yac-1 and NK
cells from the cytotoxicity assay plate were analysed by FACS analysis. Forward scatter
(FSC) was plotted against side scatter (SSC) and debris gated out in gate 1 (R1) as shown
in panel A. Gate 1 events were plotted on a SSC against DiOC18 fluorescence (FL1) dot plot
(B). Gate 2 (R2) was applied around the DiOC18-negative events (target cells). All events
corresponding to Gate 1 and 2 were displayed on a propidium iodide (FL3) histogram and
the marker, M1, was applied to dead cells as shown in panels C and D. Histograms for
spontaneous lysis (C) and maximum lysis (D) of Yac-1 cells are shown.
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Figure 5.9. Specific lysis of Yac-1 cells by MHV-68 stimulated NK cells. NK cells were
extracted from the MLNs of mice infected with 4 x 105 pfu of MHV-68 at day 3 p.i. NK cells
were mixed and incubated with Yac-1 target cells for 4 hours before specific lysis was
determined by FACS analysis. Data points represent the mean of three replicates and the
bars represent the standard error of the mean.
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An accepted method ofNK cell depletion is via the administration of an anti-NKl.l
antibody (Seaman et al., 1987). C57B1/6 mice were depleted of NK cells by
administration of PK136 on at least three occasions: day -2, -1 and +2 relative to the
day of infection (day 0). A second group were given matching doses of control serum
immunoglobulin. The efficiency of the NK cell depletions were examined by FACS
analysis of splenocytes from both the depleted and non-depleted groups using both
DX5 and biotinylated-PK136. This analysis was carried out at least twice each time
the experiment was performed and a representative result is shown in figure 5.10.
With each antibody investigated there was a small residual population that could not
be reduced with either increased doses of antibody nor increased frequency of
administration. As BALB/c mice do not express NK1.1 it was decided to use the
PK136 antibody to stain BALB/c lymphocytes and therefore investigate if the
residual PK136 staining was non-specific. Splenocytes from an untreated BALB/c
mouse were stained with an antibody to CD3 and either DX5 or PK136. The result is
shown in figure 5.11. These data show that 6.68% of splenocytes were DX5" while
1.93% of splenocytes stained positive for PK136. This suggests that there is a
considerable degree of non-specific staining when using the PK136 antibody.
Antibodies may lack specificity due to binding multiple cell types, binding a
common epitope on several proteins, binding through the Fc portion of the antibody
to non-specific receptors or by binding dead cells with disrupted membranes. As
DX5 exhibited a similar residual population it is possible that non-specific staining
was occurring through the binding of dead cells in lymphocyte preparations.
Erythrocytes are removed from the lymphocyte population by the relatively harsh
process of osmotic lysis which may also result in lysis of lymphocytes. This could be
minimised by separating the cell types by density gradient centrifugation. The non¬
specific staining of dead cells can be eliminated by gating out cells stained with a
DNA dye such as propidium iodide. The gentler treatment of cells and additional
staining step are recommended for future experiments of this type.
As well as investigating MHV-68, it was decided to look at a number of different
viruses to investigate the role of the left end of the viral genome and its interaction
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Figure 5.10. FACs analysis of in vivo NK cell depletions. In order to deplete NK cells in vivo,
C57BI/6 mice were treated with 200-500pg of NK1.1 antibody (PK136) (■). Control mice
were given matching doses of serum immunoglobulin (□). Antibody was injected
intraperitoneal^ on days -2, -1 and +2 relative to the day of infection (day 0) as denoted by
the red arrows (—»). Mice were infected intranasally with 4 x 10s pfu MHV-68 on day 0. The
efficiency of the depletion was analysed by FACS analysis of PK136+ (A) and DX5+ (B) NK
cells from both depleted and non-depleted mice at day 1 and 5 p.i. Data points represent the
percentage of NK cells ± the standard error of the mean.
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1
3
FL1 % FL2 %
CD3 & PK136 31.28 1.93
CD3& DX5 30.95 6.68
Figure 5.11. Analysis of PK136 antibody specificity. Splenocytes were extracted from a
Balb/c mouse and double stained with an antibody to CD3 (FL-1) and either an antibody to
DX5 (1) or PK136 (2) (FL-2). In both 1 and 2, (a) shows a dot plot for the splenocyte
population, (b) shows a FL-1 histogram for the proportion of CD3+ T cells and (c) shows a
FL-2 histogram for the proportion of DX5+ (1) or PK136+ (2) NK cells. Panel 3 shows a
summary table for the percentages of positive cells post-staining.
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with NK cells in vivo. The viruses used to study this in this system are shown in
figure 5.12. MHV-68 is the wild-type virus. It was hypothesised that the depletion of
NK cells may confer a replication advantage to MHV-76, thus compensating for the
lack of the genes and vtRNAs at the left end of the genome. Furthermore, it has been
postulated that the M4 gene may play a role in innate immune regulation as it is
expressed as an immediate-early/early transcript associated with productive infection
at early times post-infection and is not necessary for replication in vitro. M4.stop is a
M4 knockout virus, constructed using the MHV-68 bacterial artificial chromosome
(BAC), pHA3 (Adler et al., 2000). It contains a nonsense mutation at 8672bp within
the M4 region but retains the other genes and RNA species at the LHE. The wild-
type virus PHA4 was included as both it and the M4.Stop virus were derived by the
BAC system and contain a residual LoxP site left following Cre recombinase
excision of the BAC sequences (Geere et al., 2006).
NK cell depleted and non-depleted mice were infected intranasally with 4 x 103 pfu
of MHV-68, MHV-76 or M4.Stop. The first virus to be investigated was MHV-68.
Tissues were harvested at days 1, 2, 3 and 5 post-infection with four mice per group
per time point. Viral load was determined by quantitative PCR using primers specific
for sequences within the RTA gene. The results are shown in figure 5.13. There was
no difference in the viral load in the lung between depleted and non-depleted animals
at any time point investigated suggesting that NK cells do not influence acute
infection in the lung. Similarly, there were no significant differences in viral load in
the MLN between NK cell depleted and non-depleted mice. These data suggest that
NK cells do not play a significant role in clearance of virus from the lung. Virus
could be detected in the spleen by day 3 post-infection. There was no significant
difference between the groups suggesting that replication in the lung, virus
trafficking to the spleen or establishment of latency is not significantly controlled by
NK cells.
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Figure 5.12. Schematic diagram of the left-termini of the viruses used in this study. The
green rectangles denote the terminal repeats (TR). The unique genes, M1-M4, are labelled
in blue and the 8 viral tRNAs are denoted by a dashed line. ORF4, with a number of
homologues in several other herpesviruses, is shown in white. The remaining portion of the
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Figure 5.13. Infection of NK cell depleted mice with MHV-68. NK cells were depleted by
administration of an anti-NK 1.1 antibody (PK136) on days -2, -1 and +2 relative to the day of
infection. Mice were infected intranasally with 4 x 10s pfu of MHV-68 on day 0. NK cell
depleted mice are denoted by black squares (■) and control (non-depleted) mice by purple
squares (■). Tissues were harvested on days 1, 2, 3 & 5 p.i. using four mice per group per
time point. Viral load was determined in lung (A), MLN (B) and spleen (C) by real-time PCR
using primers specific for the viral gene, RTA. Viral DNA was quantified by amplification of
the RTA gene and normalised as determined by the level of (3-actin within each sample. The
mean viral load of each group is shown by a horizontal line. These results are representative
of two independent experiments for each tissue.
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The role of NK cells in the control of MHV-76 was also investigated. It was
expected that if a component of the left end of the virus genome was interacting with
NK cells, then the depletion of NK cells would confer a replication advantage to
MHV-76. Tissues were harvested at days 2, 3 and 4 post-infection with four mice per
group per time point. The results are shown in figure 5.14. Again, there was no
difference in the viral load in the lung between the depleted and non-depleted
animals at any time point investigated. Likewise, there were no significant
differences in viral load between the groups within the MLN or spleen. Figure 5.15
shows the data obtained when mice were infected with the M4.Stop virus or the
PHA4 control virus. Tissues were harvested at days 2, 3 and 4 post-infection with
four mice per group per time point. There was no significant difference in viral loads
between depleted and non-depleted groups at any time point investigated, nor in any
tissue. Also, there was no significant difference between the PHA4 control virus and
the M4.Stop virus load. Taken together, the results for the MHV-76 and M4.Stop
infected mice indicate that the left end of the MHV-68 genome does not play a role
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Chapter 5 Role ofNK cells
Figure 5.14. Infection of NK cell depleted mice with MHV-76. NK cells were depleted by
administration of an anti-NK1.1 antibody (PK136) on days -2, -1 and +2 relative to the day of
infection. Mice were infected intranasally with 4 x 10s pfu of MHV-76 on day 0. NK cell
depleted mice are denoted by black triangles (A) and control (non-depleted) mice by green
triangles (A). Tissues were harvested on days 2, 3 & 4 p.i. using four mice per group per
time point. Viral load was determined in lung (A), MLN (B) and spleen (C) by real-time PCR
using primers specific for the viral gene, RTA. Viral DNA was quantified by amplification of
the RTA gene and normalised as determined by the level of p-actin within each sample. The
mean viral load of each group is shown by a horizontal line. These results are representative
of two independent experiments for each tissue.
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Figure 5.15. Infection of NK cell depleted mice with M4.Stop or PHA4. NK cells were
depleted by administration of an anti-NK1.1 antibody (PK136) on days -2, -1 and +2 relative
to the day of infection. Mice were infected intranasally with 4 x 10s pfu of M4.Stop or PHA4
on day 0. NK cell depleted mice, infected with M4.Stop, are denoted by black circles (•),
control (non-depleted) mice, infected with M4.Stop, by orange circles (•) and control mice
infected with PHA4 by empty circles (o). Tissues were harvested on days 2, 3 & 4 p.i. using
four mice per group per time point. Viral load was determined in lung (A), MLN (B) and
spleen (C) by real-time PCR using primers specific for the viral gene, RTA. Viral DNA was
quantified by amplification of the RTA gene and normalised as determined by the level of (3-
actin within each sample. The mean viral load of each group is shown by a horizontal line.
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5.5. Discussion
NK cells have been shown to be critical for the control of several herpesvirus
infections where the presence of viral antigens results in their activation,
proliferation and accumulation at sites of infection. This study has focused on the
role of NK cells in the control of MHV-68 infection. An expansion of the NK cell
population in the MLN was observed at early time points. At day 2 post-infection,
NK cell levels had increased in response to MHV-68 in comparison to day 4 post¬
infection where levels had decreased. This could be due to decreasing numbers of
NK cells as the adaptive immune response is established or a smaller percentage of
NK cells in the MLN due to increased populations of other lymphocytes such as
CD8^ T cells. The expansion of NK cells observed could have been due to NK cell
proliferation within the MLN, accumulation of NK cells at this site or by a
combination of both. The level of NK cell activation was determined by means of
intracellular IFNy staining. These data show that a proportion of NK cells were
activated post-infection and that this level stayed relatively constant from day 2 to
day 4 post-infection. These data prove that the NK cell population was expanded and
activated in response to MHV-68 infection. During each experiment the role of
MHV-76 infection was investigated in parallel to MHV-68 to determine whether the
left end of the genome was responsible for regulation of the NK cell response. In
each case the results were similar for both viruses suggesting that there is no role for
the unique genes, M1-M4, in NK cell expansion and activation in the MLN.
Cytokines expressed early in infection such as IFNa/p and IL-12, are important in
shaping the NK cell response to infection. A study by Nguyen et al. has shown that
these cytokines take on quite separate roles during the NK cell response to MCMV.
IL-12 promotes IFNy production whereas IFNoc/p stimulates proliferation and
cytotoxicity (Nguyen et al., 2002). It would be of interest to determine if the NK cell
population expansion would still occur in IFNa/p receptor knockout mice and
whether this effect was IFNa/p dependent.
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The ability of activated NK cells from MHV-68 infected mice to kill target cells was
assessed by cytotoxicity assay. Initially, chromium release assays were carried out
but these assays did not prove to be sensitive enough to detect NK cell killing in the
samples. It may be that there was not sufficient cell-cell contact between NK cells
and their targets due to the presence of other lymphocyte populations in the effector
cell fraction. This effect was not improved by complement depletion of T
lymphocytes as the majority of remaining lymphocytes were B lymphocytes and
contact inhibition could still hinder NK cell cytotoxicity. Other optimisation
techniques also did not improve the sensitivity of the assay. It was decided to change
the detection of cytotoxicity from chromium release to fluorescence. A number of
studies have shown that fluorescence based cytotoxicity assays have a number of
benefits including increased sensitivity, safety and reduced background levels. A
fluorescence based cytotoxicity assay was developed to determine if the activated
NK cells from the MLNs of MHV-68 infected mice were capable of cytotoxic
killing. These results have shown that NK cells from the infected MLNs are capable
of killing susceptible cell targets. However, the level of killing was relatively low.
This was not unexpected as studies with perforin knockout mice show that a lack of
perforin has little effect on MHV-68 infection, thus suggesting that the cytotoxic
release by NK cells does not play a major role in the control of the virus (Usherwood
etal., 1997).
It would be interesting to further investigate the cytotoxic response by directly
infecting the target cells with MHV-68. It is possible that this would result in higher
killing of target cells due to the increased antigen available and down regulation of
MHC class I molecules. For example, infection of human foreskin fibroblast cells
with vaccinia virus results in increased susceptibility of targets to lysis by NK cells
(Chisholm and Reyburn 2006). Increased recognition was determined to be due to
changes in the target cell induced by the early gene products of vaccinia virus
infection and was dependent on the human natural cytotoxicity receptors NKp30,
NKp44 and NKp46. A similar outcome is possible for infection with MHV-68.
Conversely, MHV-68 infection of targets may reduce the level of killing observed
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through immune evasion strategies that are yet to be determined. MHV-68 may
employ NK cell evasion mechanisms, encoding proteins with similar functions to
those ofMCMV as discussed earlier. For example, the proteins K3 and K5 of KSHV
induce rapid down regulation of MHC class I molecules from the cell surface. This
would render cells susceptible to NK cell killing. However, K5 also down regulates
ICAM-1 and B7-2 which are ligands for NK cell activatory receptors. This results in
strong inhibition ofNK cell mediated killing (Ishido et al., 2000).
Given the important role forNK cells in other herpesvirus infections such as CMV it
was expected that NK cells would be important for the control ofMHV-68 infection.
However, these data show that NK cells do not play a major role in the control of
MHV-68 infection in vivo. Loss of NK cells did not affect viral load in the lung,
MLN or spleen at any time point investigated as there was no significant difference
between NK cell depleted and non-depleted mice. These data support previous
findings that NK cell-depletion had no effect on the control of MHV-68 during the
acute or latent stages of infection (Usherwood et al., 2005). This was surprising due
to the correlation between high NK cell numbers and lower viral loads during acute
EBV infection suggesting an important role during gammaherpesvirus infections. It
may be that the MHV-68 model underestimates the role for NK cells during human
infections with gammaherpesviruses. Similarly, it may be that NK cells contribute
more to counter infection in MHV-68's natural host, the wood mouse, than in inbred
laboratory strains of mice (Blasdell et al., 2003). A subtle role for NK cells during
MHV-68 infection can not be ruled out as the NK cells are expanded, activated and
are capable of killing susceptible targets post-infection. There is a great deal of
compensation within the immune system and it may be that a lack of NK cells is
efficiently compensated for during MHV-68 infection. It was expected that K3,
expressed by MHV-68 during infection to down regulate MHC class I from the cell
surface, would lead infected cells to be more susceptible to NK cell killing.
However, this did not appear to be the case, possibly due to further NK cell immune
evasion strategies. These data suggest that NK cells do not greatly influence the
outcome ofMHV-68 infection in vivo.
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The viruses MHV-76 and M4.Stop were investigated to determine if there was a role
for the unique genes at the left end of the MHV-68 genome in the manipulation of
the NK cell response. The M4 gene is an immediate early/early transcript, mainly
expressed during acute infection in vivo and has no role for replication in vitro. A M4
knock-in virus, MHV-76inM4, replicated to higher titres than MHV-76 at day 1 post¬
infection suggesting a possible immunoregulatory role for M4 during the innate
response (Townsley et al., 2004). However, the results show that there was no
difference in viral load between the NK cell depleted and non-depleted mice infected
with either MHV-76 or M4.Stop. From these data it has been concluded that the left
end ofMHV-68, including M4, is not involved in regulation of the NK cell response
in vivo as no difference in MHV-76 or M4.Stop viral load could be detected whether
in the presence or absence ofNK cells.
Overall, it can be concluded from these data that the NK cell population is expanded,
activated and is capable of cytotoxic killing at early time points following infection








The role of the innate immune system during gammaherpesvirus infection remains
relatively uncharacterised. Using MHV-68 as a useful small animal model, this study
was undertaken to answer the following questions concerning the role of the innate
immune system during a murine gammaherpesvirus infection:
1. What components of the type I IFN response are important in the innate
immune response to MHV-68 infection?
2. Does murine ISG12a play a role in the control ofMHV-68 infection?
3. Do natural killer cells contribute to MHV-68 control at early time points?
4. Do genes unique to MHV-68 (M1-M4) play a role in evasion of the innate
immune response?
This study has used in vitro assays and transgenic mice to increase understanding of
the type I IFN response to gammaherpesvirus infection. The induction of type I IFNs
was investigated in vitro by RT-PCR analysis. This is the first study to show that
MHV-68 infection leads to the induction of various type I IFN subtypes within the
first few hours of infection. IFNa4 and IFNp transcripts were detected first post¬
infection, followed by the expression of other IFNa subtypes (IFNnona4). This
result is supported by previous studies with other viruses in which IFNp and IFNa4
were found to be expressed very early post-infection, leading to the expression of
other IFNa subtypes by signalling through IRF7 (Marie et al., 1998). The
importance of this positive feedback loop during virus infection was demonstrated in
vivo by Prakash et al. (2005). IFNa production correlated with IRF7 production in
the lungs of mice following infection with influenza A virus. Furthermore, the levels
of IFNa were significantly reduced in STAT 1-deficient mice consistent with a role
for IRF7-mediated positive feedback.
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Analysis of MHV-68 replication in vitro was carried out in MEF cell lines deficient
in either IFNa/p receptor or IFNP, or in wt MEFs. A strong trend towards higher
titres of cell-free virus could be detected from cell lines lacking type I IFN compared
to titres of cell-free virus from the wt cell line. These studies suggest that type I IFNs
play a role in the inhibition of viral particle exit from the cell. It is postulated that the
differences observed between cell lines may be due to a lesser degree of 1SG
induction in the type I IFN deficient cell lines therefore allowing greater exit of
virions from the infected cell. The IFN-stimulated ubiquitin-like protein ISG15 has
been shown to be important during a number of viral infections. ISG15-deficient
mice are more susceptible to influenza A, influenza B, HSV-1 and Sindbis virus
infection (Lenschow et al., 2007). The addition of type I IFN to HIV-1 infected cells
has been shown to inhibit the assembly and release of virions from the cell. This
inhibition was due to the action of ISG15 as treatment of cells with ISG15 siRNA
reversed the IFN-mediated inhibition of HIV-1 release (Okumura et al., 2006).
ISG15-deficient mice are also more susceptible to MHV-68 infection. It may be
possible that ISG15 also plays a role in type I IFN-dependent inhibition of MHV-68
virion release. Determination of the role of ISG15 and other ISGs involved in
limiting MHV-68 release could be the subject of future study.
Previous studies have shown that the type I IFNs are crucial for the control of a wide
range of viruses including LCMV, SFV and vaccinia virus (Van Den Broek et al.,
1995). The type I IFNs have been shown to be an important defence against MHV-68
infection (Barton et al., 2005; Dutia et al., 1999). In this study, IFNP-deficient mice
were utilised to determine a role for IFNP specifically during MHV-68 infection.
IFNP was found to be important for the control of lytic infection. Virus titres in the
lungs of IFNP"7" mice were significantly higher during the peak of acute infection
(day 5 when infected with 4 x 105 pfu and day 7 when infected with 4 x 103 pfu) in
comparison to the viral titres in wt lungs. These data are supported by the results
observed in IFNa/p Rmice where lung titres were significantly higher than in wt
mice during acute infection (Dutia et al., 1999). However, at times other than the
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peak of acute infection, virus was cleared from the lung to a similar degree in both
IFNP"'" and wt mice suggesting that other immune components, such as IFNa, can
compensate for the lack of IFNp. There appeared to be a trend for higher viral titres
in the spleens of IFNP"'" mice compared to those of wt mice when groups were
infected with 4 x 103 pfu of MFIV-68. However, due to an outbreak of MHV
infection within the IFNP"'" stock, no further experiments could be carried out during
the course of this study. Therefore, future work is necessary to confirm differences in
the degree of latent MHV-68 infection established within the spleens of IFNP"" or wt
mice. It was expected that the lack of IFNP expression in these mice would have had
a greater effect on the titres of MHV-68 observed in the lung during the early stages
of infection. For example, IFNP"" mice infected with influenza A virus have
enhanced virus replication in the respiratory tract at 72 hours post-infection and show
more severe disease symptoms compared to wild type mice (Koerner et al., 2007).
Similarly, the importance of IFNp in the lung was shown during vaccinia virus
infection. IFNP" mice infected intranasally with vaccinia virus have significantly
elevated viral titres in the lung at day 5 post-infection and succumb to doses of virus
that are sublethal to wild type mice (Deonarain et al., 2000). On the other hand, in
mice surviving past day 5 post-infection, there was no significant difference in
vaccinia virus titres found between the spleens of IFNp"" and wild type mice
(Deonarain et al., 2000) suggesting that the adaptive immune response has
compensated for the lack of IFNP by this stage of infection. This may also be the
case for MHV-68 if no significant difference is found between the splenic titres of
IFNP"" and wild type mice in future repeats of this experiment. It is evident that
IFNP has a protective role during some but not all virus infections. For example,
there was no difference in the course of vesicular stomatits virus infection between
IFNP-deficient and wild type mice. The absence of IFN-B made no difference to the
level of IFNa produced within the first 6 hours of infection (Barchet et al., 2002).
Such observations correlate with the hypothesis that IFNa can compensate for the




The functions of particular ISGs during viral infection are currently being elucidated.
This study focused on the role of ISG12a following MHV-68 infection. A MEF cell
line was established from an ISG12a knockout mouse to investigate lSG12a function
in vitro. One step growth curves were carried out in ISG12a knockout and wt cell
lines as it was hypothesised that the nuclear localisation of ISG12a may be important
for the regulation of MHV-68 particle release during replication. A lack of ISG12a
would possibly lead to increased release of virus particles and therefore elevated
viral titres. However, there was no consistent trend observed in cell-free, cell-
associated or combined virus titres between the ISG12a knockout and wt MEFs at
any time point investigated. These results indicate that ISG12a is not playing a major
role in the regulation of MHV-68 release so is not having a major effect on the
resultant viral titres in vitro. Mice lacking ISG12a were utilised to study the role of
ISG12a in vivo. No difference in viral titres was observed in the lungs or MLNs
between lSG12a knockout and wt mice. MHV-68 titres and the degree of
splenomegaly were increased in the spleens of ISG12a knockout mice compared to
wt spleens showing that ISG12a plays a role in the early stages of the establishment
of latency following MHV-68 infection. Further characterisation of ISG12a
expression is required to determine the mechanism by which the establishment of
latency is affected. In addition to playing a role during MHV-68 infection of the
spleen, ISG12 has also been shown to play a protective role during neurotropic viral
infection. Upregulation of ISG12 expression in the brains of Sindbis virus infected
neonatal mice correlated with increased survival times (Labrada et al., 2002). It may
be that ISG12 plays an important protective role against a diverse range of viruses
but this is yet to be studied.
The third aim of this study was to determine the role of NK cells during the early
stages of a gammaherpesvirus infection. This study used FACS analysis and
intracellular staining to show that the NK cell population in the MLN was expanded
at day 2 compared to day 4 post-infection and was able to produce IFNy in response
to MHV-68 infection during the early stages of infection. The early production of
IFNy from NK cells, prior to the activation of T cells, is important for the early
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control of infection. For example, mice are more susceptible to HSV-1 infection
when the IFNy-producing capacity of NK cells is impaired (Liu et al., 2004).
Cytotoxicity assays were used to show that MLN-derived NK cells, which are
activated in response to MHV-68 infection, were capable of killing susceptible
targets. The cytotoxic activity of NK cells is vital for the control of many viral
infections. For example, higher numbers of NK cells expressing cytotoxic markers
during acute Dengue virus infection correlate with milder disease symptoms
(Azeredo et al., 2006). Perforin-mediated cytotoxicity was shown to be important for
controlling MCMV replication in the livers and spleens of MCMV-infected mice
thus demonstrating the importance of cytotoxicity for controlling certain viral
infections (Loh et al., 2005). However, perforin-mediated cytotoxicity does not
appear to be crucial for the control ofMHV-68. Perforin-deficient mice could control
MHV-68 infection to the same extent as wild type mice (Usherwood et al., 1997).
This correlates with the relatively low level of cytotoxic response observed from
MHV-68-activated NK cells in this study. Similarly, a lack of NK cell-mediated
cytotoxicity did not affect the control ofHSV-1 infection (Halford et al., 2005).
Given the fact that the NK cell population is expanded and activated during MHV-68
infection, the role of NK cells was investigated in vivo. As there is no strain of
transgenic mice in which NK cell activities are specifically and selectively deficient,
NK cells were depleted by administration of an anti-NK cell antibody. It was found
that a lack of NK cells in vivo did not result in significantly elevated virus titres in
the lung, MLN or spleen, suggesting that NK cells are not essential for the control of
MHV-68 infection. Such a result was surprising given the important role for NK
cells in other virus infections such as CMV. Depletion of NK cells expressing the
activatory receptor Ly49H results in up to 1000-fold higher MCMV titres in the
spleens, but only 5-fold higher titres in the livers, of depleted mice compared to non-
depleted mice (Daniels et al., 2001). However, no difference in virus titres between
NK cell-depleted and non-depleted animals was observed in any tissue investigated.
Infection of IL-18-deficient mice displayed a reduced level of IFNy production and
low NK cell cytotoxicity in the lung during the first few days of influenza A virus
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infection. The reduced NK cell responses in the lungs of these mice resulted in
increased mortality rates (Liu et al., 2004). It was expected that depletion ofNK cells
would result in higher MHV-68 titres in the lung at early time points during acute
infection. Such is true for other herpesvirus infections. Following intranasal infection
of mice with HSV-1, NK cell numbers increase in the lung and produce IFNy.
Furthermore, depletion of NK cells resulted in increased virus titres in the lung
(Reading et al., 2006). This was not the case for MHV-68 infection. A lack of a role
for NK cells is supported by the findings of Usherwood et al., (2005) whereby NK
cell-depletion had no effect on the control of MHV-68 during the acute or latent
stages of infection. A subtle role for NK cells during MHV-68 infection can not be
ruled out as the NK cells are expanded, activated and are capable of killing
susceptible targets post-infection. It may be that NK cells contribute more to control
ofMHV-68 infection in the natural host, the wood mouse, than in inbred laboratory
strains of mice. Besides, the MHV-68 model may underestimate the role ofNK cells
during human gammaherpesvirus infections as studies have shown an important role
for NK cells during acute EBV infection. The proportion of NK cells with an
activated phenotype was significantly higher in patients with acute infection and
increased NK cell numbers correlated with decreased EBV titres. This study
therefore suggests an important role for NK cells in dictating the outcome of human
gammaherpesvirus infection (Williams et al., 2005).
MHV-76 is a deletion mutant of MHV-68, lacking four genes (M1-M4) and eight
vtRNAs unique to MHV-68 and present at the left hand end of the genome. The left
end of the genome is thought to play a role in pathogenesis as MHV-76 is attenuated
in vivo (Macrae et al., 2001). The ability ofMHV-68 or MHV-76 to replicate in the
absence of either IFNp or NK cells was examined during this investigation in order
to determine a possible immunoregulatory role for the left end ofMHV-68 during the
innate immune response. However, this study found no difference in the induction of
type I IFN response in vitro following infection with either MHV-68 or MHV-76.
Additionally, IFNP knockout mice could control MHV-76 infection in vivo to the
same extent as wild type mice. These results suggest that M1-M4 and the 8 vtRNAs
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do not play an extensive role in the regulation of the type I IFN response. Similar
conclusions can be drawn concerning the regulation NK cells. No difference was
observed between MHV-68 or MHV-76 infection in the expansion or activation of
NK cells in the MLN or during in vivo infection of NK cell-depleted and non-
depleted mice. It was therefore concluded that the genes M1-M4 and the 8 vtRNAs
do not play a major role in the regulation ofNK cells following MHV-68 infection.
Overall, this study has shown that the innate immune system is important for the
control of gammaherpesvirus infections. It does appear that innate immune
components vary in their significance during the early stages of infection. For
example, a lack of IFNP results in greater viral titres in the lung at early time points
post-infection in comparison to wild-type mice. However, mice lacking NK cells
could control MHV-68 infection as well as wild-type mice. Given the redundancy
and complexity of the immune response a subtle role for NK cells can not be ruled
out. In addition, NK cells may be more important during human gammaherpesvirus
infections than during murine gammaherpesvirus infections.
It would be interesting to look at the effects of a lack of IFNp on NK cell function in
the IFNP" " mouse. Type I IFN can stimulate NK cell proliferation and cytotoxicity
(Nguyen et al., 2002) so a lack of IFNP may result in decreased NK cell responses
and proliferation and thus illustrate the importance of IFNP for development of
downstream responses. Furthermore, depletion ofNK cells in the IFNp"7" mouse may
reveal a more crucial role for NK cells during MHV-68 infection whereby reduced
type I IFN responses cannot compensate for NK cell-depletion.
The role of ISG 12(a) during the establishment of latency would be an interesting
topic of future work with a number of avenues to investigate. Firstly, ISG 12(a) might
have a role involving interaction with latency-associated viral antigens in the spleen
during latent infection. Infection of np27"" mice with viruses lacking various latency-
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associated genes, such as an ORF73-deletion mutant of MHV-68, or comparison of
viral gene expression in np27"'~and wild-type mice would be useful for investigating
this possibility. Alternatively, ISG12 expression in the spleen may be important for
control of infection in a specific cell population such as DCs, leading to a less
effective splenic DC response and therefore increased MHV-68 replication and/or
increased expansion ofMHV-68 infected B cells in the spleen. It would be of interest
to carry out immunostaining to determine if cell populations differed between
knockout and wild-type mice. Also, analysis of responses downstream of DCs such
as IL-12 and type I IFN production would help to determine if DC function was
significantly affected by a lack of ISG 12(a) expression.
Although components of the left end of the MHV-68 genome have been suggested to
be involved in immune regulation this study did not find any role for the genes Ml-
M4 or the vtRNAs in the modulation of either the IFN(3 or NK cell response.
However, further analysis of the downstream responses from IFNP and NK cells may
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